"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL1940668";"";"None";"576.66";"2";"5.17";"B-1";"O=C(Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1ccccc1";"Ki";"'='";"2510.0";"nM";"5.60";"";"";"UO_0000065";"9.71";"0.19";"0.43";"3.80";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1940671";"";"None";"594.65";"2";"5.31";"B-4";"O=C(Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1ccc(F)cc1";"Ki";"'='";"1940.0";"nM";"5.71";"";"";"UO_0000065";"9.61";"0.19";"0.40";"3.87";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1940679";"";"None";"606.68";"2";"5.18";"B-12";"COc1ccc(C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)cc1";"Ki";"'='";"1270.0";"nM";"5.90";"";"";"UO_0000065";"9.72";"0.19";"0.72";"3.76";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3401801";"";"None";"698.09";"2";"7.09";"15";"O=C(NS(=O)(=O)c1ccccc1)[C@H](Cc1ccc(Br)cc1)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)cc3)cc2)SC1=S";"Ki";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"9.18";"0.21";"-0.68";"7.67";"0";"CHEMBL3405856";"Inhibition of Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence polarization technique";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399977";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3699068";"";"None";"966.12";"3";"7.21";"BDBM139042";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1cccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"12.0";"nM";"7.92";"";"273176";"UO_0000065";"8.20";"0.17";"0.71";"4.40";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL385104";"";"None";"716.89";"2";"5.20";"20";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C(=O)c4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL510828";"";"None";"570.49";"1";"4.86";"ent-14f";"O=C([C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@@H]2N1Cc1ccc(Cl)c(Cl)c1)N1CCC(c2ccc(F)cc2)CC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3401826";"";"None";"598.77";"2";"5.98";"WL-276";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)/C(=C/c3ccc(-c4ccccc4)cc3)SC2=S)cc1";"Ki";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"10.32";"0.21";"0.20";"7.40";"1";"CHEMBL3632440";"Competitive binding affinity to Bcl-XL (unknown origin) preincubated for 30 mins followed by 5-FAM-Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627718";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL538895";"";"None";"718.93";"2";"5.17";"5";"CC(=O)OC[C@]1(C)[C@@H](OC(C)=O)C[C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@]2(C)[C@H]3CC=C4[C@H]5C[C@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"Ki";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"7.15";"0.14";"-0.03";"3.04";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL3735206";"";"None";"828.14";"2";"6.67";"21";"CC(C)(C)OC(=O)N1C[C@@H](Oc2ccc(-c3ccccc3)cc2)C[C@H]1C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"6.83";"0.15";"-1.01";"3.25";"0";"CHEMBL3736963";"Competitive binding affinity to Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 peptide preincubated for 30 mins before 5-FAM-Bid-BH3 peptide addition and measured 20 mins after 5-FAM-Bid-BH3 peptide addition by fluorescence polarization assayy";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734725";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL449695";"";"None";"630.21";"2";"5.06";"ent-13c";"O=C(NCCCN1CCCC1)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"8.11";"0.16";"0.05";"5.63";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL506360";"";"None";"577.11";"1";"4.22";"ent-13d";"COCCNC(=O)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2314504";"";"None";"359.43";"1";"5.04";"57";"Cn1c(C(=O)O)c(CCCOc2cccc3ccccc23)c2ccccc21";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314523";"";"None";"226.68";"0";"3.56";"5";"Cc1ccc2c(Cl)c(C(=O)O)sc2c1";"Ki";"'='";"230000.0";"nM";"3.64";"";"";"UO_0000065";"16.05";"0.35";"0.08";"9.75";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL502454";"";"None";"577.11";"1";"4.22";"13d";"COCCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL501763";"";"None";"630.21";"2";"5.06";"13c";"O=C(NCCCN1CCCC1)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"8.32";"0.16";"0.18";"5.78";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2314177";"";"None";"396.89";"1";"6.42";"64";"O=C(O)c1sc2cc(Cl)ccc2c1CCCOc1cccc2ccccc12";"Ki";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"13.02";"0.26";"-1.25";"11.11";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3704822";"";"None";"614.65";"3";"7.36";"BI79D10";"Cc1cc2c(C(=O)Cc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)Cc3ccccc3)c(O)c(O)cc2c1O";"Ki";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"10.94";"0.20";"-0.64";"4.32";"0";"CHEMBL4398462";"Inhibition of Flu-BakBH3 peptide binding to GST-tagged Bcl-xL (unknown origin) preincubated for 10 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4632892";"";"None";"284.40";"0";"4.94";"(+)-1";"CC(C)=CCCC1=CC[C@H](C(=O)O)[C@@H](c2ccccc2)C1";"Ki";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"18.44";"0.34";"0.30";"14.06";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL375841";"";"None";"766.39";"2";"7.12";"8h";"COC1(Cc2ccc(Cl)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"11.80";"0.24";"1.93";"6.74";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL221854";"";"None";"770.90";"2";"6.58";"23j";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL28137";"";"None";"434.58";"0";"4.05";"3";"COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C";"Ki";"'='";"781.0";"nM";"6.11";"";"";"UO_0000065";"14.05";"0.27";"2.06";"7.19";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1683280";"";"None";"410.53";"0";"3.78";"21";"c1ccc(Cc2cnc(N3CCN(Cc4ccccc4-c4cn[nH]c4)CC3)nc2)cc1";"Ki";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"16.80";"0.30";"3.12";"11.32";"0";"CHEMBL1686334";"Binding affinity to Bcl-xL after 2 hrs by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681673";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4176314";"";"None";"578.06";"2";"7.04";"8e";"CC(=O)c1ccc(NC(=O)OCC[C@@H]2C=C[C@]3(C(=O)O)[C@@H](CC(C)=C[C@H]3/C=C(\Cl)c3ccc(C(=O)O)cc3)C2)cc1";"Ki";"'='";"1910.0";"nM";"5.72";"";"";"UO_0000065";"9.89";"0.19";"-1.32";"4.40";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4160437";"";"None";"702.20";"3";"6.43";"18b";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CCn4cc(Cc5ccccc5)nn4)C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL221218";"";"None";"711.95";"2";"6.66";"8b";"COC1(CC(C)(C)C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"11.71";"0.23";"1.68";"6.22";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376254";"";"None";"767.90";"2";"7.94";"10e";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374214";"";"None";"734.34";"2";"7.58";"10d";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL384217";"";"None";"809.03";"3";"7.24";"23l";"COc1cccc(-c2ccccc2CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN(C)C)CSc5ccccc5)c([N+](=O)[O-])c4)cc3)CC2)c1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374941";"";"None";"700.89";"2";"6.32";"10j";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4cccnc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"12.68";"0.25";"2.57";"6.45";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL375299";"";"None";"788.01";"3";"5.40";"23g";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4N4CCOCC4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3935328";"";"None";"600.70";"2";"6.42";"10";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1";"Ki";"'='";"0.027";"nM";"10.57";"";"";"UO_0000065";"17.59";"0.33";"4.15";"9.33";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL376696";"";"None";"786.98";"3";"5.98";"18";"CC1OC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN(C)C)CSc5ccccc5)c([N+](=O)[O-])c4)cc3)CC2)N(Cc2ccccc2)C1=O";"Ki";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"10.71";"0.21";"2.45";"5.46";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL386955";"";"None";"756.95";"3";"6.60";"14b";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC4(CC3)CC(Cc3ccccc3)=NO4)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"11.59";"0.23";"2.17";"5.99";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374271";"";"None";"737.99";"2";"7.19";"8d";"COC1(CC2CCCCC2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"12.33";"0.24";"1.91";"6.78";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL387141";"";"None";"596.78";"2";"6.32";"1b";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NC(C)(C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"15.24";"0.30";"2.78";"7.48";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4741554";"";"None";"463.40";"1";"6.57";"S1-11";"CCCCNC1=C(C#N)C(=O)c2cccc3c(Sc4ccc(Br)cc4)ccc1c23";"Ki";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"13.51";"0.29";"-0.31";"11.84";"0";"CHEMBL4705651";"Inhibition of FAM-Bim peptide binding to Bcl-xl (unknown origin) measured after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699647";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"MODULATOR";""
"CHEMBL3628078";"";"None";"573.43";"2";"5.97";"42";"O=C(O)c1ccc(COc2ccc(/C=C3\SC(=S)N(c4ccc(I)cc4)C3=O)cc2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL28478";"";"None";"504.63";"2";"6.12";"9";"CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1Oc1cccc2ccccc12)C(=O)O";"Ki";"'='";"7631.0";"nM";"5.12";"";"";"UO_0000065";"10.14";"0.19";"-1.00";"5.33";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL3401826";"";"None";"598.77";"2";"5.98";"4, WL-276";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)/C(=C/c3ccc(-c4ccccc4)cc3)SC2=S)cc1";"Ki";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"10.43";"0.21";"0.26";"7.47";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3426334";"";"None";"434.32";"1";"5.67";"35";"Cc1cc(OCCCc2c(C(=O)O)n3c4c(c(Cl)ccc24)OCC3)cc(C)c1Cl";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL370837";"";"None";"804.00";"3";"5.95";"83";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL378820";"";"None";"681.88";"2";"5.64";"77S";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"10.45";"0.21";"1.48";"5.31";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL198903";"";"None";"681.88";"2";"5.64";"77R";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"13.14";"0.26";"3.32";"6.68";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL370835";"";"None";"667.90";"2";"6.64";"75";"CN(C)CCCC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"13.36";"0.26";"2.28";"7.14";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL380433";"";"None";"648.81";"2";"6.09";"66";"COc1cc(CCCN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"10.75";"0.21";"0.88";"5.33";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL382648";"";"None";"775.99";"3";"6.57";"80";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"9.21";"0.18";"0.58";"4.99";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL383229";"";"None";"568.72";"2";"5.54";"72";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"652.0";"nM";"6.19";"";"";"UO_0000065";"10.88";"0.22";"0.65";"5.08";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL382018";"";"None";"662.79";"2";"5.61";"67";"COc1cc(CCC(=O)N(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.05";"0.18";"0.39";"4.06";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2374449";"";"None";"372.57";"1";"6.47";"1, HA14-1";"CCSCCCCC(c1ccc(O)cc1)C(C)(CC)c1ccc(O)cc1";"Ki";"'='";"58900.0";"nM";"4.23";"";"";"UO_0000065";"11.35";"0.22";"-2.24";"10.45";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4638032";"";"None";"389.54";"1";"6.50";"(+)-4h";"COc1ccc(NC(=O)[C@H]2CC=C(CCC=C(C)C)C[C@@H]2c2ccccc2)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4636501";"";"None";"299.41";"0";"4.36";"(+)-4c";"CC(C)=CCCC1=CC[C@H](C(=O)NO)[C@@H](c2ccccc2)C1";"Ki";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"15.77";"0.29";"0.36";"9.57";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4648345";"";"None";"355.48";"0";"4.44";"(-)-4i";"CC(C)=CCCC1=CC[C@@H](C(=O)NCCC(=O)O)[C@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3342190";"";"None";"688.80";"3";"6.41";"8";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3cccc(-n4ncc5cncnc54)c3)s1)CC2";"Ki";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"13.75";"0.26";"3.06";"6.39";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342189";"";"None";"674.77";"3";"6.02";"7";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCOc3cccc(-n4ncc5cncnc54)c3)s1)CC2";"Ki";"'='";"2.22";"nM";"8.65";"";"";"UO_0000065";"12.82";"0.25";"2.63";"5.84";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342192";"";"None";"688.80";"3";"6.41";"10";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"Ki";"'='";"0.042";"nM";"10.38";"";"";"UO_0000065";"15.06";"0.29";"3.97";"7.00";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1269012";"";"None";"756.81";"3";"5.67";"8c";"CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c2C(=O)C(C)=C(C2=C(C)C(=O)c4c(cc(O)c(O)c4C(=O)NCCc4ccc(CC)cc4)C2=O)C3=O)cc1";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"8.98";"0.17";"1.13";"3.28";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL4448439";"";"None";"315.35";"0";"2.95";"5a";"C[C@@H](Nc1ncnc2scc(-c3cccc(O)c3)c12)C(=O)O";"Ki";"'='";"287000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL376410";"";"None";"847.00";"2";"8.25";"23r";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(C(F)(F)F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL218408";"";"None";"813.45";"2";"7.88";"23o";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4cccc(Cl)c4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL218524";"";"None";"813.45";"2";"7.88";"23n";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccccc4Cl)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376409";"";"None";"855.10";"2";"8.89";"23p";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(-c5ccccc5)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"10.53";"0.20";"0.11";"7.02";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4450255";"";"None";"513.59";"2";"6.96";"3d";"CCc1sc2ncnc(N[C@@H](Cc3ccccc3)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"9.24";"0.18";"-2.22";"5.63";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3972984";"";"None";"586.68";"2";"6.12";"6";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.296";"nM";"9.53";"";"";"UO_0000065";"16.24";"0.30";"3.41";"8.41";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL268908";"";"None";"761.97";"3";"6.47";"8k";"COc1ccccc1CC1(OC)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"11.76";"0.23";"2.49";"6.25";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"1a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"14.22";"0.28";"3.24";"7.28";"1";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"2.58";"None";"None";"None";"0";"CHEMBL1921344";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 R100E mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"R100E";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"2.46";"None";"None";"None";"0";"CHEMBL1921345";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y101H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"2.69";"None";"None";"None";"0";"CHEMBL1921530";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"2.61";"None";"None";"None";"0";"CHEMBL1921628";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"V141A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"2.45";"None";"None";"None";"0";"CHEMBL1921630";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142T";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"3.01";"None";"None";"None";"0";"CHEMBL1921631";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y195F";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921342";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E96G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921344";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 R100E mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"R100E";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL221854";"";"None";"770.90";"2";"6.58";"3";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"8.69";"0.17";"0.12";"5.23";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1269110";"";"None";"655.49";"2";"7.09";"6l";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccc(Cl)cc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccc(Cl)cc3)c2C1=O";"Ki";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"10.62";"0.21";"-0.13";"4.66";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL375842";"";"None";"749.93";"2";"6.61";"8i";"COC1(Cc2ccccc2F)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"12.06";"0.24";"2.44";"6.74";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3401826";"";"None";"598.77";"2";"5.98";"WL-276";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)/C(=C/c3ccc(-c4ccccc4)cc3)SC2=S)cc1";"Ki";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"9.89";"0.20";"-0.06";"7.09";"0";"CHEMBL4046938";"Inhibition of 5-FAM-Bid-BH3 peptide binding to Bcl-XL (unknown origin) pre-incubated for 30 mins followed by further incubation with 5-FAM-Bid-BH3 peptide for 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043209";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3962531";"";"None";"879.50";"None";"None";"18";"CC(C)(C)OC(=O)N1C[C@@H](Oc2ccc(-c3ccccc3)cc2)C[C@H]1C(=O)N[C@@H](Cc1ccc(O[Si](C)(C)C(C)(C)C)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"6.69";"None";"None";"None";"0";"CHEMBL3871750";"Inhibition of 5-FAM-DMRPEIWIAQELRRIGDEFNAYYARR binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by FAM-labeled peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871281";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL539908";"";"None";"620.82";"2";"3.64";"7";"C[C@@H]1O[C@@H](OC[C@@H]2[C@@H](O)C[C@H](O)[C@]3(C)[C@H]4CC=C5[C@H]6C[C@](C)(C(=O)O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@@H]23)[C@H](O)[C@H](O)[C@H]1O";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"gossypol";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.57";"0.22";"-0.38";"3.86";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3401817";"";"None";"753.63";"2";"6.25";"31";"O=C(NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)[C@H](Cc1ccc(Br)cc1)N1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)cc2)SC1=S";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL3405856";"Inhibition of Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence polarization technique";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399977";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3401800";"";"None";"708.64";"2";"6.34";"14";"O=C(NS(=O)(=O)c1ccccc1)[C@H](Cc1ccc(Br)cc1)N1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)cc2)SC1=S";"Ki";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"8.84";"0.19";"-0.07";"4.95";"0";"CHEMBL3405856";"Inhibition of Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence polarization technique";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399977";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL286715";"";"None";"420.55";"0";"3.96";"4";"CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C)C(=O)O";"Ki";"'='";"839.0";"nM";"6.08";"";"";"UO_0000065";"14.45";"0.28";"2.12";"6.33";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"8.02";"0.16";"-1.36";"5.09";"0";"CHEMBL1921062";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"F97V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"8.35";"0.17";"-1.08";"5.30";"0";"CHEMBL1921063";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 R100E mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"R100E";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"8.26";"0.16";"-1.16";"5.25";"1";"CHEMBL1921242";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"V141A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916193";"";"None";"812.98";"2";"7.60";"7";"CC(C)[C@H]1CN(Cc2ccccc2C(F)(F)F)CCN1c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"10.43";"0.21";"0.88";"6.62";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916194";"";"None";"812.98";"2";"7.60";"8";"CC(C)[C@@H]1CN(Cc2ccccc2C(F)(F)F)CCN1c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"9.07";"0.18";"-0.22";"5.76";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"2.34";"None";"None";"None";"0";"CHEMBL1921345";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y101H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL1921347";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"2.78";"None";"None";"None";"0";"CHEMBL1921631";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y195F";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921345";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y101H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921529";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL437148";"";"None";"781.00";"2";"4.96";"23e";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4S(C)(=O)=O)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"11.58";"0.23";"4.09";"5.57";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2188678";"Binding affinity to Bcl-XL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176946";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL370836";"";"None";"639.84";"2";"6.04";"76";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCCCN)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"14.07";"0.28";"2.96";"6.09";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL383229";"";"None";"568.72";"2";"5.54";"72";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"13.58";"0.27";"2.18";"6.35";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL370837";"";"None";"804.00";"3";"5.95";"83";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"4h, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"14.22";"0.28";"3.24";"7.28";"1";"CHEMBL1274437";"Binding affinity to Bcl-xl";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268954";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL312607";"";"None";"178.21";"0";"2.60";"1";"O=C(O)c1cc2ccccc2s1";"Ki";"'='";"230000.0";"nM";"3.64";"";"";"UO_0000065";"20.42";"0.41";"1.04";"9.75";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3426329";"";"None";"415.94";"1";"5.73";"30";"Cc1cc(OCCCc2c(C(=O)O)n3c4c(cccc24)SCC3)cc(C)c1Cl";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"3.32";"None";"None";"None";"0";"CHEMBL1921340";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"2.15";"None";"None";"None";"0";"CHEMBL1921630";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142T";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1940678";"";"None";"655.55";"2";"5.93";"B-11";"O=C(Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1ccc(Br)cc1";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"8.88";"0.19";"-0.11";"3.95";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"2.88";"None";"None";"None";"0";"CHEMBL1921632";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"G196A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL202798";"";"None";"761.97";"3";"6.18";"79R";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL202798";"";"None";"761.97";"3";"6.18";"79R";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"8.96";"0.18";"0.65";"4.76";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3342196";"";"None";"844.04";"3";"6.46";"14";"CN1CCN(CCCNc2ncnc3c2cnn3-c2ccc(OCCCc3sc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cc2)CC1";"Ki";"'='";"0.03";"nM";"10.52";"";"";"UO_0000065";"12.47";"0.24";"4.06";"6.31";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL221854";"";"None";"770.90";"2";"6.58";"3";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"10.97";"0.22";"1.88";"6.60";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3417400";"";"None";"419.51";"0";"4.36";"6";"CCOc1ccccc1CC(=O)C1C(=O)N(c2nc(-c3ccccc3)cs2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL379895";"";"None";"639.84";"2";"5.86";"73S";"CN(C)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"252.0";"nM";"6.60";"";"";"UO_0000065";"10.31";"0.20";"0.74";"5.28";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL204822";"";"None";"690.84";"2";"5.86";"68";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"7.77";"0.15";"-0.49";"3.83";"0";"CHEMBL859055";"Binding affinity to Bcl-XL in 10% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3417407";"";"None";"456.55";"1";"5.77";"13";"CCOc1ccccc1N/N=C1\C(=O)N(c2cc(O)cc(-c3ccc(C(C)C)cc3)c2)N=C1C";"Ki";"'='";"15500.0";"nM";"4.81";"";"";"UO_0000065";"10.53";"0.19";"-0.96";"5.56";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4544703";"";"None";"854.72";"3";"7.09";"8m";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccc(OCc3cccc(C#N)c3)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3401826";"";"None";"598.77";"2";"5.98";"WL-276";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)/C(=C/c3ccc(-c4ccccc4)cc3)SC2=S)cc1";"Ki";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL605114";"";"None";"506.61";"1";"4.66";"6";"COc1cccc(-c2ccc(/C=C3\SC(=S)N([C@@H](Cc4ccccc4)C(=O)O)C3=O)cn2)c1OC";"Ki";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"10.72";"0.21";"0.77";"6.11";"0";"CHEMBL1064400";"Displacement of fluorescein-labeled Bak-BH3 peptide from human Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157603";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3417401";"";"None";"433.49";"0";"4.00";"7";"CCOc1ccccc1C(=O)C(=O)C1C(=O)N(c2nc(-c3ccccc3)cs2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3793424";"";"None";"658.83";"2";"7.59";"33; A-1331852";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC12CC3CC(CC(C3)C1)C2";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3795380";"Binding affinity to Bcl-XL (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3792281";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3342193";"";"None";"702.82";"3";"6.80";"11";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"11.81";"0.23";"1.50";"5.60";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3358689";"";"None";"384.90";"1";"5.90";"I3";"O=C(CC(Cc1ccc(Cl)cc1)C(=O)O)c1ccc(C2CCCCC2)cc1";"Ki";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"13.11";"0.26";"-0.85";"9.28";"0";"CHEMBL3383564";"Reversible inhibition of human recombinant N-terminal His-tagged Bcl-xL (1 to 209) expressed in Escherichia coli BL21(DE3) after 30 to 120 mins by TR-FRET assay in presence of F-bid";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL380502";"";"None";"653.87";"2";"6.25";"74";"CN(C)CCC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"13.13";"0.26";"2.34";"6.87";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL434952";"";"None";"621.74";"2";"5.52";"70";"COc1cc(CCCO)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"2960.0";"nM";"5.53";"";"";"UO_0000065";"8.89";"0.18";"0.01";"3.74";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3417701";"";"None";"821.01";"3";"6.21";"30b";"Cc1nn(C)c(COc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)n(CCN3CCOCC3)c12";"Ki";"'>'";"660.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417963";"Displacement of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide) from BCL-XL (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414447";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1916190";"";"None";"784.93";"2";"6.97";"4";"C[C@H]1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CCN1Cc1ccccc1C(F)(F)F";"Ki";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"8.92";"0.18";"0.03";"5.47";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916191";"";"None";"784.93";"2";"6.97";"5";"C[C@@H]1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CCN1Cc1ccccc1C(F)(F)F";"Ki";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"9.03";"0.18";"0.12";"5.53";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"2.37";"None";"None";"None";"0";"CHEMBL1921346";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E129H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921629";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"2.46";"None";"None";"None";"0";"CHEMBL1921630";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142T";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"2.20";"None";"None";"None";"0";"CHEMBL1921343";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"F97V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"2.11";"None";"None";"None";"0";"CHEMBL1921346";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E129H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"2.51";"None";"None";"None";"0";"CHEMBL1921631";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y195F";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"2.44";"None";"None";"None";"0";"CHEMBL1921342";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E96G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"2.86";"None";"None";"None";"0";"CHEMBL1921343";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"F97V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"2.44";"None";"None";"None";"0";"CHEMBL1921347";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"2.85";"None";"None";"None";"0";"CHEMBL1921629";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4147763";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145520";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"2.65";"None";"None";"None";"0";"CHEMBL1921530";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"2.10";"None";"None";"None";"0";"CHEMBL1921344";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 R100E mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"R100E";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3699069";"";"None";"833.01";"3";"7.07";"BDBM139043";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)ccc2CCCc2ccccc2)cc1[N+](=O)[O-]";"Ki";"'='";"9.0";"nM";"8.05";"";"273177";"UO_0000065";"9.66";"0.19";"0.98";"4.48";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL2063882";"";"None";"1135.85";"None";"None";"6, BM-977";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)c4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3910827";"";"None";"626.59";"2";"5.81";"BDBM185603";"O=C(NS(=O)(=O)c1c(Cl)nc2sccn12)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"387.69";"nM";"6.41";"";"334796";"UO_0000065";"10.23";"0.21";"0.60";"7.37";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3957851";"";"None";"631.16";"2";"5.14";"BDBM185612";"Cc1cc(-c2oncc2S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)n(C)n1";"Ki";"'='";"447.13";"nM";"6.35";"";"334805";"UO_0000065";"10.06";"0.20";"1.21";"5.59";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"1";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"Ki";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.16";"0.20";"-0.12";"4.73";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL380709";"";"None";"761.97";"3";"6.36";"82";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCCCN)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"29.6";"nM";"7.53";"";"";"UO_0000065";"9.88";"0.19";"1.17";"4.53";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3342333";"";"None";"669.80";"2";"6.33";"18";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1F";"Ki";"'='";"0.01";"nM";"11.00";"";"";"UO_0000065";"16.42";"0.32";"4.67";"10.20";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342198";"";"None";"686.26";"2";"6.84";"16";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(Cl)c1";"Ki";"'='";"0.04";"nM";"10.40";"";"";"UO_0000065";"15.15";"0.30";"3.56";"9.64";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342197";"";"None";"651.81";"2";"6.19";"15";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1";"Ki";"'='";"0.02";"nM";"10.70";"";"";"UO_0000065";"16.41";"0.32";"4.51";"9.92";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4063862";"";"None";"703.62";"2";"8.07";"32";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cc(C(=O)O)cc4c2OCO4)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2013888";"Binding affinity to Bcl-xL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010639";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"1, ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1072270";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3972866";"";"None";"903.84";"2";"8.18";"27";"CC(C)(C)OC(=O)N1C[C@@H](Oc2ccc(-c3ccc(Cl)cc3)cc2)C[C@H]1C(=O)N[C@@H](Cc1ccc(OCCc2ccccc2)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"";"";"";"";"";"";"";"";"";"";"";"0";"CHEMBL3871750";"Inhibition of 5-FAM-DMRPEIWIAQELRRIGDEFNAYYARR binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by FAM-labeled peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871281";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL561602";"";"None";"441.48";"0";"3.53";"5q, CXL017";"CCOC(=O)CC1C(C(=O)OCC)=C(N)Oc2ccc(-c3cc(OC)cc(OC)c3)cc21";"Ki";"'='";"1236000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055757";"Inhibition of recombinant His6-tagged Bcl-XL expressed in Escherichia coli BL21 (DE3) and Flu-Bak peptide interaction by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153537";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL286730";"";"None";"492.61";"0";"3.91";"13";"CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(CC(C)C)C(C(=O)O)C(C)C)cc1OC(C)C)C(=O)O";"Ki";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL221294";"";"None";"808.04";"2";"8.13";"8m";"COC1(Cc2ccccc2-c2ccccc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL378820";"";"None";"681.88";"2";"5.64";"77S";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"6050.0";"nM";"5.22";"";"";"UO_0000065";"7.65";"0.15";"-0.42";"3.89";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL204915";"";"None";"542.64";"1";"3.75";"71";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(N2CCOCC2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3699066";"";"None";"843.05";"3";"7.12";"BDBM139040";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2csc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)n2)cc1[N+](=O)[O-]";"Ki";"'='";"0.1";"nM";"10.00";"";"273174";"UO_0000065";"11.86";"0.24";"2.88";"5.56";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL1916194";"";"None";"812.98";"2";"7.60";"8";"CC(C)[C@@H]1CN(Cc2ccccc2C(F)(F)F)CCN1c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"8.06";"0.16";"-1.05";"5.11";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921530";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"2.35";"None";"None";"None";"0";"CHEMBL1921530";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3342191";"A-1107969";"None";"674.77";"3";"6.02";"9";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"Ki";"'='";"12.4";"nM";"7.91";"";"";"UO_0000065";"11.72";"0.22";"1.89";"5.33";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2314193";"";"None";"357.84";"1";"5.15";"37";"Cc1cc(OCCCc2c(C(=O)O)[nH]c3ccccc23)cc(C)c1Cl";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL501793";"";"None";"593.70";"2";"5.35";"ent-14h";"O=C([C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@@H]2N1Cc1ccc(Oc2ccccc2)cc1)N1CCC(c2ccc(F)cc2)CC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL502211";"";"None";"630.21";"2";"5.06";"13b";"O=C(NCCN1CCCCC1)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"8.29";"0.16";"0.16";"5.76";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL560651";"";"None";"718.93";"2";"4.87";"9";"COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)[C@@H](O)C[C@H](OC(C)=O)[C@@H](CO[C@@H]6O[C@@H](C)[C@H](OC(C)=O)[C@@H](O)[C@H]6O)[C@@H]5CC[C@]43C)[C@H]2C1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL557340";"";"None";"704.90";"1";"4.78";"10";"CC(=O)O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](OC[C@@H]2[C@@H](O)C[C@H](O)[C@]3(C)[C@H]4CC=C5[C@H]6C[C@](C)(C(=O)O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@@H]23)O[C@H]1C";"Ki";"'='";"14100.0";"nM";"4.85";"";"";"UO_0000065";"6.88";"0.13";"0.07";"2.87";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL558462";"";"None";"544.77";"2";"5.84";"2";"COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)[C@@H](O)C[C@H](O)[C@@](C)(COC(C)=O)[C@@H]5CC[C@]43C)[C@H]2C1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"2, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3426321";"";"None";"435.50";"0";"4.29";"22";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCS3(=O)=O";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL372834";"";"None";"634.74";"2";"5.30";"63";"COc1cc(C(=O)N(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL202314";"";"None";"541.66";"1";"3.33";"11";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(N2CCNCC2)cc1";"Ki";"'='";"2520.0";"nM";"5.60";"";"";"UO_0000065";"10.34";"0.21";"2.27";"4.19";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL201947";"";"None";"790.02";"3";"6.96";"81";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCCCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL379013";"";"None";"653.83";"2";"5.39";"78";"CN(C)C(=O)C[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"13.01";"0.26";"3.12";"5.99";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL373631";"";"None";"717.89";"2";"7.06";"10b";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3426323";"";"None";"433.53";"1";"5.02";"24";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCC[S+]3[O-]";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3905254";"";"None";"624.19";"2";"5.17";"BDBM185601";"CC(=O)Nc1nc(C)c(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)s1";"Ki";"'='";"177.06";"nM";"6.75";"";"334794";"UO_0000065";"10.82";"0.22";"1.58";"6.04";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426320";"";"None";"387.44";"0";"4.90";"21";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCO3";"Ki";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"14.77";"0.27";"0.82";"9.43";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3426332";"";"None";"429.97";"1";"6.12";"33";"Cc1cc(OCCCc2c(C(=O)O)n3c4c(cccc24)SCCC3)cc(C)c1Cl";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3426316";"";"None";"389.48";"1";"5.22";"16";"O=C(O)c1c(CCOc2cccc3ccccc23)c2cccc3c2n1CCS3";"Ki";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"12.96";"0.25";"-0.17";"9.81";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3699074";"";"None";"810.98";"3";"6.55";"BDBM139048";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)sc2Cc2ccccc2)cc1[N+](=O)[O-]";"Ki";"'='";"41.0";"nM";"7.39";"";"273182";"UO_0000065";"9.11";"0.18";"0.84";"4.11";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3892521";"";"None";"602.68";"2";"5.82";"BDBM209090";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4O)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"8.0";"nM";"8.10";"";"369735";"UO_0000065";"13.43";"0.25";"2.28";"6.07";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3699072";"";"None";"807.92";"3";"5.34";"BDBM139046";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2csc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)n2)cc1S(=O)(=O)C(F)(F)F";"Ki";"'='";"1.7";"nM";"8.77";"";"273180";"UO_0000065";"10.85";"0.23";"3.43";"5.14";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3417399";"";"None";"335.39";"0";"3.34";"5";"CC1=NN(c2nc(-c3ccccc3)cs2)C(=O)/C1=C/c1ncc[nH]1";"Ki";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"15.41";"0.29";"1.83";"6.96";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3417398";"";"None";"395.49";"1";"5.77";"4";"CC1=NN(c2nc(-c3ccccc3)cs2)C(=O)/C1=C/c1ccc2ccccc2c1";"Ki";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"13.83";"0.26";"-0.30";"12.00";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3401826";"";"None";"598.77";"2";"5.98";"WL-276";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)/C(=C/c3ccc(-c4ccccc4)cc3)SC2=S)cc1";"Ki";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"10.32";"0.21";"0.20";"7.40";"0";"CHEMBL3405856";"Inhibition of Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence polarization technique";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399977";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3629657";"";"None";"633.08";"1";"4.49";"8h";"O=C(NS(=O)(=O)c1cccc([N+](=O)[O-])c1)[C@H](Cc1ccccc1)N1C(=O)N[C@@H](Cc2ccc(-c3ccc(Cl)cc3)cc2)C1=O";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3632440";"Competitive binding affinity to Bcl-XL (unknown origin) preincubated for 30 mins followed by 5-FAM-Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627718";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL221750";"";"None";"779.99";"3";"6.62";"23k";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4cccnc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4647854";"";"None";"417.55";"1";"6.28";"(+)-4g";"COC(=O)c1ccc(NC(=O)[C@H]2CC=C(CCC=C(C)C)C[C@@H]2c2ccccc2)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4633491";"";"None";"327.47";"0";"4.71";"(+)-10";"CON(C)C(=O)[C@H]1CC2=C(CCCC2(C)C)C[C@@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL408194";"OBATOCLAX";"3.0";"317.39";"0";"4.49";"GX15-070";"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C";"Ki";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"16.79";"0.30";"0.84";"10.02";"0";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1269107";"";"None";"586.60";"2";"5.78";"BI97D6";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccccc3)c2C1=O";"Ki";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"12.14";"0.22";"1.34";"4.77";"0";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4085804";"";"None";"1131.80";"None";"None";"32; BM-1197";"Cc1c(S(C)(=O)=O)c(-c2cc(F)cc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN6CCC(O)CC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4052860";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL2159740";"";"None";"936.60";"3";"10.62";"15";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3426330";"";"None";"397.90";"1";"5.57";"31";"Cc1cc(OCCCc2c(C(=O)O)n3c4c(cccc24)CCC3)cc(C)c1Cl";"Ki";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"12.84";"0.25";"-0.46";"9.93";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921340";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921347";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL29843";"";"None";"534.61";"2";"5.09";"15";"CC(C)CC(NC(=O)c1ccc(C(=O)N[C@@H](CC(C)C)C(=O)O)c(Oc2cccc3ccccc23)c1)C(=O)O";"Ki";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL4470807";"";"None";"417.29";"1";"5.75";"S1-6";"N#CC1=C(C#N)c2ccc(Sc3ccc(Br)cc3)c3cccc(c23)C1=O";"Ki";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"14.68";"0.32";"0.37";"9.47";"0";"CHEMBL4705651";"Inhibition of FAM-Bim peptide binding to Bcl-xl (unknown origin) measured after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699647";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"MODULATOR";""
"CHEMBL1272170";"";"None";"490.51";"0";"4.85";"ApoG2";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O";"Ki";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"12.60";"0.23";"1.33";"4.14";"0";"CHEMBL4398465";"Inhibition of Flu-BakBH3 peptide binding to recombinant human Bcl-xL after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4085804";"";"None";"1131.80";"None";"None";"BM-1197";"Cc1c(S(C)(=O)=O)c(-c2cc(F)cc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN6CCC(O)CC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3342187";"";"None";"583.74";"2";"6.74";"WEHI-539";"NCc1ccc(OCCCc2sc(-c3ccc4c(c3)/C(=N/Nc3nc5ccccc5s3)CCC4)nc2C(=O)O)cc1";"Ki";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.35";"0.30";"2.22";"7.30";"0";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL467309";"";"None";"504.68";"1";"2.78";"14c";"O=C(N[C@@H]1CCN(Cc2ccccc2)C1)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@H]2N1CC1CCCCC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL467709";"";"None";"461.61";"0";"2.68";"14b";"O=C(NC1Cc2ccccc2C1)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@H]2N1CC1CCCCC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL467508";"";"None";"504.68";"1";"2.78";"14a";"O=C(N[C@H]1CCN(Cc2ccccc2)C1)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@H]2N1CC1CCCCC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL510724";"";"None";"630.21";"2";"5.06";"ent-13b";"O=C(NCCN1CCCCC1)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"7.87";"0.15";"-0.10";"5.47";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL551288";"APOGOSSYPOL";"None";"462.54";"2";"6.76";"NSC736630";"Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O";"Ki";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"12.01";"0.22";"-1.21";"4.57";"0";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3426319";"";"None";"385.46";"1";"5.45";"20";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCC3";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3417406";"";"None";"429.48";"0";"4.23";"12";"CCOc1ccccc1N/N=C1\C(=O)N(c2cc(O)cc(-c3cccc(N)c3)c2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4456249";"";"None";"453.50";"0";"4.71";"3a";"CCc1sc2ncnc(NC(CO)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"87000.0";"nM";"4.06";"";"";"UO_0000065";"8.95";"0.17";"-0.65";"3.88";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4455139";"";"None";"405.48";"0";"4.86";"4a";"CCc1sc2ncnc(N[C@@H](C(=O)O)c3ccccc3)c2c1-c1cccc(O)c1";"Ki";"'='";"319000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL2159737";"";"None";"908.55";"3";"9.58";"12";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159735";"";"None";"1047.79";"None";"None";"10";"Cc1c(C(=O)NCCCN2CCN(C)CC2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159733";"";"None";"465.04";"0";"4.69";"8";"Cc1c(C(=O)NCCCN2CCN(C)CC2)c(-c2ccccc2)c(-c2ccc(Cl)cc2)n1C";"Ki";"'='";"88000.0";"nM";"4.06";"";"";"UO_0000065";"8.72";"0.17";"-0.63";"10.01";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063895";"";"None";"922.57";"3";"9.75";"19";"CCOC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)cn1C";"Ki";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"9.51";"0.19";"-0.98";"6.16";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063888";"";"None";"1107.84";"None";"None";"12";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4ccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL28504";"";"None";"392.50";"0";"3.02";"10";"COC(=O)[C@H](C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C";"Ki";"'='";"10960.0";"nM";"4.96";"";"";"UO_0000065";"12.64";"0.24";"1.94";"5.84";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL4163377";"";"None";"619.16";"2";"6.24";"11g";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)Nc4ccc(N5CCOCC5)cc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4162253";"";"None";"555.45";"2";"7.09";"7";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)c3ccc(Cl)cc3)C[C@@H]2C1";"Ki";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"11.33";"0.23";"-0.80";"6.24";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"2; ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3795378";"Binding affinity to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3792281";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3905577";"";"None";"744.02";"3";"7.26";"BDBM185592";"COC1(CC2CCCCC2)CCN(c2ccc(C(=O)NS(=O)(=O)c3cc([N+](=O)[O-])c(N[C@H](CCN(C)C)CSc4ccccc4)s3)cc2)CC1";"Ki";"'='";"51.45";"nM";"7.29";"";"334785";"UO_0000065";"9.80";"0.20";"0.03";"5.43";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902143";"";"None";"746.40";"2";"6.41";"BDBM185595";"CC(=O)N(CCSc1ccccc1)C1CCN(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)CC1";"Ki";"'='";"176.18";"nM";"6.75";"";"334788";"UO_0000065";"9.05";"0.18";"0.34";"7.24";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3786746";"";"None";"710.68";"2";"6.88";"67";"CC(=O)NCc1cccc(S(=O)(=O)NC(=O)c2[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc3c2CCCOc2cc(C)c(Cl)c(C)c2)c1";"Ki";"'='";"9069.0";"nM";"5.04";"";"";"UO_0000065";"7.10";"0.14";"-1.84";"3.73";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3785461";"";"None";"738.74";"2";"7.51";"68";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3cccc(CNC(=O)C(C)C)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3342192";"";"None";"688.80";"3";"6.41";"10";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"Ki";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"13.68";"0.26";"3.01";"6.35";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2063897";"";"None";"922.57";"3";"9.83";"21";"CCc1c(-c2ccc(Cl)cc2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(C(=O)O)n1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159734";"";"None";"1075.80";"None";"None";"9";"Cc1c(C(=O)NCCCN2CCN(C)CC2)c(-c2cccc(N3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3298855";"";"None";"376.50";"0";"4.84";"5";"O=C(O)[C@@H]1C=C[C@@H]2C[C@H]3[C@H](CC/C=C/Cc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3297754";"";"None";"382.46";"0";"3.11";"9";"O=C(O)C1=C[C@@H](O)[C@@H]2C[C@H]3[C@H](CCCc4ccc(O)c(O)c4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL4446378";"TAPOTOCLAX";"1.0";"613.22";"2";"5.90";"AMG176";"CO[C@H]1/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3";"Ki";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"10.04";"0.20";"0.25";"7.25";"0";"CHEMBL4398483";"Inhibition of human Biotin-DMRPEIWIAQELRRIGDEFNAYYARR peptide binding to Bcl-xL (unknown origin) after 120 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3895790";"";"None";"683.90";"2";"8.64";"G";"C=C(c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3342196";"";"None";"844.04";"3";"6.46";"14";"CN1CCN(CCCNc2ncnc3c2cnn3-c2ccc(OCCCc3sc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cc2)CC1";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342195";"";"None";"788.96";"3";"6.77";"13";"CN(C)CCCNc1ncnc2c1cnn2-c1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1";"Ki";"'='";"0.05";"nM";"10.30";"";"";"UO_0000065";"13.06";"0.25";"3.53";"6.30";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL177299";"";"None";"200.62";"0";"2.11";"16";"Cc1cc(OCC(=O)O)ccc1Cl";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314507";"";"None";"190.20";"0";"2.75";"9";"Cc1c(C(=O)O)oc2c(C)cccc12";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1612421";"";"None";"247.10";"0";"3.91";"3";"O=C(O)c1sc2cccc(Cl)c2c1Cl";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4073496";"";"None";"712.68";"2";"8.83";"29";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cc(C(=O)O)c4ccn(C)c4c2)C3=O)cc(C)c1Cl";"Ki";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3787407";"";"None";"840.75";"2";"9.19";"63";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3cccc(CNC(=O)c4ccccc4C(F)(F)F)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"4467.0";"nM";"5.35";"";"";"UO_0000065";"6.36";"0.13";"-3.84";"3.96";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3785426";"";"None";"771.77";"2";"8.21";"75";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3ccnc(NC4Cc5ccccc5C4)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"997.0";"nM";"6.00";"";"";"UO_0000065";"7.78";"0.15";"-2.21";"4.58";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"4c, AT-101";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.19";"0.23";"-0.06";"4.06";"1";"CHEMBL1274437";"Binding affinity to Bcl-xl";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268954";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL5288359";"";"None";"471.96";"1";"5.59";"5";"Cc1cc(Oc2ccc(S(=O)(=O)N3CCCc4cc(C(=O)O)ccc43)cc2)cc(C)c1Cl";"Ki";"'='";"3560.0";"nM";"5.45";"";"";"UO_0000065";"11.54";"0.23";"-0.14";"6.49";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"2.46";"None";"None";"None";"0";"CHEMBL1921628";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"V141A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"1.96";"None";"None";"None";"0";"CHEMBL1921529";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921630";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142T";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"2.74";"None";"None";"None";"0";"CHEMBL1921341";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A93V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL509472";"";"None";"589.74";"2";"5.29";"ent-14g";"O=C([C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@@H]2N1Cc1ccc(Oc2ccccc2)cc1)N1CCC(Cc2ccccc2)CC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL506763";"";"None";"566.53";"1";"4.80";"ent-14e";"O=C([C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@@H]2N1Cc1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccccc2)CC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"(-)-gossypol, 1";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.19";"0.23";"-0.06";"4.06";"0";"CHEMBL909446";"Displacement of FAM-Bak from human Bcl-xL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137390";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL217354";"";"None";"573.71";"2";"6.90";"5, TW-37";"CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O";"Ki";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"10.38";"0.20";"-0.95";"4.80";"0";"CHEMBL909446";"Displacement of FAM-Bak from human Bcl-xL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137390";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1331211";"";"None";"468.35";"0";"4.29";"UMI-77";"O=C(O)CSc1cc(NS(=O)(=O)c2ccc(Br)cc2)c2ccccc2c1O";"Ki";"'='";"7850.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL374303";"";"None";"734.34";"2";"7.58";"10c";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4Cl)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3298856";"";"None";"366.46";"0";"3.40";"6";"O=C(O)C1=C[C@@H](O)[C@@H]2C[C@H]3[C@H](CCCc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3298857";"";"None";"394.51";"0";"4.18";"7";"O=C(O)C1=C[C@H](O)[C@@H]2C[C@H]3[C@H](CCCCCc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3298854";"";"None";"366.46";"0";"3.99";"4";"O=C(O)[C@@H]1C=C[C@@H]2C[C@H]3[C@H](CCCc4ccc(O)c(O)c4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3794524";"";"None";"696.23";"1";"4.95";"22";"O=C(NS(=O)(=O)c1ccc(NC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CCOC3)CC2)cc1";"Ki";"'='";"5540.0";"nM";"5.26";"";"";"UO_0000065";"7.55";"0.15";"0.31";"3.67";"0";"CHEMBL3795378";"Binding affinity to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3792281";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"32; A-1155463";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3795380";"Binding affinity to Bcl-XL (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3792281";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1331211";"";"None";"468.35";"0";"4.29";"10";"O=C(O)CSc1cc(NS(=O)(=O)c2ccc(Br)cc2)c2ccccc2c1O";"Ki";"'='";"32990.0";"nM";"4.48";"";"";"UO_0000065";"9.57";"0.23";"0.19";"4.32";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3265296";"";"None";"465.55";"1";"5.19";"18";"O=C(O)CSc1cc(NS(=O)(=O)c2ccccc2-c2ccccc2)c2ccccc2c1O";"Ki";"'='";"48150.0";"nM";"4.32";"";"";"UO_0000065";"9.27";"0.18";"-0.87";"4.16";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"6; ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<='";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4342746";"Inhibition of BCL-XL (unknown origin) in presence of 10% human serum incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342405";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3342197";"";"None";"651.81";"2";"6.19";"15";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1";"Ki";"'='";"0.28";"nM";"9.55";"";"";"UO_0000065";"14.66";"0.28";"3.36";"8.85";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL28938";"";"None";"464.56";"0";"3.27";"5";"CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(CC(C)C)C(C)C(=O)O)cc1OC(C)C)C(=O)O";"Ki";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL3786057";"";"None";"763.70";"2";"7.16";"71";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3ccc(C(=O)NCc4ccncc4)o3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL2063889";"";"None";"785.44";"2";"8.56";"13";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"24.7";"nM";"7.61";"";"";"UO_0000065";"9.69";"0.19";"-0.95";"6.85";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921341";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A93V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921346";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E129H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL380709";"";"None";"761.97";"3";"6.36";"82";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCCCN)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"11.94";"0.23";"2.74";"5.48";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL198903";"";"None";"681.88";"2";"5.64";"77R";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL380502";"";"None";"653.87";"2";"6.25";"74";"CN(C)CCC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"728.0";"nM";"6.14";"";"";"UO_0000065";"9.39";"0.19";"-0.11";"4.91";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL201670";"";"None";"704.83";"2";"5.38";"69";"COc1cc(CCC(=O)N2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"8.66";"0.17";"0.72";"3.88";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL204822";"";"None";"690.84";"2";"5.86";"68";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"9.03";"0.18";"0.38";"4.45";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL380433";"";"None";"648.81";"2";"6.09";"66";"COc1cc(CCCN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"9.46";"0.19";"0.05";"4.69";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL596599";"";"None";"506.61";"1";"4.66";"7";"COc1ccc(-c2ccc(/C=C3\SC(=S)N([C@@H](Cc4ccccc4)C(=O)O)C3=O)cn2)cc1OC";"Ki";"'>'";"750000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1064402";"Binding affinity to human Bcl-XL by isothermal titration calorimetry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157603";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL4069319";"";"None";"614.17";"2";"6.66";"32";"CC(C)C[C@H](NC(=O)c1cn(Cc2ccc(-c3ccc(Cl)cc3)cc2)c2ccccc12)C(=O)NS(=O)(=O)c1ccccc1";"Ki";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"8.48";"0.17";"-1.45";"5.35";"0";"CHEMBL3994257";"Inhibition of N-terminal FAM-labeled Bid-BH3 peptide binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by N-terminal FAM-labeled Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992555";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4573285";"";"None";"437.50";"1";"5.74";"1f";"CCc1sc2ncnc(N[C@@H](C)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"10.24";"0.20";"-1.26";"5.31";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4521569";"";"None";"620.73";"2";"6.70";"2c";"CCNS(=O)(=O)c1cccc(-c2nc(N[C@H](C)C(=O)O)c3c(-c4cccc(Oc5ccc(F)cc5)c4)c(CC)sc3n2)c1";"Ki";"'='";"39000.0";"nM";"4.41";"";"";"UO_0000065";"7.10";"0.14";"-2.29";"3.38";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921629";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1269074";"";"None";"626.75";"2";"7.63";"6d";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCC3CCCCC3)C2=O)C(=O)c2cc(O)c(O)c(CCC3CCCCC3)c2C1=O";"Ki";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"8.10";"0.15";"-2.55";"3.40";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL219366";"";"None";"406.44";"0";"3.27";"3e";"CCOC(=O)C1=C(N)Oc2ccc(-c3ccccc3)cc2C1C(C#N)C(=O)OCC";"Ki";"'='";"52900.0";"nM";"4.28";"";"";"UO_0000065";"10.52";"0.19";"1.01";"3.83";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3426322";"";"None";"417.53";"1";"6.00";"23";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCCS3";"Ki";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"12.29";"0.23";"-0.87";"9.97";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL284686";"";"None";"406.52";"0";"3.27";"6";"COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC";"Ki";"'='";"1852.0";"nM";"5.73";"";"";"UO_0000065";"14.10";"0.27";"2.46";"6.75";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1940670";"";"None";"594.65";"2";"5.31";"B-3";"O=C(Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1cccc(F)c1";"Ki";"'='";"2080.0";"nM";"5.68";"";"";"UO_0000065";"9.56";"0.19";"0.37";"3.85";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1940680";"";"None";"612.71";"1";"4.72";"C-1";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(NS(=O)(=O)c2ccccc2)cc1";"Ki";"'='";"2290.0";"nM";"5.64";"";"";"UO_0000065";"9.21";"0.19";"0.92";"3.43";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1940669";"";"None";"594.65";"2";"5.31";"B-2";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(NC(=O)c2ccccc2F)cc1";"Ki";"'='";"1710.0";"nM";"5.77";"";"";"UO_0000065";"9.70";"0.19";"0.46";"3.91";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"2.83";"None";"None";"None";"0";"CHEMBL1921632";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"G196A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921632";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"G196A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916191";"";"None";"784.93";"2";"6.97";"5";"C[C@@H]1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CCN1Cc1ccccc1C(F)(F)F";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"11.47";"0.23";"2.03";"7.02";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3913007";"";"None";"629.74";"2";"7.45";"BDBM209170";"N#Cc1c(OC2CCCCC2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'<'";"0.1";"nM";"";"";"369815";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4160019";"";"None";"549.07";"2";"5.47";"11e";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)NCc4cccnc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4168747";"";"None";"605.13";"2";"6.15";"12g";"COC(=O)[C@@]12C=C[C@@H](CC(=O)Nc3ccc(N4CCOCC4)cc3)C[C@@H]1CC(C)=C[C@H]2/C=C(\Cl)c1ccc(C(=O)O)cc1";"Ki";"'='";"9910.0";"nM";"5.00";"";"";"UO_0000065";"8.27";"0.16";"-1.15";"4.76";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4175537";"";"None";"586.04";"2";"5.85";"17";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CCN=[N+]=[N-])C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'='";"5310.0";"nM";"5.28";"";"";"UO_0000065";"9.00";"0.18";"-0.58";"3.43";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4162625";"";"None";"545.04";"2";"5.94";"19c";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCn3cc(-c4cccnc4)nn3)C[C@@H]2C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4167208";"";"None";"458.94";"0";"4.85";"10";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)O)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4161200";"";"None";"614.92";"2";"7.60";"8c";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)Nc3cccc(Br)c3)C[C@@H]2C1";"Ki";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"9.88";"0.21";"-1.52";"5.38";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL282624";"";"None";"454.57";"0";"4.97";"8";"CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1Oc1ccccc1)C(=O)O";"Ki";"'='";"1013.0";"nM";"5.99";"";"";"UO_0000065";"13.19";"0.25";"1.02";"6.25";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL3935328";"";"None";"600.70";"2";"6.42";"BDBM209074";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1";"Ki";"'='";"2.0";"nM";"8.70";"";"369719";"UO_0000065";"14.48";"0.27";"2.28";"7.68";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899959";"";"None";"629.75";"2";"6.18";"BDBM209088";"CN(C)c1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"23.0";"nM";"7.64";"";"369733";"UO_0000065";"12.13";"0.23";"1.46";"6.56";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926206";"";"None";"649.66";"2";"6.16";"BDBM209099";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccc(F)c([N+](=O)[O-])c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"19.0";"nM";"7.72";"";"369744";"UO_0000065";"11.89";"0.22";"1.56";"4.94";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979615";"";"None";"667.80";"2";"6.03";"BDBM209105";"CN(C)CC#Cc1ccccc1Cn1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"122.0";"nM";"6.91";"";"369750";"UO_0000065";"10.35";"0.19";"0.88";"5.94";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957452";"";"None";"662.78";"2";"7.78";"BDBM209112";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(-c5ccccc5)c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"174.0";"nM";"6.76";"";"369757";"UO_0000065";"10.20";"0.19";"-1.02";"5.97";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL382648";"";"None";"775.99";"3";"6.57";"80";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"11.66";"0.23";"2.48";"6.31";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL202509";"";"None";"583.69";"1";"3.59";"12";"CC(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"894.0";"nM";"6.05";"";"";"UO_0000065";"10.36";"0.21";"2.46";"4.26";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL201669";"";"None";"620.75";"2";"5.65";"62";"COc1cc(CN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"426.0";"nM";"6.37";"";"";"UO_0000065";"10.26";"0.20";"0.72";"4.87";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL202964";"";"None";"761.97";"3";"6.18";"79S";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"7.80";"0.15";"-0.24";"4.15";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4860820";"";"None";"455.94";"1";"7.28";"9c";"O=C(O)c1ccc(Cl)cc1-c1cccc2c1ccn2CCCOc1cccc2ccccc12";"Ki";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.37";"0.23";"-1.64";"10.96";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL4864929";"";"None";"497.59";"1";"8.21";"9g";"Cc1ccccc1-c1cn(CCOc2cccc3ccccc23)c2cccc(-c3ccccc3C(=O)O)c12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4855114";"";"None";"511.62";"2";"8.47";"9i";"CCc1ccccc1-c1cn(CCOc2cccc3ccccc23)c2cccc(-c3ccccc3C(=O)O)c12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4170660";"";"None";"535.04";"2";"5.79";"11f";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)Nc4cccnc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL385101";"";"None";"717.89";"2";"7.06";"10a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4080450";"";"None";"657.79";"2";"6.39";"9c";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1)c(C)n2-c1ccc(-c2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4046938";"Inhibition of 5-FAM-Bid-BH3 peptide binding to Bcl-XL (unknown origin) pre-incubated for 30 mins followed by further incubation with 5-FAM-Bid-BH3 peptide for 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043209";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL448237";"";"None";"590.15";"1";"4.14";"ent-13a";"CN(C)CCNC(=O)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"8.78";"0.17";"1.04";"5.71";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"10.26";"0.20";"0.47";"6.51";"0";"CHEMBL1921065";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E129H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1940666";"";"None";"700.80";"2";"5.08";"A-5";"CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"6450.0";"nM";"5.19";"";"";"UO_0000065";"7.41";"0.14";"0.11";"2.70";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1916190";"";"None";"784.93";"2";"6.97";"4";"C[C@H]1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CCN1Cc1ccccc1C(F)(F)F";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3966089";"";"None";"682.85";"2";"8.63";"BDBM209150";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(C(CC4CCCCC4)c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"12.0";"nM";"7.92";"";"369795";"UO_0000065";"11.60";"0.22";"-0.71";"6.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4177395";"";"None";"570.47";"2";"7.49";"8b";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)Nc3ccc(Cl)cc3)C[C@@H]2C1";"Ki";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"9.39";"0.19";"-2.13";"4.74";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL219234";"";"None";"398.46";"0";"3.26";"3f";"CCOC(=O)C1=C(N)Oc2ccc(C3CCCC3)cc2C1C(C#N)C(=O)OCC";"Ki";"'='";"36500.0";"nM";"4.44";"";"";"UO_0000065";"11.14";"0.21";"1.18";"3.98";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4171694";"";"None";"582.52";"2";"6.73";"11a";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)NCc4ccc(Cl)cc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3903384";"";"None";"863.48";"3";"8.58";"BDBM185635";"Cc1nc(OCC2(F)CCOCC2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cccc2[nH]ncc12";"Ki";"'='";"1.637";"nM";"8.79";"";"334828";"UO_0000065";"10.18";"0.20";"0.21";"6.32";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699073";"";"None";"898.05";"3";"6.93";"BDBM139047";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)sc2Cc2ccccc2)cc1S(=O)(=O)C(F)(F)F";"Ki";"'='";"11.0";"nM";"7.96";"";"273181";"UO_0000065";"8.86";"0.18";"1.03";"4.66";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3912857";"";"None";"600.70";"2";"6.42";"BDBM209073";"Cc1nn(Cc2ccccc2)cc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"28.0";"nM";"7.55";"";"369718";"UO_0000065";"12.57";"0.23";"1.13";"6.67";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906104";"";"None";"629.75";"2";"6.18";"BDBM209134";"CN(C)c1ccccc1Cn1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"4.0";"nM";"8.40";"";"369779";"UO_0000065";"13.34";"0.25";"2.22";"7.21";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941341";"";"None";"743.89";"3";"6.53";"BDBM209135";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1OCCCN1CCOCC1";"Ki";"'='";"0.6";"nM";"9.22";"";"369780";"UO_0000065";"12.40";"0.23";"2.69";"6.83";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941020";"";"None";"620.78";"2";"7.35";"BDBM209136";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(C)CCCCC1";"Ki";"'='";"0.5";"nM";"9.30";"";"369781";"UO_0000065";"14.98";"0.28";"1.95";"8.21";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3794549";"";"None";"922.50";"3";"8.41";"23";"CN(C)CCOc1cccc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c([N+](=O)[O-])c3)c(Oc3ccc4[nH]ccc4c3)c2)CC1";"Ki";"'>'";"660.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3795380";"Binding affinity to Bcl-XL (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3792281";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1940667";"";"None";"613.72";"1";"4.02";"A-6";"CC(=O)N[C@H](C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)C(C)C";"Ki";"'='";"16440.0";"nM";"4.78";"";"";"UO_0000065";"7.80";"0.16";"0.76";"2.71";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3935806";"";"None";"863.48";"3";"8.58";"BDBM185633";"Cc1nc(OCC2(F)CCOCC2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cccc2[nH]cnc12";"Ki";"'='";"1.75";"nM";"8.76";"";"334826";"UO_0000065";"10.14";"0.20";"0.18";"6.30";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL379013";"";"None";"653.83";"2";"5.39";"78";"CN(C)C(=O)C[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1790.0";"nM";"5.75";"";"";"UO_0000065";"8.79";"0.17";"0.36";"4.05";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3629660";"";"None";"647.11";"1";"4.80";"8k";"Cc1cccc(-c2ccc(C[C@@H]3NC(=O)N([C@@H](Cc4ccccc4)C(=O)NS(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)C3=O)cc2)c1";"Ki";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"8.23";"0.16";"0.53";"3.42";"0";"CHEMBL3632440";"Competitive binding affinity to Bcl-XL (unknown origin) preincubated for 30 mins followed by 5-FAM-Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627718";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3629659";"";"None";"581.69";"1";"4.55";"8j";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)N[C@@H](Cc3ccc(-c4cccc(C)c4)cc3)C2=O)cc1";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3632440";"Competitive binding affinity to Bcl-XL (unknown origin) preincubated for 30 mins followed by 5-FAM-Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627718";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2325764";"";"None";"1013.71";"None";"None";"32, BM-1074";"Cc1c(C(=O)NS(C)(=O)=O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1269075";"";"None";"614.65";"2";"6.17";"6e";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(CCc3ccccc3)c2C1=O";"Ki";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"9.63";"0.18";"-0.25";"3.97";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL4067929";"";"None";"712.68";"2";"8.83";"39";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cn(C)c4ccc(C(=O)O)cc24)C3=O)cc(C)c1Cl";"Ki";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL335265";"";"None";"400.32";"0";"3.76";"4, BH3I-1";"CC(C)C(C(=O)O)N1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S";"Ki";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"12.64";"0.31";"1.30";"8.78";"0";"CHEMBL1064402";"Binding affinity to human Bcl-XL by isothermal titration calorimetry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157603";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"9.44";"0.19";"-0.20";"5.99";"0";"CHEMBL1921243";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2333154";"";"None";"535.63";"2";"6.20";"32";"O=C(Nc1cc(S(=O)(=O)c2ccc(Cl)cc2)ccc1Cl)c1cc(Cl)cc(Br)c1O";"Ki";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"10.06";"0.25";"-0.81";"6.45";"0";"CHEMBL2345537";"Binding affinity to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331511";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2063896";"";"None";"894.52";"3";"9.27";"20";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(C)c5C(=O)O)c4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1940663";"";"None";"627.75";"1";"4.41";"A-2";"CC[C@H](C)[C@H](NC(C)=O)C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"4840.0";"nM";"5.32";"";"";"UO_0000065";"8.47";"0.17";"0.91";"3.01";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3787158";"";"None";"775.76";"2";"7.51";"65";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3cccc(CNC(=O)c4cccn4C)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3786325";"";"None";"762.72";"2";"7.76";"70";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3ccc(C(=O)NCc4ccccc4)o3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3265297";"";"None";"500.00";"1";"5.84";"19";"O=C(O)CSc1cc(NS(=O)(=O)c2ccc(-c3ccc(Cl)cc3)cc2)c2ccccc2c1O";"Ki";"'='";"9590.0";"nM";"5.02";"";"";"UO_0000065";"10.04";"0.21";"-0.82";"4.84";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3927034";"";"None";"616.70";"2";"6.12";"BDBM209068";"COc1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"12.0";"nM";"7.92";"";"369713";"UO_0000065";"12.84";"0.24";"1.80";"6.47";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913857";"";"None";"729.31";"2";"9.39";"BDBM209137";"CC1(C)CCC(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"0.5";"nM";"9.30";"";"369782";"UO_0000065";"12.75";"0.24";"-0.09";"8.21";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965661";"";"None";"674.78";"2";"6.45";"BDBM209143";"COCCOc1ccccc1Cn1ncc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c1C";"Ki";"'='";"0.5";"nM";"9.30";"";"369788";"UO_0000065";"13.78";"0.26";"2.85";"7.06";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949188";"";"None";"644.76";"2";"6.69";"BDBM209147";"COCCC(c1ccccc1)n1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"16.0";"nM";"7.80";"";"369792";"UO_0000065";"12.09";"0.23";"1.11";"6.37";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893665";"";"None";"598.68";"2";"7.66";"BDBM209156";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccc(Oc4ccccc4)cc3)c(C(=O)O)n1)CC2";"Ki";"'<'";"0.1";"nM";"";"";"369801";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959080";"";"None";"649.75";"2";"6.22";"BDBM209180";"Cc1ccc(S(=O)(=O)n2ccc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2)cc1";"Ki";"'='";"47.0";"nM";"7.33";"";"369825";"UO_0000065";"11.28";"0.22";"1.11";"5.45";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963814";"";"None";"635.73";"2";"5.91";"BDBM209182";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccn(S(=O)(=O)c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"7.0";"nM";"8.15";"";"369827";"UO_0000065";"12.83";"0.25";"2.24";"6.06";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968809";"";"None";"666.80";"2";"6.09";"BDBM209223";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCCO)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369868";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4087636";"";"None";"712.68";"2";"8.83";"38";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cn(C)c4cc(C(=O)O)ccc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"10.88";"0.22";"0.97";"6.91";"0";"CHEMBL1921060";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A93V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"73.0";"nM";"7.14";"";"";"UO_0000065";"8.77";"0.17";"-0.74";"5.57";"0";"CHEMBL1921066";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921060";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A93V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"11.40";"0.23";"1.43";"5.84";"0";"CHEMBL1921245";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y195F";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921343";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"F97V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4167271";"";"None";"698.60";"2";"6.51";"15";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)NCc4ccc(Cl)cc4)C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'='";"20730.0";"nM";"4.68";"";"";"UO_0000065";"6.70";"0.13";"-1.83";"3.49";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4168346";"";"None";"689.17";"3";"5.90";"18c";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CCn4cc(-c5cccnc5)nn4)C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3890606";"";"None";"668.82";"2";"7.97";"BDBM209121";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4(c5ccccc5)CCCCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"7.0";"nM";"8.15";"";"369766";"UO_0000065";"12.19";"0.23";"0.18";"7.20";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897719";"";"None";"607.13";"1";"4.57";"BDBM185611";"COC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)n1C";"Ki";"'='";"188.23";"nM";"6.72";"";"334804";"UO_0000065";"11.08";"0.22";"2.16";"6.66";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3973043";"";"None";"598.56";"2";"5.14";"BDBM185618";"Cc1nn(C)c(Cl)c1S(=O)(=O)NC(=O)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"339.99";"nM";"6.47";"";"334811";"UO_0000065";"10.81";"0.22";"1.33";"7.39";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3964082";"";"None";"851.56";"3";"8.88";"BDBM185598";"CC(C)N(C)CC[C@H](CSc1ccccc1)Nc1sc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCCC4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.064";"nM";"10.19";"";"334791";"UO_0000065";"11.97";"0.24";"1.31";"7.96";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3923607";"";"None";"879.61";"3";"9.52";"BDBM185599";"CC(C)N(C)CC[C@H](CSc1ccccc1)Nc1sc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.307";"nM";"9.51";"";"334792";"UO_0000065";"10.81";"0.22";"-0.01";"7.42";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3951689";"";"None";"687.83";"2";"6.37";"BDBM209103";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1OCCN(C)C";"Ki";"'='";"0.6";"nM";"9.22";"";"369748";"UO_0000065";"13.41";"0.25";"2.85";"7.34";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL380433";"";"None";"648.81";"2";"6.09";"66";"COc1cc(CCCN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"5660.0";"nM";"5.25";"";"";"UO_0000065";"8.09";"0.16";"-0.84";"4.01";"0";"CHEMBL859055";"Binding affinity to Bcl-XL in 10% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"10.13";"0.20";"0.36";"6.43";"0";"CHEMBL1921061";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E96G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"11.45";"0.23";"1.47";"5.87";"0";"CHEMBL1921066";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3899060";"";"None";"636.74";"2";"7.27";"BDBM209242";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cn(Cc4ccccc4)c4cnccc34)c(C(=O)O)n1)CC2";"Ki";"'='";"0.5";"nM";"9.30";"";"369886";"UO_0000065";"14.61";"0.27";"2.03";"8.21";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918764";"";"None";"914.39";"3";"7.70";"40";"Cc1ccc(-c2ccc(O[C@H]3C[C@@H](C(=O)N[C@@H](Cc4ccc(OCc5ccc([N+](=O)[O-])cc5)cc4)C(=O)NS(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)N(C(=O)OC(C)(C)C)C3)cc2)cc1";"Ki";"";"";"";"";"";"";"";"";"";"";"";"0";"CHEMBL3871750";"Inhibition of 5-FAM-DMRPEIWIAQELRRIGDEFNAYYARR binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by FAM-labeled peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871281";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921341";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A93V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL221854";"";"None";"770.90";"2";"6.58";"3";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"10.32";"0.21";"1.38";"6.21";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916190";"";"None";"784.93";"2";"6.97";"4";"C[C@H]1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CCN1Cc1ccccc1C(F)(F)F";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2159742";"";"None";"2711.04";"None";"None";"BIM";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159736";"";"None";"921.59";"3";"9.24";"11";"CNC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n(C)c1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3913077";"";"None";"552.12";"2";"5.51";"BDBM185609";"O=C(NS(=O)(=O)c1cccs1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"234.12";"nM";"6.63";"";"334802";"UO_0000065";"12.01";"0.24";"1.12";"9.51";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3786706";"";"None";"762.72";"2";"7.76";"66";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3cccc(CNC(=O)c4ccoc4)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"1404.0";"nM";"5.85";"";"";"UO_0000065";"7.67";"0.15";"-1.91";"3.95";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3924937";"";"None";"622.66";"2";"6.39";"BDBM209108";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cc(F)ccc4F)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"15.0";"nM";"7.82";"";"369753";"UO_0000065";"12.57";"0.24";"1.43";"6.91";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986530";"";"None";"664.83";"2";"7.36";"BDBM209144";"COCCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCC1";"Ki";"'='";"1.0";"nM";"9.00";"";"369789";"UO_0000065";"13.54";"0.26";"1.64";"7.35";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931310";"";"None";"718.84";"3";"5.79";"BDBM209152";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1OCC(C)(CO)CO";"Ki";"'='";"2.0";"nM";"8.70";"";"369797";"UO_0000065";"12.10";"0.23";"2.91";"5.34";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933526";"";"None";"616.70";"2";"6.12";"BDBM209065";"COc1ccc2nc(NC(=O)c3cccc4c3CN(c3ccc(-c5cnn(Cc6ccccc6)c5)c(C(=O)O)n3)CC4)sc2c1";"Ki";"'='";"180.0";"nM";"6.75";"";"369710";"UO_0000065";"10.94";"0.20";"0.62";"5.51";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908218";"";"None";"643.77";"2";"6.18";"BDBM209122";"CN(C)Cc1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"279.0";"nM";"6.55";"";"369767";"UO_0000065";"10.18";"0.19";"0.37";"5.63";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970633";"";"None";"662.78";"2";"7.71";"BDBM209129";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(C(c4ccccc4)c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"28.0";"nM";"7.55";"";"369774";"UO_0000065";"11.40";"0.21";"-0.16";"6.67";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907071";"";"None";"618.69";"2";"6.56";"BDBM209095";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1F";"Ki";"'='";"1.0";"nM";"9.00";"";"369740";"UO_0000065";"14.55";"0.27";"2.44";"7.95";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975564";"";"None";"636.74";"2";"7.27";"BDBM209241";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc4c3cnn4Cc3ccccc3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.4";"nM";"9.40";"";"369885";"UO_0000065";"14.76";"0.27";"2.13";"8.30";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL410802";"";"None";"2437.73";"None";"None";"Bid BH3 peptide";"CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C";"Ki";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"3.35";"None";"None";"None";"0";"CHEMBL909446";"Displacement of FAM-Bak from human Bcl-xL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137390";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3891330";"";"None";"614.73";"2";"6.73";"BDBM209066";"Cc1nn(Cc2ccccc2)c(C)c1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"8.0";"nM";"8.10";"";"369711";"UO_0000065";"13.17";"0.25";"1.37";"7.15";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934794";"";"None";"612.72";"2";"6.60";"BDBM209091";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(C4CCc5ccccc54)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"17.0";"nM";"7.77";"";"369736";"UO_0000065";"12.68";"0.24";"1.17";"6.86";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967972";"";"None";"622.66";"2";"6.39";"BDBM209107";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cc(F)cc(F)c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"14.0";"nM";"7.85";"";"369752";"UO_0000065";"12.61";"0.24";"1.46";"6.94";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981796";"";"None";"614.69";"2";"5.93";"BDBM209118";"O=Cc1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"61.0";"nM";"7.21";"";"369763";"UO_0000065";"11.74";"0.22";"1.28";"5.54";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926978";"";"None";"632.79";"2";"7.53";"BDBM209124";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4CCCCC4)c3C3CC3)c(C(=O)O)n1)CC2";"Ki";"'='";"5.0";"nM";"8.30";"";"369769";"UO_0000065";"13.12";"0.25";"0.77";"7.33";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926315";"";"None";"642.73";"2";"7.20";"BDBM209127";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCC(F)(F)CC1";"Ki";"'='";"0.9";"nM";"9.05";"";"369772";"UO_0000065";"14.07";"0.27";"1.85";"7.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933415";"";"None";"632.79";"2";"8.14";"BDBM209166";"Cc1c(OCC2CCCCC2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.7";"nM";"9.15";"";"369811";"UO_0000065";"14.47";"0.27";"1.01";"8.75";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930331";"";"None";"618.76";"2";"7.89";"BDBM209167";"Cc1cc(OC2CCCCC2)ccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"19.0";"nM";"7.72";"";"369812";"UO_0000065";"12.48";"0.23";"-0.17";"7.38";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937478";"";"None";"639.18";"2";"8.24";"BDBM209171";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(OC4CCCCC4)c3Cl)c(C(=O)O)n1)CC2";"Ki";"'<'";"0.1";"nM";"";"";"369816";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983880";"";"None";"587.67";"2";"5.51";"BDBM209176";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cn(Cc4ccccc4)nn3)c(C(=O)O)n1)CC2";"Ki";"'='";"117.0";"nM";"6.93";"";"369821";"UO_0000065";"11.80";"0.22";"1.42";"5.50";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901568";"";"None";"585.69";"2";"6.72";"BDBM209179";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.3";"nM";"9.52";"";"369824";"UO_0000065";"16.26";"0.30";"2.80";"9.49";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914767";"";"None";"692.89";"2";"8.14";"BDBM209201";"COCCCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369846";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922702";"";"None";"608.72";"2";"5.95";"BDBM209208";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCCCO1";"Ki";"'<'";"0.1";"nM";"";"";"369853";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4101866";"";"None";"710.66";"2";"8.89";"34";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2ccc(C(=O)O)c4cccnc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3896583";"";"None";"618.69";"2";"6.45";"BDBM209062";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CCc4ccc(F)cc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"98.0";"nM";"7.01";"";"369707";"UO_0000065";"11.33";"0.21";"0.56";"6.19";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949624";"";"None";"692.80";"2";"7.70";"BDBM209070";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(OCc5ccccc5)c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"159.0";"nM";"6.80";"";"369715";"UO_0000065";"9.81";"0.18";"-0.90";"5.55";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2333140";"";"None";"412.85";"0";"4.73";"29";"NC(=O)c1ccccc1C(=O)c1ccc(Sc2ccc(Cl)cc2)c([N+](=O)[O-])c1";"Ki";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"15.26";"0.31";"1.57";"6.10";"0";"CHEMBL2345537";"Binding affinity to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331511";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL3930124";"";"None";"811.07";"3";"7.55";"BDBM185594";"CN(C)CC[C@H](CSc1ccccc1)Nc1sc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC=C(c4ccccc4)c4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"51.7";"nM";"7.29";"";"334787";"UO_0000065";"8.98";"0.18";"-0.26";"5.69";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3933269";"";"None";"625.18";"1";"3.69";"BDBM185600";"CC(=O)/N=c1\sc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)nn1C";"Ki";"'='";"743.18";"nM";"6.13";"";"334793";"UO_0000065";"9.80";"0.20";"2.44";"5.24";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3919771";"";"None";"581.16";"2";"5.52";"BDBM185605";"Cc1nc(C)c(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)s1";"Ki";"'='";"282.11";"nM";"6.55";"";"334798";"UO_0000065";"11.27";"0.23";"1.03";"7.93";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3964503";"";"None";"858.96";"3";"8.39";"BDBM209186";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c(C(=O)O)n1)CC2";"Ki";"'='";"3.0";"nM";"8.52";"";"369831";"UO_0000065";"9.92";"0.19";"0.13";"4.47";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901546";"";"None";"636.74";"2";"7.27";"BDBM209195";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cn(Cc4ccccc4)c4ncccc34)c(C(=O)O)n1)CC2";"Ki";"'='";"1.0";"nM";"9.00";"";"369840";"UO_0000065";"14.13";"0.26";"1.73";"7.95";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977617";"";"None";"613.70";"2";"7.37";"BDBM209196";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)ccnc1Oc1ccccc1";"Ki";"'='";"0.5";"nM";"9.30";"";"369841";"UO_0000065";"15.16";"0.28";"1.93";"7.91";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL596599";"";"None";"506.61";"1";"4.66";"7";"COc1ccc(-c2ccc(/C=C3\SC(=S)N([C@@H](Cc4ccccc4)C(=O)O)C3=O)cn2)cc1OC";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1064400";"Displacement of fluorescein-labeled Bak-BH3 peptide from human Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157603";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL384218";"";"None";"809.03";"3";"7.24";"23m";"COc1ccc(-c2ccccc2CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN(C)C)CSc5ccccc5)c([N+](=O)[O-])c4)cc3)CC2)cc1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL426535";"";"None";"766.39";"2";"7.12";"8f";"COC1(Cc2ccccc2Cl)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376921";"";"None";"702.90";"2";"5.56";"23a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"12.21";"0.24";"3.03";"6.70";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2159743";"";"None";"2748.09";"None";"None";"BAD";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159739";"";"None";"922.57";"3";"10.06";"14";"CCn1c(C)c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1-c1ccc(Cl)cc1";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2333153";"";"None";"317.39";"0";"4.49";"27";"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C/c1[nH]cc(C)c1C";"Ki";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"16.79";"0.30";"0.84";"10.02";"0";"CHEMBL2345537";"Binding affinity to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331511";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2314516";"";"None";"362.45";"1";"5.76";"23";"O=C(O)c1sc2ccccc2c1CCCOc1cccc2ccccc12";"Ki";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"13.31";"0.25";"-0.94";"10.37";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL217960";"";"None";"796.99";"2";"7.37";"23q";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3965688";"";"None";"616.15";"1";"4.50";"BDBM185610";"Cc1cc(C)n2nc(S(=O)(=O)NC(=O)c3ccc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)cc3)nc2n1";"Ki";"'='";"48.08";"nM";"7.32";"";"334803";"UO_0000065";"11.88";"0.23";"2.82";"6.49";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3342334";"";"None";"687.79";"2";"6.47";"19";"CN(C)CC#Cc1cc(F)c(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1F";"Ki";"'='";"0.03";"nM";"10.52";"";"";"UO_0000065";"15.30";"0.30";"4.05";"9.75";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"17, A-1155463";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3985835";"";"None";"699.84";"2";"6.38";"BDBM209131";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(C(CCN4CCOCC4)c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"10.0";"nM";"8.00";"";"369776";"UO_0000065";"11.43";"0.21";"1.62";"6.36";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913717";"";"None";"719.91";"2";"7.22";"BDBM209206";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1C(CCN1CCOCC1)C1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369851";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2314519";"";"None";"346.38";"1";"5.30";"26";"O=C(O)c1oc2ccccc2c1CCCOc1cccc2ccccc12";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314176";"";"None";"409.33";"1";"6.53";"63";"Cc1cc(OCCCc2c(C(=O)O)sc3cc(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"13.16";"0.28";"-1.14";"11.58";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314172";"";"None";"435.52";"1";"6.55";"59";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2ccccc2n1Cc1ccccc1";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314210";"";"None";"379.84";"1";"5.68";"54";"O=C(O)c1[nH]c2cc(Cl)ccc2c1CCCOc1cccc2ccccc12";"Ki";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"13.60";"0.26";"-0.51";"8.29";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"11.04";"0.22";"1.21";"5.66";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3905128";"";"None";"662.78";"2";"7.78";"BDBM209116";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4-c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"61.0";"nM";"7.21";"";"369761";"UO_0000065";"10.89";"0.20";"-0.57";"6.37";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL221805";"";"None";"776.00";"2";"8.59";"10k";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4-c4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374309";"";"None";"779.00";"2";"7.23";"23i";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3904077";"";"None";"634.20";"2";"7.11";"BDBM185607";"Cc1c(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)sc2ccc(F)cc12";"Ki";"'='";"356.26";"nM";"6.45";"";"334800";"UO_0000065";"10.17";"0.20";"-0.66";"9.25";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3265294";"";"None";"465.55";"1";"5.19";"16";"O=C(O)CSc1cc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)c2ccccc2c1O";"Ki";"'='";"8050.0";"nM";"5.09";"";"";"UO_0000065";"10.94";"0.22";"-0.10";"4.91";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3265295";"";"None";"465.55";"1";"5.19";"17";"O=C(O)CSc1cc(NS(=O)(=O)c2cccc(-c3ccccc3)c2)c2ccccc2c1O";"Ki";"'='";"15140.0";"nM";"4.82";"";"";"UO_0000065";"10.35";"0.21";"-0.37";"4.65";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3342334";"";"None";"687.79";"2";"6.47";"19";"CN(C)CC#Cc1cc(F)c(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1F";"Ki";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"13.79";"0.27";"3.01";"8.79";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3899305";"";"None";"934.26";"2";"8.25";"36";"CC(C)(C)OC(=O)N1C[C@@H](Oc2ccc(-c3ccccc3)cc2)C[C@H]1C(=O)N[C@@H](Cc1ccc(OCc2ccc(Br)cc2)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"";"";"";"";"";"";"";"";"";"";"";"0";"CHEMBL3871750";"Inhibition of 5-FAM-DMRPEIWIAQELRRIGDEFNAYYARR binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by FAM-labeled peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871281";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3971723";"";"None";"670.69";"2";"6.59";"E-11";"O=C(/C=C/c1ccccc1C(F)(F)F)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"10.09";"0.20";"0.18";"4.59";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2399245";"Binding affinity to human GST-tagged Bcl-Xl by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3417409";"";"None";"463.54";"1";"5.47";"15";"CC1=NN(c2cc(O)cc(-c3ccc(N(C)C)cc3)c2)C(=O)/C1=N\Nc1ccc2ccccc2c1";"Ki";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"11.80";"0.21";"0.00";"6.79";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3901568";"";"None";"585.69";"2";"6.72";"5";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.329";"nM";"9.48";"";"";"UO_0000065";"16.19";"0.30";"2.76";"9.45";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3912857";"";"None";"600.70";"2";"6.42";"9";"Cc1nn(Cc2ccccc2)cc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"15.29";"0.29";"2.77";"8.11";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3910958";"";"None";"587.67";"2";"5.51";"8";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccncc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.13";"0.26";"2.79";"6.58";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL2063885";"";"None";"1075.75";"None";"None";"9, BM-593";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(C#Cc3cccc(-c4c(-c5ccc(Cl)cc5)cn(CC[C@H](O)CO)c4C(=O)NCCCN4CCN(C)CC4)c3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1272170";"";"None";"490.51";"0";"4.85";"6a";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O";"Ki";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"13.00";"0.24";"1.53";"4.27";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3891088";"";"None";"632.72";"2";"5.58";"E-7";"COc1ccc(/C=C/C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)cc1";"Ki";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"11.31";"0.22";"1.57";"4.56";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3960206";"";"None";"637.14";"2";"6.22";"E-10";"O=C(/C=C/c1ccc(Cl)cc1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"10.48";"0.21";"0.46";"4.53";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3918541";"";"None";"803.02";"2";"9.89";"F";"C=C(c1ccc(C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"11.67";"0.23";"1.61";"5.98";"0";"CHEMBL1921065";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E129H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL217354";"";"None";"573.71";"2";"6.90";"9, TW-37";"CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O";"Ki";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"10.38";"0.20";"-0.95";"4.80";"1";"CHEMBL1072275";"Displacement of FAM-Bid peptide from human recombinant Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL28872";"";"None";"406.52";"0";"3.27";"7";"COC(=O)[C@@H](CC(C)C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC";"Ki";"'='";"1785.0";"nM";"5.75";"";"";"UO_0000065";"14.14";"0.27";"2.48";"6.77";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1269107";"";"None";"586.60";"2";"5.78";"6i";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccccc3)c2C1=O";"Ki";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"11.32";"0.21";"0.86";"4.45";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3342191";"A-1107969";"None";"674.77";"3";"6.02";"9";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"Ki";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"9.63";"0.18";"0.47";"4.38";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342189";"";"None";"674.77";"3";"6.02";"7";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCOc3cccc(-n4ncc5cncnc54)c3)s1)CC2";"Ki";"'='";"41.1";"nM";"7.39";"";"";"UO_0000065";"10.95";"0.21";"1.37";"4.98";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3417397";"";"None";"421.53";"1";"6.28";"3";"CC1=NN(c2nc(-c3ccccc3)cs2)C(=O)/C1=C/c1ccc(-c2ccccc2)cc1";"Ki";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"13.07";"0.24";"-0.77";"12.09";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3978299";"";"None";"620.78";"2";"7.28";"BDBM209146";"CC1(C)CCCC(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)C1";"Ki";"'='";"2.0";"nM";"8.70";"";"369791";"UO_0000065";"14.01";"0.26";"1.42";"7.68";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918145";"";"None";"598.68";"2";"7.66";"BDBM209157";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(Oc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.6";"nM";"9.22";"";"369802";"UO_0000065";"15.40";"0.29";"1.56";"8.81";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1374578";"";"None";"413.84";"1";"5.33";"BI21-C6";"O=C(O)c1ccccc1C(=O)c1ccc(Sc2ccc(Cl)cc2)c([N+](=O)[O-])c1";"Ki";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"15.23";"0.31";"0.97";"6.46";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4174087";"";"None";"568.50";"2";"6.64";"12a";"COC(=O)[C@@]12C=C[C@@H](CC(=O)NCc3ccc(Cl)cc3)C[C@@H]1CC(C)=C[C@H]2/C=C(\Cl)c1ccc(C(=O)O)cc1";"Ki";"'='";"2730.0";"nM";"5.56";"";"";"UO_0000065";"9.79";"0.19";"-1.08";"6.00";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3949482";"";"None";"650.80";"2";"6.97";"BDBM209198";"COCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369843";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929193";"";"None";"694.86";"2";"7.13";"BDBM209205";"COCCOC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369850";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936294";"";"None";"643.77";"2";"6.91";"BDBM209218";"CN(c1nccc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c1C#N)C1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369863";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"1";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"Ki";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"13.49";"0.27";"1.72";"6.29";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL202509";"";"None";"583.69";"1";"3.59";"12";"CC(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"2970.0";"nM";"5.53";"";"";"UO_0000065";"9.47";"0.19";"1.94";"3.89";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3260042";"";"None";"312.11";"0";"3.27";"53";"COc1c(I)cc(C=O)c2ccccc12";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4872671";"";"None";"551.56";"2";"8.92";"9e";"O=C(O)c1ccccc1-c1cccc2c1c(-c1cccc(C(F)(F)F)c1)cn2CCOc1cccc2ccccc12";"Ki";"'='";"6100.0";"nM";"5.21";"";"";"UO_0000065";"9.45";"0.17";"-3.71";"10.13";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL281240";"";"None";"419.57";"0";"4.00";"17";"CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1NC(C)C)C(=O)O";"Ki";"'='";"3313.0";"nM";"5.48";"";"";"UO_0000065";"13.06";"0.25";"1.48";"5.55";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL4112359";"";"None";"660.84";"2";"7.84";"BDBM209212";"Cc1nn(C[C@@H]2CC[C@H]3C[C@@H](C2)C3(C)C)cc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'<'";"0.1";"nM";"";"";"369857";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"9.92";"0.20";"0.49";"5.08";"0";"CHEMBL1921064";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y101H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3358688";"";"None";"402.94";"1";"6.21";"I1";"O=C(CC(Sc1ccc(Cl)cc1)C(=O)O)c1ccc(C2CCCCC2)cc1";"Ki";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"12.13";"0.25";"-1.32";"8.99";"0";"CHEMBL3383564";"Reversible inhibition of human recombinant N-terminal His-tagged Bcl-xL (1 to 209) expressed in Escherichia coli BL21(DE3) after 30 to 120 mins by TR-FRET assay in presence of F-bid";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL202540";"";"None";"641.77";"1";"4.97";"10";"CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"3350.0";"nM";"5.47";"";"";"UO_0000065";"8.53";"0.17";"0.50";"3.62";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3400493";"";"None";"436.32";"1";"5.09";"BH3-I2";"Cc1cc(Cl)cc(C(=O)Nc2ccc(S(=O)(=O)c3ccc(Cl)cc3)cc2)c1O";"Ki";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"12.35";"0.26";"0.30";"6.45";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL335265";"";"None";"400.32";"0";"3.76";"BH3I-1";"CC(C)C(C(=O)O)N1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S";"Ki";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"14.04";"0.35";"1.86";"9.75";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL335265";"";"None";"400.32";"0";"3.76";"4, BH3I-1";"CC(C)C(C(=O)O)N1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S";"Ki";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"12.49";"0.31";"1.24";"8.68";"0";"CHEMBL1064400";"Displacement of fluorescein-labeled Bak-BH3 peptide from human Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157603";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3974157";"";"None";"626.61";"2";"5.50";"BDBM185616";"Cc1nn(CCCl)c(C)c1S(=O)(=O)NC(=O)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"434.0";"nM";"6.36";"";"334809";"UO_0000065";"10.15";"0.21";"0.86";"7.27";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3926506";"";"None";"565.10";"2";"5.05";"BDBM185621";"Cc1noc(C)c1S(=O)(=O)NC(=O)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"437.92";"nM";"6.36";"";"334814";"UO_0000065";"11.25";"0.22";"1.31";"6.64";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3926447";"";"None";"815.35";"2";"7.85";"BDBM185629";"Cc1cc(C)n2nc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cc4cc[nH]c4c(F)c3F)nc2n1";"Ki";"'='";"0.039";"nM";"10.41";"";"334822";"UO_0000065";"12.77";"0.25";"2.56";"7.55";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2159738";"";"None";"864.54";"2";"9.88";"13";"Cc1cc(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"Ki";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"10.32";"0.20";"-0.96";"7.69";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3956947";"";"None";"687.83";"2";"6.45";"BDBM209101";"CN(C)CCCOc1ccccc1Cn1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"16.0";"nM";"7.80";"";"369746";"UO_0000065";"11.33";"0.21";"1.35";"6.20";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917338";"";"None";"594.70";"2";"5.49";"BDBM209110";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4CCCOC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"24.0";"nM";"7.62";"";"369755";"UO_0000065";"12.81";"0.24";"2.13";"6.22";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952597";"";"None";"612.71";"2";"7.97";"BDBM209164";"Cc1c(Oc2ccccc2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.3";"nM";"9.52";"";"369809";"UO_0000065";"15.54";"0.29";"1.55";"9.10";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937433";"";"None";"783.98";"3";"5.83";"BDBM209221";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCCN2CCS(=O)(=O)CC2)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369866";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL373712";"";"None";"731.94";"2";"6.47";"8e";"COC1(Cc2ccccc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"11.95";"0.23";"2.27";"6.52";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL470541";"";"None";"527.67";"1";"4.50";"14d";"O=C(NCc1ccc(Oc2ccccc2)cc1)[C@H]1[C@H](CO)[C@H]2Cn3c(cccc3=O)[C@H]2N1CC1CCCCC1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3417404";"";"None";"415.45";"0";"4.04";"10";"CCOc1ccccc1N/N=C1\C(=O)N(c2cc(O)cc(-c3ccncc3)c2)N=C1C";"Ki";"'='";"30900.0";"nM";"4.51";"";"";"UO_0000065";"10.86";"0.20";"0.47";"4.54";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3342195";"";"None";"788.96";"3";"6.77";"13";"CN(C)CCCNc1ncnc2c1cnn2-c1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3785279";"";"None";"773.79";"2";"8.31";"74";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3ccnc(N(C)CCc4ccccc4)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"943.0";"nM";"6.03";"";"";"UO_0000065";"7.79";"0.16";"-2.28";"4.93";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL2063880";"";"None";"525.09";"1";"3.59";"B50";"CN1CCN(CCCNC(=O)c2c(-c3ccccc3)c(-c3ccc(Cl)cc3)cn2CC[C@H](O)CO)CC1";"Ki";"'='";"138000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400492";"";"None";"609.75";"2";"6.47";"BCL-LZH-040";"CCOC(=O)C1=C(C)C(c2ccccc2)n2c(s/c(=C/n3cc(Cc4ccc(-c5ccccc5)cc4)c4ccccc43)c2=O)=N1";"Ki";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.74";"0.24";"1.30";"11.85";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400491";"";"None";"569.06";"2";"6.20";"19-93";"COc1ccc2c(c1)c(CC(=O)N[C@@H](CC(=O)O)Cc1cccc3ccccc13)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"10.60";"0.20";"-0.17";"6.18";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3893173";"";"None";"752.00";"3";"6.84";"BDBM185593";"COC1(Cc2cccc(C)c2)CCN(c2ccc(C(=O)NS(=O)(=O)c3cc([N+](=O)[O-])c(N[C@H](CCN(C)C)CSc4ccccc4)s3)cc2)CC1";"Ki";"'='";"82.92";"nM";"7.08";"";"334786";"UO_0000065";"9.42";"0.19";"0.24";"5.28";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3905470";"";"None";"680.25";"2";"6.41";"BDBM185619";"O=C(NS(=O)(=O)c1cc([N+](=O)[O-])c(N2CCCCC2)s1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"269.18";"nM";"6.57";"";"334812";"UO_0000065";"9.66";"0.20";"0.16";"5.66";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3910451";"";"None";"603.10";"2";"5.70";"BDBM185620";"O=C(NS(=O)(=O)c1ccc(-c2ccno2)o1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"138.75";"nM";"6.86";"";"334813";"UO_0000065";"11.37";"0.22";"1.16";"6.30";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3947773";"";"None";"773.93";"2";"8.00";"BDBM185625";"CN(C)CC[C@H](CSc1ccccc1)Nc1sc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"293.81";"nM";"6.53";"";"334818";"UO_0000065";"8.44";"0.17";"-1.47";"5.23";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL439495";"";"None";"766.97";"3";"5.06";"21";"Cc1ccc(S(=O)(=O)N2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN(C)C)CSc5ccccc5)c([N+](=O)[O-])c4)cc3)CC2)cc1";"Ki";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"10.95";"0.22";"3.34";"5.18";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2159741";"";"None";"934.58";"3";"10.38";"16";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C1CC1";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3929557";"";"None";"600.70";"2";"6.31";"BDBM209092";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CCc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"48.0";"nM";"7.32";"";"369737";"UO_0000065";"12.18";"0.23";"1.01";"6.46";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"11.55";"0.23";"1.53";"5.91";"0";"CHEMBL1921246";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"G196A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2314503";"";"None";"371.86";"1";"5.16";"56";"Cc1cc(OCCCc2c(C(=O)O)n(C)c3ccccc23)cc(C)c1Cl";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314208";"";"None";"378.26";"1";"5.49";"52";"Cc1cc(OCCCc2c(C(=O)O)[nH]c3cc(Cl)ccc23)ccc1Cl";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314512";"";"None";"228.67";"0";"2.81";"17";"Cc1cc(OCCC(=O)O)cc(C)c1Cl";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314511";"";"None";"251.28";"0";"3.84";"15";"Cc1cccc2c(-c3ccccc3)c(C(=O)O)[nH]c12";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3417396";"";"None";"435.55";"1";"6.29";"2";"CC1=NN(c2nc(-c3ccccc3)cs2)C(=O)/C1=C/C(c1ccccc1)c1ccccc1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1683285";"";"None";"393.92";"0";"3.63";"26";"Nc1ccc(Cl)c(CN2CCN(c3ncc(Cc4ccccc4)cn3)CC2)c1";"Ki";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"17.19";"0.33";"3.14";"11.62";"0";"CHEMBL1686334";"Binding affinity to Bcl-xL after 2 hrs by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681673";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL605114";"";"None";"506.61";"1";"4.66";"6";"COc1cccc(-c2ccc(/C=C3\SC(=S)N([C@@H](Cc4ccccc4)C(=O)O)C3=O)cn2)c1OC";"Ki";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.79";"0.21";"0.81";"6.15";"0";"CHEMBL1064402";"Binding affinity to human Bcl-XL by isothermal titration calorimetry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157603";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL556082";"MEIOGYNIN A";"None";"468.68";"1";"7.44";"1";"CC(C)=CCC[C@@H](C)[C@H]1C=C[C@@]2(C(=O)O)[C@H](CC(C)=C[C@@H]2/C=C(\C)C2CCC(C(=O)O)CC2)C1";"Ki";"'='";"10800.0";"nM";"4.97";"";"";"UO_0000065";"10.60";"0.20";"-2.47";"6.66";"0";"CHEMBL1057818";"Displacement of fluorescent-tagged BH3 domain of Bak from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152310";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL550027";"1-EPI-MEIOGYNIN A";"None";"468.68";"1";"7.44";"2";"CC(C)=CCC[C@@H](C)[C@H]1C=C[C@@]2(C(=O)O)[C@H](CC(C)=C[C@H]2/C=C(\C)C2CCC(C(=O)O)CC2)C1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1057818";"Displacement of fluorescent-tagged BH3 domain of Bak from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152310";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL375770";"";"None";"745.97";"2";"6.77";"8j";"COC1(Cc2ccccc2C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL373544";"";"None";"724.91";"2";"6.79";"10h";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4C#N)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2333155";"";"None";"784.40";"2";"8.73";"36";"CCCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"9.79";"0.19";"-1.05";"6.15";"0";"CHEMBL2345537";"Binding affinity to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331511";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL1272224";"";"None";"518.56";"1";"5.00";"6b";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CC(C)C)C2=O)C(=O)c2cc(O)c(O)c(CC(C)C)c2C1=O";"Ki";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"12.40";"0.23";"1.43";"4.31";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921246";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"G196A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921631";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y195F";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916192";"";"None";"798.95";"2";"7.36";"6";"CC1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC(C)N1Cc1ccccc1C(F)(F)F";"Ki";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"8.58";"0.17";"-0.51";"5.35";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"2.83";"None";"None";"None";"0";"CHEMBL1921340";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921342";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E96G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"2.27";"None";"None";"None";"0";"CHEMBL1921343";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"F97V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3426318";"";"None";"373.41";"0";"4.51";"18";"O=C(O)c1c(CCOc2cccc3ccccc23)c2cccc3c2n1CCO3";"Ki";"'='";"12700.0";"nM";"4.90";"";"";"UO_0000065";"13.11";"0.24";"0.39";"8.07";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3426326";"";"None";"437.95";"1";"6.26";"27";"O=C(O)c1c(CCCOc2ccc(Cl)c3ccccc23)c2cccc3c2n1CCS3";"Ki";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"12.17";"0.24";"-0.93";"10.35";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3426333";"";"None";"432.35";"1";"6.22";"34";"Cc1cc(OCCCc2c(C(=O)O)n3c4c(c(Cl)ccc24)CCC3)cc(C)c1Cl";"Ki";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"12.22";"0.25";"-0.94";"10.27";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3417395";"";"None";"405.48";"0";"4.40";"1";"CCOc1ccccc1N/N=C1/C(=O)N(c2nc(-c3ccccc3)cs2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL2159744";"";"None";"2681.08";"None";"None";"NOXA";"CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O";"Ki";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"2.04";"None";"None";"None";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL552717";"";"None";"568.80";"2";"6.90";"15";"CC(C)=CC(=O)O[C@@H]1CC(C)(C)C[C@@H]2C3=CC[C@@H]4[C@@]5(C)CCC(=O)[C@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]21C(=O)O";"Ki";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"9.28";"0.18";"-1.62";"5.23";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL552716";"";"None";"746.94";"3";"5.35";"3";"CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](OC[C@@H]2[C@@H](OC(C)=O)C[C@H](O)[C@]3(C)[C@H]4CC=C5[C@H]6C[C@](C)(C(=O)O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@@H]23)O[C@H]1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL538412";"";"None";"704.90";"1";"4.78";"4";"CC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@H](OC[C@@H]2[C@@H](OC(C)=O)C[C@H](O)[C@]3(C)[C@H]4CC=C5[C@H]6C[C@](C)(C(=O)O)CC[C@]6(C)CC[C@@]5(C)[C@]4(C)CC[C@@H]23)O[C@H]1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL560141";"";"None";"381.43";"0";"3.52";"5a, sHA 14-1";"CCOC(=O)CC1C(C(=O)OCC)=C(N)Oc2ccc(-c3ccccc3)cc21";"Ki";"'='";"343800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055757";"Inhibition of recombinant His6-tagged Bcl-XL expressed in Escherichia coli BL21 (DE3) and Flu-Bak peptide interaction by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153537";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1269076";"";"None";"642.70";"2";"6.79";"6f";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCc3ccc(C)cc3)C2=O)C(=O)c2cc(O)c(O)c(CCc3ccc(C)cc3)c2C1=O";"Ki";"'='";"2070.0";"nM";"5.68";"";"";"UO_0000065";"8.84";"0.16";"-1.11";"3.81";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"4i, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"9.25";"0.18";"-0.36";"5.87";"0";"CHEMBL1274437";"Binding affinity to Bcl-xl";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268954";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL451196";"";"None";"590.15";"1";"4.14";"13a";"CN(C)CCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(-c2ccc(Cl)cc2)c(-c2ccccc2)s1";"Ki";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"8.89";"0.17";"1.10";"5.78";"0";"CHEMBL969586";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by chemiluminescent nitrogen detection method";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138601";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL4086474";"";"None";"648.18";"2";"6.86";"13";"O=C(N[C@@H](Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1)c1cn(Cc2ccc(-c3ccc(Cl)cc3)cc2)c2ccccc12";"Ki";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"8.76";"0.17";"-1.18";"5.84";"0";"CHEMBL3994257";"Inhibition of N-terminal FAM-labeled Bid-BH3 peptide binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by N-terminal FAM-labeled Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992555";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL2314198";"";"None";"345.40";"1";"5.03";"42";"O=C(O)c1[nH]c2ccccc2c1CCCOc1cccc2ccccc12";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314513";"";"None";"241.32";"0";"3.25";"18";"c1ccc2c(CSc3ncn[nH]3)cccc2c1";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL373577";"";"None";"697.92";"2";"6.27";"8a";"COC1(CC(C)C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"11.77";"0.23";"1.94";"6.12";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL202540";"";"None";"641.77";"1";"4.97";"10";"CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"396.0";"nM";"6.40";"";"";"UO_0000065";"9.98";"0.20";"1.43";"4.23";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL204822";"";"None";"690.84";"2";"5.86";"68";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"10.4";"nM";"7.98";"";"";"UO_0000065";"11.56";"0.23";"2.12";"5.70";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL370835";"";"None";"667.90";"2";"6.64";"75";"CN(C)CCCC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"174.0";"nM";"6.76";"";"";"UO_0000065";"10.12";"0.20";"0.12";"5.41";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"73R";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"14.22";"0.28";"3.24";"7.28";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL382018";"";"None";"662.79";"2";"5.61";"67";"COc1cc(CCC(=O)N(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"38.9";"nM";"7.41";"";"";"UO_0000065";"11.18";"0.22";"1.80";"5.01";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL382361";"";"None";"648.76";"2";"5.22";"65";"COc1cc(CC(=O)N(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"251.0";"nM";"6.60";"";"";"UO_0000065";"10.17";"0.20";"1.38";"4.46";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL379895";"";"None";"639.84";"2";"5.86";"73S";"CN(C)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"3850.0";"nM";"5.42";"";"";"UO_0000065";"8.46";"0.17";"-0.45";"4.34";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"73R";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"10.07";"0.20";"0.58";"5.16";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL216089";"";"None";"462.55";"0";"4.56";"3g";"CCOC(=O)C1=C(N)Oc2ccc(-c3ccc(C(C)(C)C)cc3)cc2C1C(C#N)C(=O)OCC";"Ki";"'='";"21700.0";"nM";"4.66";"";"";"UO_0000065";"10.08";"0.19";"0.10";"4.18";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL425792";"";"None";"372.42";"0";"2.55";"3d";"CCCc1ccc2c(c1)C(C(C#N)C(=O)OCC)C(C(=O)OCC)=C(N)O2";"Ki";"'='";"70700.0";"nM";"4.15";"";"";"UO_0000065";"11.14";"0.21";"1.60";"3.72";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL220296";"";"None";"330.34";"0";"1.60";"3a";"CCOC(=O)C1=C(N)Oc2ccccc2C1C(C#N)C(=O)OCC";"Ki";"'='";"570000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL485891";"";"None";"394.45";"1";"7.03";"4";"O=C(O)c1ccc(-c2ccc(F)cc2)cc1/C=C/c1cccc(-c2ccccc2)c1";"Ki";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"14.84";"0.27";"-1.18";"15.69";"0";"CHEMBL4342744";"Inhibition of BCL-XL (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342405";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1683276";"";"None";"360.46";"0";"3.10";"17";"Oc1cccc(CN2CCN(c3ncc(Cc4ccccc4)cn3)CC2)c1";"Ki";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"17.43";"0.32";"3.18";"11.97";"0";"CHEMBL1686334";"Binding affinity to Bcl-xL after 2 hrs by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681673";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4244090";"";"None";"796.95";"2";"7.97";"6i";"Cc1ccc(CC(=O)N[C@@H](Cc2ccc(OCc3ccc(-c4ccccc4)cc3)cc2)C(=O)NS(=O)(=O)c2ccc(NCCCc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4236687";"Inhibition of Bid-BH3 peptide binding to Bcl-xL (unknown origin) after 3 hrs by fluorescence polarization method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229556";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1916193";"";"None";"812.98";"2";"7.60";"7";"CC(C)[C@H]1CN(Cc2ccccc2C(F)(F)F)CCN1c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"8.71";"0.17";"-0.52";"5.53";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"8.90";"0.18";"-0.64";"5.65";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"10.02";"0.20";"0.55";"5.13";"0";"CHEMBL1921242";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"V141A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"10.22";"0.20";"0.68";"5.23";"0";"CHEMBL1921243";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"10.41";"0.21";"0.59";"6.61";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"8.04";"0.16";"-1.34";"5.10";"0";"CHEMBL1921067";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"11.91";"0.24";"1.76";"6.10";"0";"CHEMBL1921061";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E96G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"9.60";"0.19";"0.28";"4.92";"0";"CHEMBL1921244";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142T";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL372834";"";"None";"634.74";"2";"5.30";"63";"COc1cc(C(=O)N(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"471.0";"nM";"6.33";"";"";"UO_0000065";"9.97";"0.20";"1.03";"4.28";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2063891";"";"None";"584.77";"1";"4.33";"15";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCNCC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"8.97";"0.18";"0.91";"4.38";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063897";"";"None";"922.57";"3";"9.83";"6";"CCc1c(-c2ccc(Cl)cc2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(C(=O)O)n1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3342190";"";"None";"688.80";"3";"6.41";"8";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3cccc(-n4ncc5cncnc54)c3)s1)CC2";"Ki";"'='";"10.4";"nM";"7.98";"";"";"UO_0000065";"11.59";"0.22";"1.57";"5.38";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342194";"";"None";"636.76";"2";"6.46";"12";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3ccc(-n4cccn4)cc3)s1)CC2";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3382381";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3400494";"";"None";"587.74";"2";"7.07";"TW-37";"CC(C)(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O";"Ki";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"10.14";"0.19";"-1.11";"4.81";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3342198";"";"None";"686.26";"2";"6.84";"16";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(Cl)c1";"Ki";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"13.68";"0.27";"2.55";"8.70";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3946397";"";"None";"644.71";"2";"6.12";"BDBM209089";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(C(=O)O)nn1Cc1ccccc1";"Ki";"'='";"91.0";"nM";"7.04";"";"369734";"UO_0000065";"10.92";"0.20";"0.92";"4.68";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975856";"";"None";"643.73";"2";"6.73";"BDBM209178";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc(C(=O)O)n1Cc1ccccc1";"Ki";"'<'";"0.1";"nM";"";"";"369823";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963138";"";"None";"715.88";"2";"6.89";"BDBM209222";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc(C#N)n1CC1(N2CCOCC2)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369867";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2063892";"";"None";"1033.77";"None";"None";"16";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(C)c5C(=O)NCCCN5CCN(C)CC5)c4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4064897";"";"None";"712.68";"2";"8.83";"31";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cc(C(=O)O)cc4ccn(C)c24)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4061061";"";"None";"712.68";"2";"8.83";"37";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cn(C)c4c(C(=O)O)cccc24)C3=O)cc(C)c1Cl";"Ki";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4111466";"";"None";"660.84";"2";"7.84";"BDBM209140";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCC2C[C@@H](C1)C2(C)C";"Ki";"'='";"2.0";"nM";"8.70";"";"369785";"UO_0000065";"13.16";"0.25";"0.86";"7.68";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942687";"";"None";"644.71";"2";"5.83";"BDBM209149";"COC(=O)C(c1ccccc1)n1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"11.0";"nM";"7.96";"";"369794";"UO_0000065";"12.34";"0.23";"2.13";"5.70";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902632";"";"None";"643.68";"2";"7.57";"BDBM209158";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(Oc4ccc([N+](=O)[O-])cc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"14.0";"nM";"7.85";"";"369803";"UO_0000065";"12.20";"0.23";"0.28";"5.31";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903275";"";"None";"618.76";"2";"7.89";"BDBM209168";"Cc1c(OC2CCCCC2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.2";"nM";"9.70";"";"369813";"UO_0000065";"15.67";"0.29";"1.81";"9.27";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937063";"";"None";"651.79";"2";"7.43";"BDBM209187";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccc4c(c3)CCN(Cc3ccccc3)C4)c(C(=O)O)n1)CC2";"Ki";"'='";"0.9";"nM";"9.05";"";"369832";"UO_0000065";"13.88";"0.26";"1.62";"9.17";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984574";"";"None";"692.89";"2";"8.00";"BDBM209200";"COCCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369845";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973825";"";"None";"902.54";"3";"8.62";"BDBM185624";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cc([N+](=O)[O-])c(NCCCN5CCOCC5)s4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"2.067";"nM";"8.69";"";"334817";"UO_0000065";"9.62";"0.19";"0.06";"5.35";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1269077";"";"None";"642.70";"2";"6.95";"6g";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCCc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(CCCc3ccccc3)c2C1=O";"Ki";"'='";"960.0";"nM";"6.02";"";"";"UO_0000065";"9.36";"0.17";"-0.93";"4.03";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269070";"";"None";"728.75";"3";"5.67";"8a";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(=O)NCC(C)c3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(C(=O)NCC(C)c3ccccc3)c2C1=O";"Ki";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"9.16";"0.17";"1.01";"3.22";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL383399";"";"None";"775.95";"3";"5.71";"84";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@@H](CSc3ccccc3)CC(=O)N(C)C)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"11.30";"0.22";"3.06";"5.47";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL202964";"";"None";"761.97";"3";"6.18";"79S";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"8.66";"0.17";"0.42";"4.61";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3932865";"";"None";"659.86";"2";"8.81";"BDBM209213";"Cc1c(NCC2CCCC(C)(C)C2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.2";"nM";"9.70";"";"369858";"UO_0000065";"14.70";"0.28";"0.89";"9.03";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949706";"";"None";"602.68";"2";"5.82";"BDBM209058";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccc(O)cc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"115.0";"nM";"6.94";"";"369703";"UO_0000065";"11.51";"0.22";"1.12";"5.20";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937189";"";"None";"656.77";"2";"6.11";"BDBM209076";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(N5CCCC5)n4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"6.0";"nM";"8.22";"";"369721";"UO_0000065";"12.52";"0.23";"2.11";"6.36";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891761";"";"None";"621.12";"2";"6.77";"BDBM209079";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4Cl)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"8.0";"nM";"8.10";"";"369724";"UO_0000065";"13.04";"0.25";"1.33";"7.15";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971433";"";"None";"625.75";"2";"7.95";"BDBM209210";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cccc1N(C)c1ccccc1";"Ki";"'='";"0.2";"nM";"9.70";"";"369855";"UO_0000065";"15.50";"0.29";"1.75";"9.83";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951428";"";"None";"616.72";"2";"5.88";"E-4";"Cc1ccc(/C=C/C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)cc1";"Ki";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"11.17";"0.22";"1.01";"4.67";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"2.42";"None";"None";"None";"0";"CHEMBL1921344";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 R100E mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"R100E";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916195";"";"None";"3003.40";"None";"None";"Bad";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O";"Ki";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"2.06";"None";"None";"None";"0";"CHEMBL1921529";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"2.18";"None";"None";"None";"0";"CHEMBL1921628";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"V141A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"9.7";"nM";"8.01";"";"";"UO_0000065";"2.50";"None";"None";"None";"0";"CHEMBL1921629";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"2.51";"None";"None";"None";"0";"CHEMBL1921632";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"G196A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"2.16";"None";"None";"None";"0";"CHEMBL1921529";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3977347";"";"None";"612.71";"2";"7.97";"BDBM209162";"Cc1ccc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1Oc1ccccc1";"Ki";"'='";"9.0";"nM";"8.05";"";"369807";"UO_0000065";"13.13";"0.24";"0.08";"7.69";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901090";"";"None";"624.73";"2";"6.90";"BDBM209183";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc(C#N)n1Cc1ccccc1";"Ki";"'<'";"0.1";"nM";"";"";"369828";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"10.85";"0.22";"0.94";"6.89";"0";"CHEMBL1921245";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y195F";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3629661";"";"None";"661.09";"1";"4.31";"8l";"O=Cc1ccc(-c2ccc(C[C@@H]3NC(=O)N([C@@H](Cc4ccccc4)C(=O)NS(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)C3=O)cc2)cc1";"Ki";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3632440";"Competitive binding affinity to Bcl-XL (unknown origin) preincubated for 30 mins followed by 5-FAM-Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627718";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL27963";"";"None";"484.55";"0";"3.94";"14";"CC(C)CC(NC(=O)c1ccc(C(=O)N[C@@H](CC(C)C)C(=O)O)c(Oc2ccccc2)c1)C(=O)O";"Ki";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL2063886";"";"None";"1047.74";"None";"None";"10, BM-748";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(C#Cc3cccc(-c4c(-c5ccc(Cl)cc5)cn(CC[C@H](O)CO)c4C(=O)NCCCN4CCN(C)CC4)c3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"8.37";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL28926";"";"None";"454.57";"0";"4.38";"12";"COC(=O)[C@@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C)c1ccccc1";"Ki";"'='";"10920.0";"nM";"4.96";"";"";"UO_0000065";"10.92";"0.21";"0.58";"5.84";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL2063894";"";"None";"850.51";"2";"9.57";"18";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5cn(C)cc5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"9.50";"0.19";"-1.49";"6.97";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063890";"";"None";"500.65";"1";"4.92";"14";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"Ki";"'='";"166000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3935841";"";"None";"587.67";"2";"5.51";"BDBM209080";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccn4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"167.0";"nM";"6.78";"";"369725";"UO_0000065";"11.53";"0.22";"1.27";"5.37";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948810";"";"None";"698.89";"2";"8.71";"BDBM209125";"CC(C)(C)c1cc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)cc(C(C)(C)C)c1";"Ki";"'='";"18.0";"nM";"7.75";"";"369770";"UO_0000065";"11.08";"0.21";"-0.97";"6.84";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951698";"";"None";"693.83";"2";"6.72";"BDBM209132";"CC(C)(C)OC(=O)N1CCC(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)CC1";"Ki";"'='";"379.0";"nM";"6.42";"";"369777";"UO_0000065";"9.25";"0.18";"-0.30";"4.50";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924869";"";"None";"729.86";"3";"6.14";"BDBM209133";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1OCCN1CCOCC1";"Ki";"'='";"0.5";"nM";"9.30";"";"369778";"UO_0000065";"12.74";"0.24";"3.16";"6.89";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892280";"";"None";"755.97";"3";"6.74";"BDBM209202";"COCCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)NS(C)(=O)=O)c2C)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369847";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908449";"";"None";"659.81";"2";"7.72";"BDBM209231";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cccc1N(C)C(=O)C1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369876";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902618";"";"None";"633.13";"2";"8.32";"BDBM209159";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(Oc4ccc(Cl)cc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"7.0";"nM";"8.15";"";"369804";"UO_0000065";"12.88";"0.25";"-0.17";"7.79";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935831";"";"None";"593.71";"2";"5.07";"BDBM209189";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4CCNCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"78.0";"nM";"7.11";"";"369834";"UO_0000065";"11.97";"0.23";"2.04";"5.67";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916115";"";"None";"652.78";"2";"6.82";"BDBM209190";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccc4c(c3)CCN(Cc3ccccn3)C4)c(C(=O)O)n1)CC2";"Ki";"'='";"1.4";"nM";"8.85";"";"369835";"UO_0000065";"13.56";"0.25";"2.03";"7.94";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972650";"";"None";"599.67";"2";"7.06";"BDBM209194";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccnc(Oc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"2.3";"nM";"8.64";"";"369839";"UO_0000065";"14.41";"0.27";"1.58";"7.35";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3628069";"";"None";"475.59";"1";"5.99";"33";"Cc1cccc(C)c1N1C(=O)/C(=C/c2ccc(OCc3ccc(C(=O)O)cc3)cc2)SC1=S";"Ki";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"11.37";"0.22";"-0.58";"8.09";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"2.76";"None";"None";"None";"0";"CHEMBL1921340";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3298851";"";"None";"350.46";"0";"4.29";"1";"O=C(O)[C@@H]1C=C[C@@H]2C[C@H]3[C@H](CCCc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"Gossypol";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"11.94";"0.22";"-0.19";"3.98";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL2063884";"";"None";"1090.77";"None";"None";"8, BM-908";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cn(-c4cccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)c4)nn3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063893";"";"None";"907.56";"3";"8.93";"17";"CNC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)cn1C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"12.82";"0.25";"2.34";"6.57";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2314173";"";"None";"374.89";"1";"5.88";"60";"Cc1cc(OCCCc2c(C(=O)O)sc3ccccc23)cc(C)c1Cl";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314209";"";"None";"392.28";"1";"5.80";"53";"Cc1cc(OCCCc2c(C(=O)O)[nH]c3cc(Cl)ccc23)cc(C)c1Cl";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2063880";"";"None";"525.09";"1";"3.59";"7";"CN1CCN(CCCNC(=O)c2c(-c3ccccc3)c(-c3ccc(Cl)cc3)cn2CC[C@H](O)CO)CC1";"Ki";"'='";"138000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1940664";"";"None";"645.78";"1";"4.11";"A-3";"CSCC[C@H](NC(C)=O)C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"3910.0";"nM";"5.41";"";"";"UO_0000065";"8.37";"0.17";"1.30";"3.06";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030270";"";"None";"395.48";"0";"3.58";"1";"O=C(O)CSc1cc(NS(=O)(=O)c2cccs2)c2ccccc2c1O";"Ki";"'='";"99000.0";"nM";"4.00";"";"";"UO_0000065";"10.13";"0.22";"0.42";"3.86";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"7, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"188.4";"nM";"6.72";"";"";"UO_0000065";"8.27";"0.16";"-1.16";"5.25";"0";"CHEMBL1055757";"Inhibition of recombinant His6-tagged Bcl-XL expressed in Escherichia coli BL21 (DE3) and Flu-Bak peptide interaction by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153537";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL554122";"ICTEROGENIN";"None";"568.80";"2";"6.90";"14";"C/C=C(/C)C(=O)O[C@@H]1CC(C)(C)C[C@@H]2C3=CC[C@@H]4[C@@]5(C)CCC(=O)[C@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]21C(=O)O";"Ki";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"9.00";"0.17";"-1.78";"5.07";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL539907";"";"None";"572.78";"2";"6.32";"1";"CC(=O)OC[C@]1(C)[C@@H](OC(C)=O)C[C@H](O)[C@]2(C)[C@H]3CC=C4[C@H]5C[C@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"Ki";"'='";"17800.0";"nM";"4.75";"";"";"UO_0000065";"8.29";"0.16";"-1.57";"4.31";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL510691";"LANTADENE A";"None";"552.80";"2";"7.93";"11";"C/C=C(/C)C(=O)O[C@@H]1CC(C)(C)C[C@H]2C3=CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]12C(=O)O";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL555367";"LANTADENE B";"None";"552.80";"2";"7.93";"12";"CC(C)=CC(=O)O[C@@H]1CC(C)(C)C[C@@H]2C3=CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]21C(=O)O";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL2374449";"";"None";"372.57";"1";"6.47";"6, HA14-1";"CCSCCCCC(c1ccc(O)cc1)C(C)(CC)c1ccc(O)cc1";"Ki";"'='";"659600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055757";"Inhibition of recombinant His6-tagged Bcl-XL expressed in Escherichia coli BL21 (DE3) and Flu-Bak peptide interaction by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153537";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3699075";"";"None";"885.09";"3";"6.89";"BDBM139049";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"0.14";"nM";"9.85";"";"273183";"UO_0000065";"11.13";"0.22";"2.96";"5.21";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL2063887";"";"None";"1081.81";"None";"None";"11, BM-987";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(NCCNc3cccc(-c4c(-c5ccc(Cl)cc5)cn(CC[C@H](O)CO)c4C(=O)NCCCN4CCN(C)CC4)c3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"7.35";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL433422";"";"None";"420.55";"0";"3.66";"11";"COC(=O)[C@@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C)C(C)C";"Ki";"'='";"5846.0";"nM";"5.23";"";"";"UO_0000065";"12.44";"0.24";"1.57";"6.16";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL203620";"";"None";"612.73";"1";"3.72";"13";"CN(C)C(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"869.0";"nM";"6.06";"";"";"UO_0000065";"9.89";"0.20";"2.34";"4.17";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL383399";"";"None";"775.95";"3";"5.71";"84";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@@H](CSc3ccccc3)CC(=O)N(C)C)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"7.73";"0.15";"0.29";"3.74";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL201947";"";"None";"790.02";"3";"6.96";"81";"COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCCCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"215.0";"nM";"6.67";"";"";"UO_0000065";"8.44";"0.17";"-0.29";"4.65";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3299034";"";"None";"350.46";"0";"4.29";"11";"O=C(O)/C=C/[C@H]1[C@H]2C=C[C@H]3[C@@H]1C[C@H]1[C@H](CCCc4ccc(O)cc4)[C@@H]2[C@@H]31";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL204915";"";"None";"542.64";"1";"3.75";"71";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(N2CCOCC2)cc1";"Ki";"'='";"1080.0";"nM";"5.97";"";"";"UO_0000065";"11.00";"0.22";"2.22";"4.56";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3960600";"";"None";"670.69";"2";"6.59";"E-13";"O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"9.38";"0.19";"-0.30";"4.27";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"4j, ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"7.64";"0.16";"-1.39";"5.80";"0";"CHEMBL1274437";"Binding affinity to Bcl-xl";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268954";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3417580";"";"None";"299.41";"1";"5.16";"1";"O=C(O)c1[nH]c2ccccc2c1CCCCC1CCCCC1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417972";"Inhibition of BCL-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414447";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4635324";"";"None";"299.41";"0";"4.36";"(-)-4c";"CC(C)=CCCC1=CC[C@@H](C(=O)NO)[C@H](c2ccccc2)C1";"Ki";"'='";"17400.0";"nM";"4.76";"";"";"UO_0000065";"15.90";"0.30";"0.40";"9.65";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL29180";"";"None";"264.28";"0";"0.29";"16";"COC(=O)CNC(=O)c1ccc(C(=O)N(C)C)cc1";"Ki";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647262";"Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149221";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"21";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'='";"0.055";"nM";"10.26";"";"";"UO_0000065";"10.53";"0.22";"1.43";"7.99";"0";"CHEMBL4220002";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219043";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"23";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"1";"CHEMBL4220002";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219043";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4083870";"";"None";"712.68";"2";"8.83";"35";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cccc4c(C(=O)O)cn(C)c24)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL221295";"";"None";"808.04";"2";"8.13";"8n";"COC1(Cc2ccc(-c3ccccc3)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"11.19";"0.22";"0.92";"6.74";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3417403";"";"None";"414.47";"0";"4.65";"9";"CCOc1ccccc1N/N=C1\C(=O)N(c2cc(O)cc(-c3ccccc3)c2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3417402";"";"None";"457.53";"0";"4.71";"8";"CCOc1ccccc1N/N=C1\C(=O)N(c2cc(O)cc(-c3ccc(N(C)C)cc3)c2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4091647";"";"None";"712.68";"2";"8.83";"33";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2ccc(C(=O)O)c4ccn(C)c24)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL542004";"";"None";"690.92";"1";"4.69";"6";"COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)[C@@H](O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)C[C@H](O)[C@@](C)(COC(C)=O)[C@@H]5CC[C@]43C)[C@H]2C1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL553855";"";"None";"732.95";"3";"5.26";"8";"COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)[C@@H](O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)C[C@H](OC(C)=O)[C@@](C)(COC(C)=O)[C@@H]5CC[C@]43C)[C@H]2C1";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051620";"Binding affinity to Bcl-xL by fluorescein-labeled Bak-BH3 peptide competition binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152410";"1";"Scientific Literature";"J Nat Prod";"2009";"None";"";"";""
"CHEMBL3908357";"";"None";"889.81";"2";"8.14";"34";"CC(C)(C)OC(=O)N1C[C@@H](Oc2ccc(-c3ccc(Cl)cc3)cc2)C[C@H]1C(=O)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"";"";"";"";"";"";"";"";"";"";"";"0";"CHEMBL3871750";"Inhibition of 5-FAM-DMRPEIWIAQELRRIGDEFNAYYARR binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by FAM-labeled peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871281";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4859740";"";"None";"511.62";"2";"8.52";"9l";"Cc1cccc(-c2cn(CCOc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)c1C";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4870837";"";"None";"453.54";"1";"7.88";"9t";"O=C(O)c1ccccc1-c1cccc2c1c(-c1ccccc1)cn2Cc1cccc2ccccc12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4878113";"";"None";"565.59";"2";"9.31";"9b";"O=C(O)c1ccccc1-c1cccc2c1c(-c1cccc(C(F)(F)F)c1)cn2CCCOc1cccc2ccccc12";"Ki";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"9.74";"0.18";"-3.80";"10.70";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL4876147";"";"None";"521.54";"2";"8.89";"9r";"O=C(O)c1ccccc1-c1cccc2c1c(-c1cccc(C(F)(F)F)c1)cn2Cc1cccc2ccccc12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4872320";"";"None";"487.99";"1";"8.53";"9q";"O=C(O)c1ccccc1-c1cccc2c1c(-c1cccc(Cl)c1)cn2Cc1cccc2ccccc12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL221708";"";"None";"700.89";"2";"6.32";"10i";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccn4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"12.05";"0.24";"2.12";"6.13";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376659";"";"None";"729.93";"2";"6.93";"10g";"COc1ccccc1C=C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"12.63";"0.25";"2.29";"6.88";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374097";"";"None";"785.05";"2";"7.61";"23h";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C4CCCCC4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL385119";"";"None";"732.93";"3";"5.57";"23c";"COc1ccccc1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL387142";"";"None";"716.93";"2";"5.87";"23b";"Cc1ccccc1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"11.89";"0.23";"2.65";"6.65";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL5209295";"";"None";"734.62";"2";"8.08";"14m";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCCc4ccco4)c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL5182219";"";"None";"745.64";"2";"7.88";"14r";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCCc4ccncc4)c3)cc2)cc(C)c1Cl";"Ki";"";"";"";"";"";"NA";"";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL374270";"";"None";"711.95";"2";"6.80";"8c";"CCCCCC1(OC)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"12.48";"0.25";"2.09";"6.63";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL222069";"";"None";"767.90";"2";"7.94";"10f";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(C(F)(F)F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"11.53";"0.23";"0.91";"7.09";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL221856";"";"None";"800.06";"3";"7.30";"23f";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4NC4CCCCC4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"11.53";"0.22";"1.92";"6.58";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL202314";"";"None";"541.66";"1";"3.33";"11";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(N2CCNCC2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL382361";"";"None";"648.76";"2";"5.22";"65";"COc1cc(CC(=O)N(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL378808";"";"None";"634.78";"2";"5.70";"64";"COc1cc(CCN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"998.0";"nM";"6.00";"";"";"UO_0000065";"9.45";"0.19";"0.30";"4.59";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL201669";"";"None";"620.75";"2";"5.65";"62";"COc1cc(CN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.67";"0.19";"0.35";"4.58";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL203620";"";"None";"612.73";"1";"3.72";"13";"CN(C)C(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"294.0";"nM";"6.53";"";"";"UO_0000065";"10.66";"0.21";"2.81";"4.50";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL378808";"";"None";"634.78";"2";"5.70";"64";"COc1cc(CCN(C)C)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"665.0";"nM";"6.18";"";"";"UO_0000065";"9.73";"0.19";"0.48";"4.72";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4164915";"";"None";"688.18";"3";"6.50";"18a";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CCn4cc(-c5ccccc5)nn4)C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'='";"16470.0";"nM";"4.78";"";"";"UO_0000065";"6.95";"0.13";"-1.72";"3.52";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3417704";"";"None";"850.05";"3";"6.05";"A-1210477";"Cc1nn(C)c(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)n(CCN3CCOCC3)c12";"Ki";"'>'";"660.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5096352";"Binding affinity to BCL-XL (unknown origin) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL5181405";"";"None";"734.62";"2";"8.08";"14e";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCCc4ccco4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"7.44";"0.15";"-2.61";"3.45";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5197460";"";"None";"745.64";"2";"7.88";"14p";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCCc4cccnc4)c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL5182327";"";"None";"745.64";"2";"7.88";"14h";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCCc4cccnc4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL5203579";"";"None";"710.60";"2";"6.66";"14k";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(N4CCOCC4)c3)cc2)cc(C)c1Cl";"Ki";"'='";"6660.0";"nM";"5.18";"";"";"UO_0000065";"7.28";"0.15";"-1.48";"3.55";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4637044";"";"None";"284.40";"0";"4.94";"(-)-1";"CC(C)=CCCC1=CC[C@@H](C(=O)O)[C@H](c2ccccc2)C1";"Ki";"'='";"9600.0";"nM";"5.02";"";"";"UO_0000065";"17.64";"0.33";"0.08";"13.45";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"7; ABT-236";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"7.51";"0.15";"-1.51";"5.70";"0";"CHEMBL4342748";"Inhibition of BCL-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342405";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3786327";"";"None";"759.76";"2";"8.29";"73";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3ccnc(NCCc4ccccc4)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"1109.0";"nM";"5.96";"";"";"UO_0000065";"7.84";"0.16";"-2.33";"4.55";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3699067";"";"None";"972.15";"3";"7.28";"BDBM139041";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"0.1";"nM";"10.00";"";"273175";"UO_0000065";"10.29";"0.21";"2.72";"5.56";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4868913";"";"None";"518.01";"2";"8.56";"9f";"O=C(O)c1ccccc1-c1cccc2c1c(-c1cccc(Cl)c1)cn2CCOc1cccc2ccccc12";"Ki";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"10.88";"0.20";"-2.92";"10.96";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL4865871";"";"None";"467.57";"1";"8.18";"9n";"Cc1cccc(-c2cn(Cc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)c1";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4852823";"";"None";"483.57";"1";"7.88";"9s";"COc1cccc(-c2cn(Cc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)c1";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL437146";"";"None";"731.90";"2";"5.59";"22";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C(=O)Nc4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"11.75";"0.23";"3.01";"5.47";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL385101";"";"None";"717.89";"2";"7.06";"10a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL373713";"";"None";"742.92";"3";"6.40";"14a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC4(CC3)CC(c3ccccc3)=NO4)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"11.25";"0.22";"1.96";"5.70";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4073496";"";"None";"712.68";"2";"8.83";"Fesik's compound 4";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cc(C(=O)O)c4ccn(C)c4c2)C3=O)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5035029";"Inhibition of FITC-labeled BH3 peptide binding to Bcl-xl (unknown origin) expressed in Escherichia coli BL21 (DE3) incubated for 0.5 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.5 hr";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"Gossypol";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"11.98";"0.22";"-0.17";"4.00";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL3287293";"";"None";"436.52";"0";"4.27";"2";"O=C(O)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"16.46";"0.33";"2.92";"7.53";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3919588";"";"None";"606.75";"2";"6.96";"12";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCCCC1";"Ki";"'='";"0.008";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4639800";"";"None";"417.55";"1";"6.28";"(-)-4g";"COC(=O)c1ccc(NC(=O)[C@@H]2CC=C(CCC=C(C)C)C[C@H]2c2ccccc2)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3972984";"";"None";"586.68";"2";"6.12";"BDBM209055";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"12.0";"nM";"7.92";"";"369700";"UO_0000065";"13.50";"0.25";"1.80";"6.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969110";"";"None";"628.71";"2";"6.44";"BDBM209093";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(C4CCOc5ccccc54)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"56.0";"nM";"7.25";"";"369738";"UO_0000065";"11.53";"0.22";"0.81";"5.92";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964361";"";"None";"714.85";"2";"7.23";"BDBM209153";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1OCC1CCOCC1";"Ki";"'='";"0.9";"nM";"9.05";"";"369798";"UO_0000065";"12.65";"0.24";"1.82";"6.87";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL220350";"";"None";"344.37";"0";"1.91";"3b";"CCOC(=O)C1=C(N)Oc2ccc(C)cc2C1C(C#N)C(=O)OCC";"Ki";"'='";"191000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL221855";"";"None";"749.00";"3";"6.28";"23d";"CSc1ccccc1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3891111";"";"None";"673.80";"2";"6.06";"BDBM209060";"CN(C)CCOc1ccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)cc1";"Ki";"'>'";"1000.0";"nM";"";"";"369705";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940857";"";"None";"673.80";"2";"6.06";"BDBM209072";"CN(C)CCOc1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"38.0";"nM";"7.42";"";"369717";"UO_0000065";"11.01";"0.21";"1.36";"5.90";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903849";"";"None";"621.12";"2";"6.77";"BDBM209075";"O=C(Nc1nc2cccc(Cl)c2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"183.0";"nM";"6.74";"";"369720";"UO_0000065";"10.85";"0.21";"-0.03";"5.95";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898365";"";"None";"572.65";"2";"6.06";"BDBM209077";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(-c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"182.0";"nM";"6.74";"";"369722";"UO_0000065";"11.77";"0.22";"0.68";"5.95";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978544";"";"None";"630.73";"2";"5.92";"BDBM209084";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(CO)nn1Cc1ccccc1";"Ki";"'='";"2.0";"nM";"8.70";"";"369729";"UO_0000065";"13.79";"0.26";"2.78";"6.52";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919588";"";"None";"606.75";"2";"6.96";"BDBM209097";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCCCC1";"Ki";"'='";"0.9";"nM";"9.05";"";"369742";"UO_0000065";"14.91";"0.28";"2.09";"7.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980575";"";"None";"693.79";"2";"7.09";"BDBM209102";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4OCc4ccncc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"7.0";"nM";"8.15";"";"369747";"UO_0000065";"11.75";"0.22";"1.06";"6.02";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945230";"";"None";"631.67";"2";"6.02";"BDBM209111";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4[N+](=O)[O-])c3)c(C(=O)O)n1)CC2";"Ki";"'='";"14.0";"nM";"7.85";"";"369756";"UO_0000065";"12.43";"0.23";"1.83";"5.02";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897213";"";"None";"660.72";"2";"7.58";"BDBM209128";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4(C(F)(F)F)CCCCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"6.0";"nM";"8.22";"";"369773";"UO_0000065";"12.44";"0.24";"0.64";"7.26";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964249";"";"None";"660.84";"2";"7.84";"BDBM209139";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCC2CC(C1)C2(C)C";"Ki";"'='";"0.7";"nM";"9.15";"";"369784";"UO_0000065";"13.85";"0.26";"1.31";"8.08";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4113873";"";"None";"616.75";"2";"6.59";"BDBM209145";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CC2C=C[C@@H]1C2";"Ki";"'='";"0.9";"nM";"9.05";"";"369790";"UO_0000065";"14.67";"0.27";"2.46";"7.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894741";"";"None";"678.86";"2";"7.75";"BDBM209151";"COCCCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCC1";"Ki";"'='";"2.0";"nM";"8.70";"";"369796";"UO_0000065";"12.81";"0.24";"0.95";"7.10";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900505";"";"None";"617.78";"2";"7.92";"BDBM209172";"Cc1c(NC2CCCCC2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.2";"nM";"9.70";"";"369817";"UO_0000065";"15.70";"0.29";"1.78";"9.03";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891489";"";"None";"672.73";"2";"8.60";"BDBM209174";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(OC4CCCCC4)c3C(F)(F)F)c(C(=O)O)n1)CC2";"Ki";"'='";"0.4";"nM";"9.40";"";"369819";"UO_0000065";"13.97";"0.27";"0.80";"8.98";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914056";"";"None";"671.78";"2";"7.21";"BDBM209177";"CCOC(=O)c1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(C)n1Cc1ccccc1";"Ki";"'<'";"0.1";"nM";"";"";"369822";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945826";"";"None";"630.77";"2";"7.43";"BDBM209184";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc(C#N)n1CC1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369829";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923735";"";"None";"678.86";"2";"7.75";"BDBM209188";"COCCC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369833";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952822";"";"None";"605.72";"2";"6.98";"BDBM209193";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccnc(OC4CCCCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.4";"nM";"9.40";"";"369838";"UO_0000065";"15.52";"0.29";"2.42";"8.00";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978558";"";"None";"719.91";"2";"7.05";"BDBM209199";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(N2CCOCC2)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369844";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950423";"";"None";"763.97";"3";"7.21";"BDBM209209";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCCCN2CCOCC2)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369854";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946359";"";"None";"741.94";"3";"6.35";"BDBM209216";"COC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)NS(C)(=O)=O)c2C)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369861";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918488";"";"None";"634.81";"2";"7.91";"BDBM209217";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3C)nc2C(=O)O)cnn1CC1(C)CCCCC1";"Ki";"'='";"0.4";"nM";"9.40";"";"369862";"UO_0000065";"14.80";"0.28";"1.49";"8.30";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920915";"";"None";"673.84";"2";"8.11";"BDBM209233";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cccc1N(C)C(=O)C1(C)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369878";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930937";"";"None";"734.93";"2";"8.93";"BDBM209236";"N#Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cccc1N1CCCC1C12CC3CC(CC(C3)C1)C2";"Ki";"'='";"0.2";"nM";"9.70";"";"369880";"UO_0000065";"13.20";"0.25";"0.77";"7.92";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4169534";"";"None";"570.47";"2";"7.49";"8a";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)Nc3cccc(Cl)c3)C[C@@H]2C1";"Ki";"'='";"3920.0";"nM";"5.41";"";"";"UO_0000065";"9.48";"0.19";"-2.08";"4.79";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3928078";"";"None";"621.12";"2";"6.77";"BDBM209063";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(Cl)c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"6.0";"nM";"8.22";"";"369708";"UO_0000065";"13.24";"0.26";"1.45";"7.26";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974347";"";"None";"670.80";"2";"6.42";"BDBM209086";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1cccc(N2CCCC2)n1";"Ki";"'='";"5.0";"nM";"8.30";"";"369731";"UO_0000065";"12.37";"0.23";"1.88";"6.42";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953848";"";"None";"731.84";"3";"6.39";"BDBM209098";"CN(C)CCCNc1ccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)cc1[N+](=O)[O-]";"Ki";"'='";"17.0";"nM";"7.77";"";"369743";"UO_0000065";"10.62";"0.20";"1.38";"4.53";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5176177";"";"None";"734.62";"3";"7.17";"14f";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCc4ccn(C)n4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'='";"3450.0";"nM";"5.46";"";"";"UO_0000065";"7.44";"0.15";"-1.71";"3.35";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL551288";"APOGOSSYPOL";"None";"462.54";"2";"6.76";"2b";"Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O";"Ki";"'='";"3690.0";"nM";"5.43";"";"";"UO_0000065";"11.75";"0.22";"-1.33";"4.48";"0";"CHEMBL3822340";"Inhibition of FITC-labeled Bak BH3 peptide binding to GST-tagged Bcl-XL (unknown origin) preincubated for 10 mins followed by FITC-labeled Bak BH3 peptide addition measured after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL1269073";"";"None";"570.64";"2";"6.07";"6c";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CC3CCCC3)C2=O)C(=O)c2cc(O)c(O)c(CC3CCCC3)c2C1=O";"Ki";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.99";"0.19";"-0.37";"3.82";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269072";"";"None";"642.62";"2";"5.45";"7";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(=O)Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(C(=O)Cc3ccccc3)c2C1=O";"Ki";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"10.30";"0.19";"1.17";"3.61";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3976674";"";"None";"590.68";"2";"5.10";"D-1";"O=C(Cc1ccccc1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"10.74";"0.21";"1.25";"4.30";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"11.06";"0.22";"1.12";"7.02";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3942501";"";"None";"600.70";"2";"6.42";"BDBM209067";"Cc1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"12.0";"nM";"7.92";"";"369712";"UO_0000065";"13.19";"0.25";"1.50";"6.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912911";"";"None";"668.74";"3";"6.47";"BDBM209083";"Cc1noc(-c2cccc(Cn3cc(-c4ccc(N5CCc6cccc(C(=O)Nc7nc8ccccc8s7)c6C5)nc4C(=O)O)cn3)c2)n1";"Ki";"'='";"18.0";"nM";"7.75";"";"369728";"UO_0000065";"11.58";"0.22";"1.27";"5.09";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905757";"";"None";"594.70";"2";"5.49";"BDBM209104";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4CCOCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"99.0";"nM";"7.00";"";"369749";"UO_0000065";"11.78";"0.22";"1.51";"5.72";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893422";"";"None";"622.66";"2";"6.39";"BDBM209109";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4c(F)cccc4F)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"18.0";"nM";"7.75";"";"369754";"UO_0000065";"12.44";"0.24";"1.35";"6.84";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982752";"";"None";"566.69";"2";"6.11";"BDBM209113";"CC(C)(C)Cn1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"424.0";"nM";"6.37";"";"369758";"UO_0000065";"11.25";"0.21";"0.26";"5.63";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939902";"";"None";"592.73";"2";"6.57";"BDBM209117";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCCC1";"Ki";"'='";"2.0";"nM";"8.70";"";"369762";"UO_0000065";"14.68";"0.28";"2.13";"7.68";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923784";"";"None";"594.70";"2";"5.64";"BDBM209203";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4CCCCO4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.3";"nM";"9.52";"";"369848";"UO_0000065";"16.01";"0.30";"3.88";"7.78";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964488";"";"None";"736.90";"3";"6.90";"BDBM209227";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCC2COCCO2)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369872";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910958";"";"None";"587.67";"2";"5.51";"BDBM209056";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccncc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"205.0";"nM";"6.69";"";"369701";"UO_0000065";"11.38";"0.21";"1.18";"5.30";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940367";"";"None";"710.86";"3";"5.84";"BDBM209229";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCC(O)CO)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369874";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4073167";"";"None";"727.63";"2";"7.42";"17";"O=C(N[C@@H](Cc1ccccc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c1cn(Cc2ccc(-c3ccc(Cl)cc3)cc2)c2ccccc12";"Ki";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"8.45";"0.17";"-1.27";"4.38";"0";"CHEMBL3994257";"Inhibition of N-terminal FAM-labeled Bid-BH3 peptide binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by N-terminal FAM-labeled Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992555";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL1940662";"";"None";"627.75";"1";"4.41";"A-1";"CC(=O)N[C@@H](CC(C)C)C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"5820.0";"nM";"5.24";"";"";"UO_0000065";"8.34";"0.17";"0.83";"2.96";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL4533559";"";"None";"583.78";"2";"5.50";"26";"COc1cccc(CCSc2ccc(NS(=O)(=O)N3CCN(c4ccc(C(C)(C)C)cc4)CC3)c(C(=O)O)c2)c1";"Ki";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"8.86";"0.18";"-0.33";"5.22";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL2063881";"";"None";"424.55";"0";"2.77";"5, BM-955";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(N)(=O)=O)cc1[N+](=O)[O-]";"Ki";"'='";"75000.0";"nM";"4.12";"";"";"UO_0000065";"9.72";"0.20";"1.35";"3.48";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL5192657";"";"None";"731.62";"2";"7.83";"14q";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCc4ccncc4)c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL4475729";"";"None";"497.64";"0";"4.20";"20";"O=C(O)c1cc(SCCc2ccccc2)ccc1NS(=O)(=O)N1CCN(c2ccccc2)CC1";"Ki";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"10.41";"0.21";"0.98";"5.76";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3426327";"";"None";"407.54";"1";"5.34";"28";"O=C(O)c1c(CCCOc2ccc3c(c2)CCCC3)c2cccc3c2n1CCS3";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1916191";"";"None";"784.93";"2";"6.97";"5";"C[C@@H]1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CCN1Cc1ccccc1C(F)(F)F";"Ki";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"10.74";"0.21";"1.46";"6.58";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916192";"";"None";"798.95";"2";"7.36";"6";"CC1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC(C)N1Cc1ccccc1C(F)(F)F";"Ki";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"8.97";"0.18";"-0.19";"5.59";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916192";"";"None";"798.95";"2";"7.36";"6";"CC1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC(C)N1Cc1ccccc1C(F)(F)F";"Ki";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"8.78";"0.17";"-0.34";"5.48";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921342";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E96G";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916197";"";"None";"2444.81";"None";"None";"Bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O";"Ki";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"2.57";"None";"None";"None";"0";"CHEMBL1921346";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"E129H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4472592";"";"None";"514.58";"2";"6.80";"2b";"CCc1sc2nc(-c3cccnc3)nc(N[C@H](C)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"9.22";"0.18";"-2.06";"4.88";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4460382";"";"None";"499.57";"1";"7.09";"3b";"CCc1sc2ncnc(NC(C(=O)O)c3ccccc3)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"9.66";"0.18";"-2.27";"5.72";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"7.89";"0.16";"-1.46";"5.01";"0";"CHEMBL1921064";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y101H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"2.16";"None";"None";"None";"0";"CHEMBL1921347";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916198";"";"None";"3075.60";"None";"None";"Noxa";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921628";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"V141A";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1940665";"";"None";"661.76";"1";"4.60";"A-4";"CC(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"3420.0";"nM";"5.47";"";"";"UO_0000065";"8.26";"0.16";"0.87";"3.09";"0";"CHEMBL1943218";"Binding affinity to Bcl-xL by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938241";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2063880";"";"None";"525.09";"1";"3.59";"4, BM-501";"CN1CCN(CCCNC(=O)c2c(-c3ccccc3)c(-c3ccc(Cl)cc3)cn2CC[C@H](O)CO)CC1";"Ki";"'='";"138000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063883";"";"None";"1107.84";"None";"None";"7, BM-907";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)c4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4635645";"";"None";"327.47";"0";"4.87";"(-)-2";"CON(C)C(=O)[C@@H]1CC=C(CCC=C(C)C)C[C@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4439691";"";"None";"854.72";"3";"7.09";"8l";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccc(OCc3ccc(C#N)cc3)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4564434";"";"None";"712.68";"2";"9.01";"38";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cc(C(=O)O)cc4c2ccn4C)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4524392";"";"None";"703.62";"2";"8.24";"39";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cc(C(=O)O)cc4c2OCO4)C3=O)cc(C)c1Cl";"Ki";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"6.54";"0.13";"-3.64";"4.26";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4525487";"";"None";"709.67";"2";"9.67";"40";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cccc4c(C(=O)O)cccc24)C3=O)cc(C)c1Cl";"Ki";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"6.46";"0.13";"-5.08";"5.12";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4469869";"";"None";"712.68";"2";"9.01";"42; VU0661013";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cn(C)c4ccc(C(=O)O)cc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4442085";"";"None";"515.59";"2";"5.14";"2a";"CCc1sc2nc(S(C)(=O)=O)nc(N[C@H](C)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"8.89";"0.18";"-0.55";"3.87";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4514111";"";"None";"513.59";"2";"6.96";"3c";"CCc1sc2ncnc(N[C@H](Cc3ccccc3)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"9.00";"0.17";"-2.34";"5.48";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4455822";"";"None";"519.64";"2";"7.69";"3e";"CCc1sc2ncnc(N[C@H](CC3CCCCC3)C(=O)O)c2c1-c1cccc(Oc2ccc(F)cc2)c1";"Ki";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"9.18";"0.18";"-2.92";"5.66";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4471326";"";"None";"405.48";"0";"4.86";"4b";"CCc1sc2ncnc(N[C@H](C(=O)O)c3ccccc3)c2c1-c1cccc(O)c1";"Ki";"'='";"107000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4436725";"";"None";"442.54";"1";"5.51";"8a";"CCc1sc2ncnc(N[C@H](Cc3ccccc3)C(=O)O)c2c1-c1cccc2[nH]ccc12";"Ki";"'='";"135000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL426558";"";"None";"810.84";"2";"7.23";"8l";"COC1(Cc2ccccc2Br)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL375628";"";"None";"766.39";"2";"7.12";"8g";"COC1(Cc2cccc(Cl)c2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3265299";"";"None";"481.55";"1";"5.32";"21";"O=C(O)CSc1cc(NS(=O)(=O)c2ccc(Oc3ccccc3)cc2)c2ccccc2c1O";"Ki";"'='";"10580.0";"nM";"4.98";"";"";"UO_0000065";"10.33";"0.21";"-0.34";"4.41";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2070024";"";"None";"612.81";"2";"8.49";"BH3-M6";"CC(C)Cc1cc(-c2ccc(-c3ccc(CCC(=O)O)cc3CC(C)C)cc2Cc2ccccc2)ccc1OCC(=O)O.N.N";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.06";"0.18";"-2.67";"6.95";"0";"CHEMBL4398472";"Inhibition of GST-tagged Bcl-xL (unknown origin) after 3 hrs by pull-down assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL343002";"";"None";"452.56";"0";"4.92";"BXI-72";"CCOc1ccc(-c2nc3cc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)ccc3[nH]2)cc1";"Ki";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"19.99";"0.36";"4.13";"12.38";"0";"CHEMBL4398477";"Inhibition of FAM-GQVGRQLAIIGDDINR peptide binding to human Bcl-xL after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"8.08";"0.16";"-1.31";"5.13";"0";"CHEMBL1921244";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A142T";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"2, A-385358";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"11.07";"0.22";"1.23";"5.67";"0";"CHEMBL1921062";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"F97V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916193";"";"None";"812.98";"2";"7.60";"7";"CC(C)[C@H]1CN(Cc2ccccc2C(F)(F)F)CCN1c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"8.86";"0.18";"-0.40";"5.62";"0";"CHEMBL1921068";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"L130V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916194";"";"None";"812.98";"2";"7.60";"8";"CC(C)[C@@H]1CN(Cc2ccccc2C(F)(F)F)CCN1c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"10.56";"0.21";"0.99";"6.70";"0";"CHEMBL1921059";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1921341";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"A93V";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1916196";"";"None";"3205.53";"None";"None";"Puma";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O";"Ki";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"2.00";"None";"None";"None";"0";"CHEMBL1921345";"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"Q07817";"Y101H";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914418";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4762875";"";"None";"688.85";"2";"7.36";"14";"COC12CC3CC(CC(Cn4ncc(-c5ccc(N6CCc7cccc(C(=O)Nc8nc9ccccc9s8)c7C6)nc5C(=O)O)c4C)(C3)C1)C2";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5276241";"";"None";"349.41";"0";"2.94";"22ba";"CC(C)CN(c1ccc(O)c(C(=O)O)c1)S(=O)(=O)c1ccccc1";"Ki";"'='";"49300.0";"nM";"4.31";"";"";"UO_0000065";"12.33";"0.25";"1.37";"4.54";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL5266385";"";"None";"504.00";"2";"6.00";"6e-OH-5";"Cc1cc(Oc2ccc(S(=O)(=O)N(CC(C)C)c3ccc(O)c(C(=O)O)c3)cc2)cc(C)c1Cl";"Ki";"'='";"2910.0";"nM";"5.54";"";"";"UO_0000065";"10.98";"0.22";"-0.46";"5.32";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL384519";"";"None";"358.39";"0";"2.16";"3c";"CCOC(=O)C1=C(N)Oc2ccc(CC)cc2C1C(C#N)C(=O)OCC";"Ki";"'='";"135000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL911622";"Binding affinity to BclXL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138218";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4446378";"TAPOTOCLAX";"1.0";"613.22";"2";"5.90";"AMG176";"CO[C@H]1/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3";"Ki";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"10.04";"0.20";"0.25";"7.25";"1";"CHEMBL5096372";"Inhibition of recombinant His6-tagged human Bcl-xL (1 to 196 residues) expressed in Escherichia coli using biotinylated Bim BH3 peptide as substrate incubated for 60 mins by TR-FRET analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3828055";"";"None";"390.39";"0";"4.18";"2'-Benzyl-7-methoxyluteolin";"COc1cc(O)c2c(=O)cc(-c3cc(O)c(O)cc3Cc3ccccc3)oc2c1";"Ki";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"14.35";"0.26";"1.42";"5.59";"0";"CHEMBL3830807";"Inhibition of Bcl-XL (unknown origin) using FAM-Bid peptide as substrate by fluorescence polarization-based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3826894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4467409";"";"None";"659.61";"2";"8.51";"36";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2ccc(C(=O)O)cc2)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4469869";"";"None";"712.68";"2";"9.01";"42; VU0661013";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cn(C)c4ccc(C(=O)O)cc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL201670";"";"None";"704.83";"2";"5.38";"69";"COc1cc(CCC(=O)N2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"57.9";"nM";"7.24";"";"";"UO_0000065";"10.27";"0.20";"1.86";"4.60";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL370836";"";"None";"639.84";"2";"6.04";"76";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCCCN)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"Ki";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"10.30";"0.20";"0.55";"4.46";"0";"CHEMBL859054";"Binding affinity to Bcl-XL in 1% human serum by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3954629";"";"None";"946.59";"3";"8.69";"BDBM185631";"Cc1nc(OC[C@@H]2CN(C(=O)OC(C)(C)C)CCO2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cccc2[nH]cnc12";"Ki";"'='";"24.78";"nM";"7.61";"";"334824";"UO_0000065";"8.04";"0.16";"-1.08";"4.51";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699078";"";"None";"825.01";"3";"6.74";"BDBM139052";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)sc2CCc2ccccc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.8";"nM";"9.10";"";"273186";"UO_0000065";"11.03";"0.22";"2.36";"5.06";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3961198";"";"None";"637.14";"2";"6.22";"E-9";"O=C(/C=C/c1cccc(Cl)c1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"10.26";"0.21";"0.32";"4.43";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3417408";"";"None";"441.54";"1";"5.01";"14";"CCOc1ccccc1N/N=C1\C(=O)N(c2cccc(-c3ccc(N(C)C)cc3)c2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3401816";"";"None";"743.08";"2";"7.00";"30";"O=C(NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)[C@H](Cc1ccc(Br)cc1)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)cc3)cc2)SC1=S";"Ki";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"8.49";"0.19";"-0.69";"4.98";"0";"CHEMBL3405856";"Inhibition of Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence polarization technique";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399977";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"3; ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"1";"CHEMBL3795380";"Binding affinity to Bcl-XL (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3792281";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1940679";"";"None";"606.68";"2";"5.18";"5b";"COc1ccc(C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)cc1";"Ki";"'='";"1270.0";"nM";"5.90";"";"";"UO_0000065";"9.72";"0.19";"0.72";"3.76";"1";"CHEMBL3819998";"Binding affinity to Bcl-XL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL5079372";"";"None";"661.60";"2";"6.76";"TJ-A2";"O=C(NCCNS(=O)(=O)c1ccc(-c2ccccc2Oc2ccc(O)c(O)c2)s1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"8.80";"0.18";"-0.94";"4.25";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL2314191";"";"None";"343.81";"0";"4.84";"35";"Cc1cc(OCCCc2c(C(=O)O)[nH]c3ccccc23)ccc1Cl";"Ki";"'>'";"15000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2314508";"";"None";"204.22";"0";"3.06";"10";"Cc1ccc2c(C)c(C(=O)O)oc2c1C";"Ki";"'>'";"1000000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2320308";"Displacement of FITC-AHx-GQVGRQLAIIGDDINR-NH2 from Bcl-xL (unknown origin) after 1 hr by fluorescence polarization anisotropy assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311248";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3628077";"";"None";"526.43";"2";"6.13";"41";"O=C(O)c1ccc(COc2ccc(/C=C3\SC(=S)N(c4ccc(Br)cc4)C3=O)cc2)cc1";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3629837";"";"None";"477.56";"1";"5.38";"22";"COc1ccccc1N1C(=O)/C(=C/c2cccc(OCc3ccc(C(=O)O)cc3)c2)SC1=S";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3342333";"";"None";"669.80";"2";"6.33";"18";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc1F";"Ki";"'='";"1.12";"nM";"8.95";"";"";"UO_0000065";"13.36";"0.26";"2.62";"8.30";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"N3B";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"Ki";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"13.49";"0.27";"1.72";"6.29";"1";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4650225";"MURIZATOCLAX";"1.0";"765.46";"2";"6.44";"AMG397";"CO[C@]1(CN2CCN3CCCC[C@@H]3C2)/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3";"Ki";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5096372";"Inhibition of recombinant His6-tagged human Bcl-xL (1 to 196 residues) expressed in Escherichia coli using biotinylated Bim BH3 peptide as substrate incubated for 60 mins by TR-FRET analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"";""
"CHEMBL5206019";"";"None";"753.66";"3";"6.57";"14c";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCCN4CCOCC4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"";"";"";"";"";"NA";"";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL3793424";"";"None";"658.83";"2";"7.59";"13, A-1331852";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC12CC3CC(CC(C3)C1)C2";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4165700";"";"None";"537.01";"2";"6.23";"8f";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)Nc3cccnc3)C[C@@H]2C1";"Ki";"'='";"8480.0";"nM";"5.07";"";"";"UO_0000065";"9.44";"0.18";"-1.16";"4.03";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3358688";"";"None";"402.94";"1";"6.21";"I1";"O=C(CC(Sc1ccc(Cl)cc1)C(=O)O)c1ccc(C2CCCCC2)cc1";"Ki";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"13.22";"0.27";"-0.88";"9.80";"0";"CHEMBL3382994";"Displacement of F-bid from human recombinant N-terminal His-tagged Bcl-xL (1 to 209) expressed in Escherichia coli BL21(DE3) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4169123";"";"None";"614.92";"2";"7.60";"8d";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)Nc3ccc(Br)cc3)C[C@@H]2C1";"Ki";"'='";"2190.0";"nM";"5.66";"";"";"UO_0000065";"9.20";"0.20";"-1.94";"5.01";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4644487";"";"None";"375.51";"1";"6.20";"(-)-4k";"CC(C)=CCCC1=CC[C@@H](C(=O)Nc2ccc(O)cc2)[C@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL434952";"";"None";"621.74";"2";"5.52";"70";"COc1cc(CCCO)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"21.5";"nM";"7.67";"";"";"UO_0000065";"12.33";"0.24";"2.15";"5.19";"0";"CHEMBL859053";"Binding affinity to Bcl-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4161959";"";"None";"468.68";"1";"7.44";"1, Natural";"CC(C)=CCC[C@H](C)[C@@H]1C=C[C@]2(C(=O)O)[C@@H](CC(C)=C[C@H]2/C=C(\C)C2CCC(C(=O)O)CC2)C1";"Ki";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"10.84";"0.20";"-2.36";"6.81";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4176611";"";"None";"554.47";"2";"6.96";"12c";"COC(=O)[C@@]12C=C[C@@H](CC(=O)Nc3ccc(Cl)cc3)C[C@@H]1CC(C)=C[C@H]2/C=C(\Cl)c1ccc(C(=O)O)cc1";"Ki";"'='";"2740.0";"nM";"5.56";"";"";"UO_0000065";"10.03";"0.20";"-1.40";"6.00";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3979383";"";"None";"616.72";"2";"5.88";"E-2";"Cc1ccccc1/C=C/C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"10.83";"0.21";"0.80";"4.53";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL5178609";"";"None";"731.62";"2";"7.83";"14g";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCc4cccnc4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'='";"4420.0";"nM";"5.36";"";"";"UO_0000065";"7.32";"0.15";"-2.48";"3.38";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5180236";"";"None";"731.62";"2";"7.83";"14o";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCc4cccnc4)c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"1";"CHEMBL4147766";"Inhibition of Bcl-xL (unknown origin) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145520";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2173049";"Binding affinity to Bcl-XL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2169820";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";""
"CHEMBL5172723";"";"None";"720.59";"2";"8.03";"14d";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCc4ccco4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL5192774";"";"None";"734.62";"3";"7.17";"14n";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCc4ccn(C)n4)c3)cc2)cc(C)c1Cl";"Ki";"'='";"7410.0";"nM";"5.13";"";"";"UO_0000065";"6.98";"0.14";"-2.04";"3.14";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3983880";"";"None";"587.67";"2";"5.51";"7";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cn(Cc4ccccc4)nn3)c(C(=O)O)n1)CC2";"Ki";"'='";"5.96";"nM";"8.22";"";"";"UO_0000065";"14.00";"0.26";"2.71";"6.52";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4439276";"";"None";"829.27";"3";"7.76";"S63845";"Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(O[C@H](Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5096365";"Binding affinity to human Bcl-xL assessed as inhibition constant incubated for 2 hrs in presence of fluorescein-PUMA peptide by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 2.0 hr";"";""
"CHEMBL4864735";"";"None";"511.62";"2";"8.60";"9a";"Cc1cccc(-c2cn(CCCOc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)c1";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4870608";"";"None";"497.59";"1";"8.21";"9d";"Cc1cccc(-c2cn(CCOc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)c1";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4856143";"";"None";"513.59";"2";"7.91";"9k";"COc1ccccc1-c1cn(CCOc2cccc3ccccc23)c2cccc(-c3ccccc3C(=O)O)c12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4870458";"";"None";"467.57";"1";"8.18";"9o";"Cc1ccccc1-c1cn(Cc2cccc3ccccc23)c2cccc(-c3ccccc3C(=O)O)c12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4872495";"";"None";"483.57";"1";"7.88";"9p";"COc1ccccc1-c1cn(Cc2cccc3ccccc23)c2cccc(-c3ccccc3C(=O)O)c12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4851522";"";"None";"613.26";"2";"7.01";"AMG-176";"CO[C@H]1/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)CNc2ccc3c(c2)N(CC[C@@]2(CCCc4cc(Cl)ccc42)CO3)C[C@@H]2CC[C@H]21";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4640455";"";"None";"468.68";"1";"7.44";"Meiogynin A";"CC(C)=CCC[C@H](C)[C@@H]1C=C[C@]2(C(=O)O)[C@@H](CC(C)=C[C@H]2/C=C(\C)[C@H]2CC[C@H](C(=O)O)CC2)C1";"Ki";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"10.84";"0.20";"-2.36";"6.81";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3736193";"";"None";"842.17";"2";"6.98";"29";"Cc1ccc(-c2ccc(O[C@H]3C[C@@H](C(=O)N[C@@H](Cc4ccc(Br)cc4)C(=O)NS(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)N(C(=O)OC(C)(C)C)C3)cc2)cc1";"Ki";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"7.03";"0.15";"-1.06";"3.40";"0";"CHEMBL3736963";"Competitive binding affinity to Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 peptide preincubated for 30 mins before 5-FAM-Bid-BH3 peptide addition and measured 20 mins after 5-FAM-Bid-BH3 peptide addition by fluorescence polarization assayy";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734725";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4086356";"";"None";"712.68";"2";"8.83";"30";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cc(C(=O)O)cc4c2ccn4C)C3=O)cc(C)c1Cl";"Ki";"'>'";"36000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"284.0";"nM";"6.55";"";"";"UO_0000065";"8.05";"0.16";"-1.33";"5.11";"0";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4163814";"";"None";"561.03";"1";"4.53";"13";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CCO)C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4216956";"";"None";"508.00";"2";"6.48";"12b";"Cc1cc(Oc2ccc(/C=C3\SC(=O)N([C@@H](Cc4ccccc4)C(=O)O)C3=O)cc2)cc(C)c1Cl";"Ki";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"13.87";"0.27";"0.57";"8.40";"0";"CHEMBL4184603";"Inhibition of FITC-labeled Bak-BH3 peptide binding to Bcl-XL (2 to 212 residues) (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184084";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4632968";"";"None";"313.44";"0";"4.70";"(+)-4b";"CC(C)=CCCC1=CC[C@H](C(=O)N(C)O)[C@@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4637744";"";"None";"327.47";"0";"4.71";"(-)-10";"CON(C)C(=O)[C@@H]1CC2=C(CCCC2(C)C)C[C@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3785689";"";"None";"725.74";"2";"8.09";"72";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3ccnc(NCCC(C)C)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"4467.0";"nM";"5.35";"";"";"UO_0000065";"7.37";"0.15";"-2.74";"4.08";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"ABT-199; GDC-0199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"0";"CHEMBL3819992";"Binding affinity to His-tagged Bcl-XL (unknown origin) incubated for 30 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL4457901";"";"None";"463.58";"1";"5.67";"15";"O=C(O)c1cc(SCCc2ccccc2)ccc1NS(=O)(=O)c1ccc2ccccc2c1";"Ki";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"11.40";"0.23";"-0.39";"6.33";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3417410";"";"None";"345.43";"0";"4.62";"16";"CC1=NN(c2nc(-c3ccccc3)cs2)C(=O)/C1=C/c1ccccc1";"Ki";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"16.27";"0.31";"1.00";"12.33";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4469869";"";"None";"712.68";"2";"9.01";"42; VU0661013";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cn(C)c4ccc(C(=O)O)cc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3937724";"";"None";"612.71";"2";"7.97";"BDBM209165";"Cc1cc(Oc2ccccc2)ccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"21.0";"nM";"7.68";"";"369810";"UO_0000065";"12.53";"0.23";"-0.29";"7.34";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974222";"";"None";"632.79";"2";"8.14";"BDBM209169";"Cc1cc(OCC2CCCCC2)ccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"5.0";"nM";"8.30";"";"369814";"UO_0000065";"13.12";"0.25";"0.16";"7.93";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895034";"";"None";"691.86";"2";"6.41";"BDBM209214";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(N2CCOCC2)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369859";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4177447";"";"None";"544.05";"2";"6.54";"19a";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCn3cc(-c4ccccc4)nn3)C[C@@H]2C1";"Ki";"'='";"2440.0";"nM";"5.61";"";"";"UO_0000065";"10.32";"0.20";"-0.93";"5.33";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4175138";"";"None";"568.50";"2";"7.05";"11c";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)Nc4ccc(Cl)cc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"Gossypol";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.29";"0.21";"-0.53";"3.76";"0";"CHEMBL3871750";"Inhibition of 5-FAM-DMRPEIWIAQELRRIGDEFNAYYARR binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by FAM-labeled peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871281";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3754255";"";"None";"1747.08";"None";"None";"7";"CC(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"4.98";"None";"None";"None";"0";"CHEMBL3754932";"Inhibition of BCL-xL-BH3 domain (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751840";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4247875";"";"None";"490.51";"2";"5.57";"Gossypol";"Cc1cc2c(C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4236687";"Inhibition of Bid-BH3 peptide binding to Bcl-xL (unknown origin) after 3 hrs by fluorescence polarization method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229556";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1; ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4052837";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4061247";"";"None";"628.81";"2";"9.64";"page 831, R17C2";"CC(C)Cc1cc(-c2ccc(-c3ccc(CCC(=O)O)cc3CC(C)C)cc2Cc2cccc3ccccc23)ccc1OCC(=O)O";"Ki";"'='";"114.0";"nM";"6.94";"";"";"UO_0000065";"11.04";"0.20";"-2.70";"8.28";"0";"CHEMBL4052864";"Inhibition of fluorescein-labeled 16-mer Bak peptide binding to Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3736460";"";"None";"862.58";"2";"7.32";"30";"CC(C)(C)OC(=O)N1C[C@@H](Oc2ccc(-c3ccc(Cl)cc3)cc2)C[C@H]1C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"6.58";"0.14";"-1.64";"3.26";"0";"CHEMBL3736963";"Competitive binding affinity to Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 peptide preincubated for 30 mins before 5-FAM-Bid-BH3 peptide addition and measured 20 mins after 5-FAM-Bid-BH3 peptide addition by fluorescence polarization assayy";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734725";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3935424";"";"None";"774.77";"2";"7.74";"BDBM185627";"Cc1cc(C)n2nc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cccc(Cl)c3)nc2n1";"Ki";"'='";"0.407";"nM";"9.39";"";"334820";"UO_0000065";"12.12";"0.24";"1.65";"7.70";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3982046";"";"None";"646.19";"2";"6.06";"BDBM185615";"O=C(NS(=O)(=O)c1ccc(/C=C/c2ncon2)s1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"393.36";"nM";"6.41";"";"334808";"UO_0000065";"9.91";"0.20";"0.35";"5.90";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3819991";"Binding affinity to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL4876348";"";"None";"497.59";"1";"8.21";"9h";"Cc1ccc(-c2cn(CCOc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)cc1";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL3828618";"";"None";"376.36";"0";"3.87";"2'-Benzylluteolin";"O=c1cc(-c2cc(O)c(O)cc2Cc2ccccc2)oc2cc(O)cc(O)c12";"Ki";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"13.49";"0.25";"1.21";"4.57";"0";"CHEMBL3830807";"Inhibition of Bcl-XL (unknown origin) using FAM-Bid peptide as substrate by fluorescence polarization-based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3826894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"AT-101";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"12.55";"0.23";"0.13";"4.19";"0";"CHEMBL3830807";"Inhibition of Bcl-XL (unknown origin) using FAM-Bid peptide as substrate by fluorescence polarization-based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3826894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4644062";"";"None";"327.47";"0";"4.87";"(+)-2";"CON(C)C(=O)[C@H]1CC=C(CCC=C(C)C)C[C@@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649510";"";"None";"283.42";"0";"4.34";"(+)-4d";"CC(C)=CCCC1=CC[C@H](C(N)=O)[C@@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4643058";"";"None";"283.42";"0";"4.34";"(-)-4d";"CC(C)=CCCC1=CC[C@@H](C(N)=O)[C@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4522193";"";"None";"553.75";"2";"5.50";"23";"CC(C)(C)c1ccc(N2CCN(S(=O)(=O)Nc3ccc(SCCc4ccccc4)cc3C(=O)O)CC2)cc1";"Ki";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"9.85";"0.20";"-0.04";"6.07";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4525910";"";"None";"596.78";"2";"5.28";"27";"CC(C)(C)c1ccc(N2CCN(S(=O)(=O)Nc3ccc(SCCC(=O)Nc4ccccc4)cc3C(=O)O)CC2)cc1";"Ki";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4247553";"";"None";"666.15";"2";"6.44";"4a";"CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OCc2ccc(-c3ccccc3)cc2)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4236687";"Inhibition of Bid-BH3 peptide binding to Bcl-xL (unknown origin) after 3 hrs by fluorescence polarization method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229556";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3900077";"";"None";"602.69";"2";"5.57";"E-1";"O=C(/C=C/c1ccccc1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"11.37";"0.22";"1.28";"4.65";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3287296";"";"None";"564.67";"2";"6.22";"4";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(CCCOc3ccccc3)c(C(=O)O)n1)CC2";"Ki";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.09";"0.27";"1.74";"7.60";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4250906";"";"None";"720.85";"2";"6.30";"6e";"Cc1ccc(CC(=O)N[C@@H](Cc2ccc(OCc3ccccc3)cc2)C(=O)NS(=O)(=O)c2ccc(NCCCc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4236687";"Inhibition of Bid-BH3 peptide binding to Bcl-xL (unknown origin) after 3 hrs by fluorescence polarization method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229556";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4802151";"PELCITOCLAX";"1.0";"1281.87";"None";"None";"9; APG-1252";"Cc1c(S(C)(=O)=O)c(-c2cc(F)cc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN6CCC(C(=O)OCCCP(=O)(O)O)CC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5108721";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107957";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4875429";"";"None";"525.65";"2";"9.03";"9j";"CC(C)c1ccccc1-c1cn(CCOc2cccc3ccccc23)c2cccc(-c3ccccc3C(=O)O)c12";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL4846508";"";"None";"467.57";"1";"8.18";"9m";"Cc1ccc(-c2cn(Cc3cccc4ccccc34)c3cccc(-c4ccccc4C(=O)O)c23)cc1";"Ki";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL3971226";"";"None";"604.71";"2";"5.49";"D-2";"O=C(CCc1ccccc1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"10.74";"0.21";"1.00";"4.40";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4167274";"";"None";"596.55";"2";"6.77";"11d";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)NCCc4ccc(Cl)cc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL5091070";"";"None";"677.67";"2";"6.92";"TJ-A1";"O=S(=O)(NCCNC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(-c2ccccc2Oc2ccc(O)c(O)c2)s1";"Ki";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"8.90";"0.19";"-0.89";"5.03";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL4171691";"";"None";"575.01";"1";"4.63";"14";"CC(=O)OCOC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)O)C=C[C@]32C(=O)OCOC(C)=O)cc1";"Ki";"'='";"15630.0";"nM";"4.81";"";"";"UO_0000065";"8.36";"0.16";"0.18";"3.37";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4175134";"";"None";"554.47";"2";"6.55";"16";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CC(=O)NCc3ccc(Cl)cc3)C[C@@H]2C1";"Ki";"'='";"14080.0";"nM";"4.85";"";"";"UO_0000065";"8.75";"0.17";"-1.70";"4.68";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4159296";"";"None";"444.96";"0";"4.75";"9";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CCO)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3699070";"";"None";"920.07";"3";"7.46";"BDBM139044";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)ccc2CCCc2ccccc2)cc1S(=O)(=O)C(F)(F)F";"Ki";"'='";"48.0";"nM";"7.32";"";"273178";"UO_0000065";"7.95";"0.16";"-0.14";"4.29";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL5270912";"";"None";"399.47";"0";"4.09";"17ab";"CC(C)CN(c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1ccc2ccccc2c1";"Ki";"'='";"43100.0";"nM";"4.37";"";"";"UO_0000065";"10.93";"0.21";"0.28";"4.60";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL5283389";"";"None";"538.02";"2";"6.55";"17cd";"Cc1cc(Oc2ccc(S(=O)(=O)N(Cc3ccccc3)c3ccc(C(=O)O)c(O)c3)cc2)cc(C)c1Cl";"Ki";"'='";"1670.0";"nM";"5.78";"";"";"UO_0000065";"10.74";"0.21";"-0.77";"5.55";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL5207619";"";"None";"731.62";"2";"7.83";"14i";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCc4ccncc4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL5183183";"";"None";"745.64";"2";"7.88";"14j";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(NCCc4ccncc4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL5191785";"";"None";"720.59";"2";"8.03";"14l";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc([N+](=O)[O-])c(NCc4ccco4)c3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL3358688";"";"None";"402.94";"1";"6.21";"I1";"O=C(CC(Sc1ccc(Cl)cc1)C(=O)O)c1ccc(C2CCCCC2)cc1";"Ki";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"12.21";"0.25";"-1.29";"9.05";"0";"CHEMBL3383563";"Displacement of F-bid from human recombinant N-terminal His-tagged Bcl-xL (1 to 209) expressed in Escherichia coli BL21(DE3) after 120 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4085804";"";"None";"1131.80";"None";"None";"8; BM-1197";"Cc1c(S(C)(=O)=O)c(-c2cc(F)cc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN6CCC(O)CC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5108719";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107957";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4860027";"";"None";"421.50";"1";"6.63";"3";"O=C(O)c1ccccc1-c1cccc2c1ccn2CCCOc1cccc2ccccc12";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";""
"CHEMBL3930426";"";"None";"636.74";"2";"7.27";"BDBM209082";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccc5ccccc5c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"33.0";"nM";"7.48";"";"369727";"UO_0000065";"11.75";"0.22";"0.21";"6.61";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930283";"";"None";"738.91";"3";"7.15";"BDBM209224";"COCC(COC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCCC1)OC";"Ki";"'<'";"0.1";"nM";"";"";"369869";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5078508";"";"None";"677.67";"2";"6.92";"TJ-B1";"O=S(=O)(NCCNC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(-c2ccccc2Oc2ccc(O)c(O)c2)cs1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"8.85";"0.19";"-0.92";"5.00";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3980363";"";"None";"632.72";"2";"5.58";"E-5";"COc1ccccc1/C=C/C(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"11.14";"0.22";"1.47";"4.50";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1940668";"";"None";"576.66";"2";"5.17";"B-1";"O=C(Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1ccccc1";"Ki";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"10.75";"0.21";"1.03";"4.20";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3902269";"";"None";"670.69";"2";"6.59";"E-12";"O=C(/C=C/c1cccc(C(F)(F)F)c1)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"9.75";"0.19";"-0.05";"4.43";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4440978";"";"None";"373.50";"0";"4.53";"1c";"CCc1sc2ncnc(N[C@@H](C)C(=O)O)c2c1-c1ccc(SC)cc1";"Ki";"'='";"216000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3426328";"";"None";"401.92";"1";"5.42";"29";"Cc1cc(OCCCc2c(C(=O)O)n3c4c(cccc24)SCC3)ccc1Cl";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4443675";"";"None";"391.45";"0";"4.62";"5b";"C[C@@H](Nc1ncnc2sc(-c3ccccc3)c(-c3cccc(O)c3)c12)C(=O)O";"Ki";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"11.18";"0.21";"-0.24";"4.59";"0";"CHEMBL4375086";"Inhibition of Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373699";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<='";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3364171";"Binding affinity to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351920";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";""
"CHEMBL3977941";"";"None";"587.67";"2";"5.51";"BDBM209057";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccnc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"258.0";"nM";"6.59";"";"369702";"UO_0000065";"11.21";"0.21";"1.08";"5.22";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921932";"";"None";"600.70";"2";"6.68";"BDBM209059";"CC(c1ccccc1)n1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"19.0";"nM";"7.72";"";"369704";"UO_0000065";"12.85";"0.24";"1.04";"6.82";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943990";"";"None";"592.73";"2";"6.65";"BDBM209096";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CC4CCCCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"2.0";"nM";"8.70";"";"369741";"UO_0000065";"14.68";"0.28";"2.05";"7.68";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891345";"";"None";"715.84";"3";"5.83";"BDBM209100";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4OCCN4CCOCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"9.0";"nM";"8.05";"";"369745";"UO_0000065";"11.24";"0.21";"2.22";"5.96";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950490";"";"None";"735.85";"3";"5.14";"BDBM209126";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4S(=O)(=O)N4CCOCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"28.0";"nM";"7.55";"";"369771";"UO_0000065";"10.26";"0.20";"2.41";"4.72";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971522";"";"None";"664.83";"2";"7.53";"BDBM209238";"COCCC(C1CCCCC1)n1ncc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c1C";"Ki";"'<'";"0.1";"nM";"";"";"369882";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3426317";"";"None";"371.44";"1";"5.06";"17";"O=C(O)c1c(CCOc2cccc3ccccc23)c2cccc3c2n1CCC3";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3425519";"";"None";"403.50";"1";"5.61";"19";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCS3";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3426324";"";"None";"449.53";"0";"4.68";"25";"O=C(O)c1c(CCCOc2cccc3ccccc23)c2cccc3c2n1CCCS3(=O)=O";"Ki";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3426325";"";"None";"407.54";"1";"5.34";"26";"O=C(O)c1c(CCCOc2cccc3c2CCCC3)c2cccc3c2n1CCS3";"Ki";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"13.55";"0.26";"0.18";"10.73";"0";"CHEMBL3429295";"Displacement of FITC-Bak-BH3 peptide from Bcl-xL (unknown origin) incubated for 1.5 hrs by FPA competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425420";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3941926";"";"None";"707.90";"2";"6.95";"BDBM209239";"CNCCOC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369883";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912413";"";"None";"692.80";"2";"7.70";"BDBM209085";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4OCc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"18.0";"nM";"7.75";"";"369730";"UO_0000065";"11.18";"0.21";"0.04";"6.32";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4060912";"";"None";"737.23";"2";"6.95";"9h";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccccc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c(C)n2-c1ccc(-c2ccccc2)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4046938";"Inhibition of 5-FAM-Bid-BH3 peptide binding to Bcl-XL (unknown origin) pre-incubated for 30 mins followed by further incubation with 5-FAM-Bid-BH3 peptide for 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043209";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3401826";"";"None";"598.77";"2";"5.98";"WL-276";"Cc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)N2C(=O)/C(=C/c3ccc(-c4ccccc4)cc3)SC2=S)cc1";"Ki";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"10.17";"0.20";"0.11";"7.29";"0";"CHEMBL3994257";"Inhibition of N-terminal FAM-labeled Bid-BH3 peptide binding to Bcl-XL (unknown origin) preincubated for 30 mins followed by N-terminal FAM-labeled Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992555";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4646779";"";"None";"313.44";"0";"4.70";"(-)-4b";"CC(C)=CCCC1=CC[C@@H](C(=O)N(C)O)[C@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL335265";"";"None";"400.32";"0";"3.76";"1; BH3I-1";"CC(C)C(C(=O)O)N1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S";"Ki";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"14.04";"0.35";"1.86";"9.75";"1";"CHEMBL4184604";"Inhibition of succinimidyl Oregon Green-labeled Bak-BH3 peptide binding to GST-tagged Bcl-XL (unknown origin) expressed in human Jurkat cells after 1 to 2 hrs by fluorescence polarization competition assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184084";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3629836";"";"None";"477.56";"1";"5.38";"21";"COc1ccccc1N1C(=O)/C(=C/c2ccc(OCc3ccc(C(=O)O)cc3)cc2)SC1=S";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3902902";"";"None";"606.75";"2";"7.04";"BDBM209114";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(CCC4CCCCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"5.0";"nM";"8.30";"";"369759";"UO_0000065";"13.68";"0.26";"1.26";"7.33";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930891";"";"None";"654.67";"2";"7.14";"BDBM209115";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"11.0";"nM";"7.96";"";"369760";"UO_0000065";"12.16";"0.23";"0.82";"7.03";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911838";"";"None";"662.78";"2";"7.78";"BDBM209119";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4)c3-c3ccccc3)c(C(=O)O)n1)CC2";"Ki";"'='";"393.0";"nM";"6.41";"";"369764";"UO_0000065";"9.66";"0.18";"-1.37";"5.66";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899168";"";"None";"608.72";"2";"5.80";"BDBM209120";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCCOC1";"Ki";"'='";"3.0";"nM";"8.52";"";"369765";"UO_0000065";"14.00";"0.26";"2.72";"6.96";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964893";"";"None";"671.78";"2";"5.95";"BDBM209130";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4N4CCOCC4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"29.0";"nM";"7.54";"";"369775";"UO_0000065";"11.22";"0.21";"1.59";"6.00";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977349";"";"None";"648.83";"2";"8.06";"BDBM209141";"CC(C)CC1(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)CCCCC1";"Ki";"'='";"4.0";"nM";"8.40";"";"369786";"UO_0000065";"12.94";"0.24";"0.34";"7.42";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948854";"";"None";"886.54";"3";"9.39";"BDBM185622";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cc([N+](=O)[O-])c(NCCCN5CCCC5)s4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"0.649";"nM";"9.19";"";"334815";"UO_0000065";"10.36";"0.21";"-0.20";"6.00";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3921048";"";"None";"860.50";"3";"8.85";"BDBM185623";"CN(C)CCCNc1sc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CC(C)(C)CC4)CC3)cc2Oc2ccc3[nH]ccc3c2)cc1[N+](=O)[O-]";"Ki";"'='";"1.791";"nM";"8.75";"";"334816";"UO_0000065";"10.16";"0.20";"-0.10";"5.71";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3950005";"";"None";"797.36";"2";"7.71";"BDBM185628";"Cc1cc(C)n2nc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cc4cc[nH]c4cc3F)nc2n1";"Ki";"'='";"0.053";"nM";"10.28";"";"334821";"UO_0000065";"12.89";"0.25";"2.57";"7.46";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3911407";"";"None";"863.48";"3";"8.58";"BDBM185632";"Cc1nc(OCC2(F)CCOCC2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cnc2[nH]ccc2c1";"Ki";"'='";"6.735";"nM";"8.17";"";"334825";"UO_0000065";"9.46";"0.19";"-0.41";"5.88";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3912602";"";"None";"946.59";"3";"8.69";"BDBM185634";"Cc1nc(OC[C@@H]2CN(C(=O)OC(C)(C)C)CCO2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cccc2[nH]ncc12";"Ki";"'='";"20.42";"nM";"7.69";"";"334827";"UO_0000065";"8.12";"0.16";"-1.00";"4.56";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"20";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4220002";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219043";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4228713";"A-1211212";"None";"896.51";"3";"9.44";"22";"CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"Ki";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"8.76";"0.17";"-1.59";"4.57";"0";"CHEMBL4220002";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219043";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4641996";"";"None";"311.47";"0";"4.94";"(+)-4e";"CC(C)=CCCC1=CC[C@H](C(=O)N(C)C)[C@@H](c2ccccc2)C1";"Ki";"'='";"20100.0";"nM";"4.70";"";"";"UO_0000065";"15.08";"0.28";"-0.24";"23.13";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4639809";"";"None";"311.47";"0";"4.94";"(-)-4e";"CC(C)=CCCC1=CC[C@@H](C(=O)N(C)C)[C@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3699066";"";"None";"843.05";"3";"7.12";"5";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2csc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)n2)cc1[N+](=O)[O-]";"Ki";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"11.69";"0.24";"2.73";"5.48";"0";"CHEMBL4715587";"Inhibition of F-Bak binding to GST-tagged BCL-XL (unknown origin) measured after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706772";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4082941";"";"None";"709.67";"2";"9.50";"36";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)CCCN(c2cccc4c(C(=O)O)cccc24)C3=O)cc(C)c1Cl";"Ki";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4023203";"Inhibition of FITC-Bak-BH3 binding to Bcl-XL (unknown origin) after 1.5 hrs by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020825";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4163818";"";"None";"596.55";"2";"7.07";"11b";"COC(=O)c1ccc(/C(Cl)=C/[C@@H]2C=C(C)C[C@H]3C[C@H](CC(=O)N(C)Cc4ccc(Cl)cc4)C=C[C@]32C(=O)OC)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4172927";"";"None";"776.28";"2";"9.56";"3";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)c3ccc(Oc4ccc(NC(=O)COc5ccc(C)cc5)cc4)cc3)C[C@@H]2C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4640677";"";"None";"369.51";"0";"4.53";"(+)-4f";"COC(=O)CCNC(=O)[C@H]1CC=C(CCC=C(C)C)C[C@@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4647892";"";"None";"369.51";"0";"4.53";"(-)-4f";"COC(=O)CCNC(=O)[C@@H]1CC=C(CCC=C(C)C)C[C@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4644989";"";"None";"355.48";"0";"4.44";"(+)-4i";"CC(C)=CCCC1=CC[C@H](C(=O)NCCC(=O)O)[C@@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4633307";"";"None";"284.40";"0";"4.77";"(-)-9";"CC1(C)CCCC2=C1C[C@@H](C(=O)O)[C@H](c1ccccc1)C2";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3920602";"";"None";"620.78";"2";"7.21";"BDBM209138";"CCc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1CCCCC1";"Ki";"'='";"0.7";"nM";"9.15";"";"369783";"UO_0000065";"14.75";"0.28";"1.94";"8.08";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894225";"";"None";"650.80";"2";"7.06";"BDBM209142";"COCCC1(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)CCCCC1";"Ki";"'='";"3.0";"nM";"8.52";"";"369787";"UO_0000065";"13.10";"0.25";"1.46";"6.96";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968769";"";"None";"658.78";"2";"7.08";"BDBM209148";"COCCCC(c1ccccc1)n1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"5.0";"nM";"8.30";"";"369793";"UO_0000065";"12.60";"0.24";"1.22";"6.78";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899394";"";"None";"604.74";"2";"6.57";"BDBM209237";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)ccnc1N1CCCCC1";"Ki";"'='";"0.7";"nM";"9.15";"";"369881";"UO_0000065";"15.14";"0.28";"2.58";"8.21";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"22; ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"1";"CHEMBL4052851";"Binding affinity to Bcl-xL (unknown origin) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3909211";"";"None";"680.83";"2";"6.74";"BDBM209155";"COCCOC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCC1";"Ki";"'='";"0.4";"nM";"9.40";"";"369800";"UO_0000065";"13.80";"0.26";"2.66";"7.14";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923044";"";"None";"646.81";"2";"8.53";"BDBM209175";"Cc1c(OC2CCCC(C)(C)C2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.1";"nM";"10.00";"";"369820";"UO_0000065";"15.46";"0.29";"1.47";"9.56";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945287";"";"None";"664.83";"2";"7.36";"BDBM209211";"COC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369856";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923925";"";"None";"646.82";"2";"7.34";"BDBM209215";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)ccnc1CN(C)C1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369860";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921464";"";"None";"713.91";"2";"7.86";"BDBM209185";"CC1CCC(C#N)CC1(Cn1ccc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c1)N1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369830";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928574";"";"None";"619.75";"2";"7.29";"BDBM209192";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)ccnc1OC1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369837";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954665";"";"None";"621.12";"2";"6.77";"BDBM209069";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccc(Cl)cc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"35.0";"nM";"7.46";"";"369714";"UO_0000065";"12.00";"0.23";"0.69";"6.58";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916278";"";"None";"611.69";"2";"5.99";"BDBM209078";"N#Cc1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"64.0";"nM";"7.19";"";"369723";"UO_0000065";"11.76";"0.22";"1.20";"5.25";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903407";"";"None";"672.77";"2";"6.60";"BDBM209087";"CCOC(=O)c1nn(Cc2ccccc2)c(C)c1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"169.0";"nM";"6.77";"";"369732";"UO_0000065";"10.07";"0.19";"0.17";"4.85";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4109874";"";"None";"690.87";"2";"7.40";"BDBM209204";"COCC[C@H]1C(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)C[C@@H]2C[C@H]1C2(C)C";"Ki";"'='";"0.2";"nM";"9.70";"";"369849";"UO_0000065";"14.04";"0.26";"2.30";"7.92";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968862";"";"None";"596.71";"2";"7.46";"BDBM209160";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.1";"nM";"10.00";"";"369805";"UO_0000065";"16.76";"0.31";"2.54";"10.48";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939320";"";"None";"616.79";"2";"8.30";"BDBM209161";"Cc1c(CC2CCCCC2)cccc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.2";"nM";"9.70";"";"369806";"UO_0000065";"15.72";"0.29";"1.40";"10.16";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928464";"";"None";"622.72";"2";"7.72";"BDBM209173";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cccc(OC4CCCCC4)c3F)c(C(=O)O)n1)CC2";"Ki";"'<'";"0.1";"nM";"";"";"369818";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911895";"";"None";"636.78";"2";"6.73";"BDBM209219";"COC1(Cn2ncc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369864";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915850";"";"None";"749.89";"3";"5.95";"BDBM209228";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCC(=O)N2CCOCC2)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369873";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894010";"";"None";"706.85";"2";"6.84";"BDBM209235";"CN(c1cccc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c1C#N)S(=O)(=O)C1CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369879";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910441";"";"None";"664.77";"2";"5.52";"BDBM209123";"CS(=O)(=O)c1cccc(Cn2cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)cn2)c1";"Ki";"'='";"91.0";"nM";"7.04";"";"369768";"UO_0000065";"10.59";"0.20";"1.52";"4.78";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936044";"";"None";"601.58";"2";"5.87";"BDBM185613";"Cc1nsc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)c1Cl";"Ki";"'='";"342.1";"nM";"6.47";"";"334806";"UO_0000065";"10.75";"0.23";"0.60";"7.83";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3956645";"";"None";"695.10";"2";"7.73";"BDBM185614";"Cc1c(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)sc2ccc(Br)cc12";"Ki";"'='";"372.11";"nM";"6.43";"";"334807";"UO_0000065";"9.25";"0.20";"-1.30";"9.22";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1940678";"";"None";"655.55";"2";"5.93";"5a";"O=C(Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1)c1ccc(Br)cc1";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"8.88";"0.19";"-0.11";"3.95";"1";"CHEMBL3819998";"Binding affinity to Bcl-XL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL4449014";"";"None";"712.68";"2";"9.01";"41";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cn(C)c4cc(C(=O)O)ccc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4398468";"Inhibition of Flu-Bax peptide binding to Bcl-xL (unknown origin) by time-resolved fluorescence resonance energy transfer assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3793424";"";"None";"658.83";"2";"7.59";"A-1331,852";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC12CC3CC(CC(C3)C1)C2";"Ki";"'<'";"0.01";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"AT-101";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.19";"0.23";"-0.06";"4.06";"1";"CHEMBL4398457";"Inhibition of Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3914582";"";"None";"847.53";"3";"8.72";"BDBM185597";"CC(C)N(C)CC[C@H](CSc1ccccc1)Nc1sc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"0.084";"nM";"10.08";"";"334790";"UO_0000065";"11.89";"0.24";"1.36";"7.86";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942247";"";"None";"685.27";"2";"6.44";"BDBM185602";"O=C(NCc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)s1)c1ccccc1";"Ki";"'='";"392.53";"nM";"6.41";"";"334795";"UO_0000065";"9.35";"0.19";"-0.03";"6.48";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3978310";"";"None";"696.22";"2";"8.20";"BDBM185606";"O=C(NS(=O)(=O)c1csc(C(F)(F)F)c1-c1ccccc1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"37.86";"nM";"7.42";"";"334799";"UO_0000065";"10.66";"0.22";"-0.78";"10.65";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3903210";"";"None";"667.26";"2";"5.22";"BDBM185617";"CCC(CC)NC(=O)c1nnc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)s1";"Ki";"'='";"417.29";"nM";"6.38";"";"334810";"UO_0000065";"9.56";"0.19";"1.16";"5.12";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4172616";"";"None";"614.09";"2";"7.63";"2";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCOC(=O)c3ccc(Oc4cccnc4)cc3)C[C@@H]2C1";"Ki";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.11";"0.21";"-0.81";"5.55";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4166826";"";"None";"558.08";"2";"6.47";"19b";"CC1=C[C@@H](/C=C(\Cl)c2ccc(C(=O)O)cc2)[C@]2(C(=O)O)C=C[C@@H](CCn3cc(Cc4ccccc4)nn3)C[C@@H]2C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4148754";"Inhibition of FITC-AhxBak-OH binding to human 45-84/C37 Bcl-xL after 2 hrs by fluorescent polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145547";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4645693";"";"None";"389.54";"1";"6.50";"(-)-4h";"COc1ccc(NC(=O)[C@@H]2CC=C(CCC=C(C)C)C[C@H]2c2ccccc2)cc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4448621";"";"None";"413.52";"0";"4.52";"1";"O=C(O)c1cc(SCCc2ccccc2)ccc1NS(=O)(=O)c1ccccc1";"Ki";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4440719";"";"None";"529.66";"1";"4.33";"22";"O=C(O)c1cc(SCCc2ccccc2)ccc1NS(=O)(=O)N1CCN(Cc2ccc(F)cc2)CC1";"Ki";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3947557";"";"None";"555.10";"1";"3.64";"BDBM185604";"O=C(NS(=O)(=O)N1CCOCC1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"408.57";"nM";"6.39";"";"334797";"UO_0000065";"11.51";"0.23";"2.75";"7.77";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4640067";"";"None";"403.52";"1";"6.19";"(+)-4j";"CC(C)=CCCC1=CC[C@H](C(=O)Nc2ccc(C(=O)O)cc2)[C@@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4646299";"";"None";"313.44";"0";"4.53";"(-)-4a";"CONC(=O)[C@@H]1CC=C(CCC=C(C)C)C[C@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4648756";"";"None";"403.52";"1";"6.19";"(-)-4j";"CC(C)=CCCC1=CC[C@@H](C(=O)Nc2ccc(C(=O)O)cc2)[C@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4646811";"";"None";"284.40";"0";"4.77";"(+)-9";"CC1(C)CCCC2=C1C[C@H](C(=O)O)[C@@H](c1ccccc1)C2";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3735093";"";"None";"763.27";"2";"6.21";"28";"Cc1ccc(-c2ccc(O[C@H]3C[C@@H](C(=O)N[C@@H](Cc4ccccc4)C(=O)NS(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)N(C(=O)OC(C)(C)C)C3)cc2)cc1";"Ki";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"6.63";"0.13";"-1.15";"2.90";"0";"CHEMBL3736963";"Competitive binding affinity to Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 peptide preincubated for 30 mins before 5-FAM-Bid-BH3 peptide addition and measured 20 mins after 5-FAM-Bid-BH3 peptide addition by fluorescence polarization assayy";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734725";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3629656";"";"None";"667.53";"2";"5.15";"8g";"O=C(NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)[C@H](Cc1ccccc1)N1C(=O)N[C@@H](Cc2ccc(-c3ccc(Cl)cc3)cc2)C1=O";"Ki";"'='";"6100.0";"nM";"5.21";"";"";"UO_0000065";"7.81";"0.16";"0.06";"3.35";"0";"CHEMBL3632440";"Competitive binding affinity to Bcl-XL (unknown origin) preincubated for 30 mins followed by 5-FAM-Bid-BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627718";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3979454";"";"None";"716.82";"3";"6.22";"BDBM209154";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1Cc1ccccc1OCC1COCCO1";"Ki";"'='";"3.0";"nM";"8.52";"";"369799";"UO_0000065";"11.89";"0.22";"2.30";"6.05";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938659";"";"None";"626.74";"2";"7.34";"BDBM209197";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)ccnc1N(C)c1ccccc1";"Ki";"'<'";"0.1";"nM";"";"";"369842";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951516";"";"None";"612.71";"2";"7.97";"BDBM209163";"Cc1ccc(Oc2ccccc2)cc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"49.0";"nM";"7.31";"";"369808";"UO_0000065";"11.93";"0.22";"-0.66";"6.99";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3961230";"";"None";"707.88";"2";"6.49";"BDBM209225";"Cc1[nH]c(C#N)c(CC2CCCCC2)c1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)NS(C)(=O)=O";"Ki";"'<'";"0.1";"nM";"";"";"369870";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924846";"";"None";"718.88";"2";"7.61";"BDBM209226";"COCCOC1(Cn2c(C#N)cc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369871";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985366";"";"None";"673.84";"2";"7.12";"BDBM209230";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cc(C#N)n1CC1(N(C)C)CCCCC1";"Ki";"'<'";"0.1";"nM";"";"";"369875";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945285";"";"None";"756.95";"3";"6.78";"BDBM209232";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(OCCS(C)(=O)=O)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369877";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"17, A-1155463";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"Ki";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.93";"0.29";"3.67";"9.27";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342194";"";"None";"636.76";"2";"6.46";"12";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3ccc(-n4cccn4)cc3)s1)CC2";"Ki";"'='";"0.99";"nM";"9.00";"";"";"UO_0000065";"14.14";"0.27";"2.54";"7.35";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3342193";"";"None";"702.82";"3";"6.80";"11";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"Ki";"'='";"55.4";"nM";"7.26";"";"";"UO_0000065";"10.32";"0.20";"0.46";"4.89";"0";"CHEMBL3382382";"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351549";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3947409";"";"None";"561.64";"2";"5.15";"C";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(C(=O)c2ccccc2)cc1";"Ki";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"11.54";"0.23";"1.33";"4.78";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"AT-101";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"12.55";"0.23";"0.13";"4.19";"1";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3909131";"";"None";"616.72";"2";"5.88";"E-3";"Cc1cccc(/C=C/C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)c1";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"11.02";"0.22";"0.92";"4.61";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3785313";"";"None";"840.75";"2";"9.19";"64";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3cccc(CNC(=O)c4cccc(C(F)(F)F)c4)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"12854.0";"nM";"4.89";"";"";"UO_0000065";"5.82";"0.12";"-4.30";"3.62";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3785178";"";"None";"752.76";"2";"7.90";"69";"Cc1cc(OCCCc2c(C(=O)NS(=O)(=O)c3cccc(CNC(=O)CC(C)C)c3)[nH]c3c(-c4c(C)nn(C)c4C)c(Cl)ccc23)cc(C)c1Cl";"Ki";"'='";"1566.0";"nM";"5.80";"";"";"UO_0000065";"7.71";"0.16";"-2.09";"4.29";"0";"CHEMBL3789426";"Binding affinity to Bcl-xL (unknown origin) after 1.5 hrs by FPA assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785006";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4473259";"";"None";"659.61";"2";"8.51";"35";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cccc(C(=O)O)c2)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3941074";"";"None";"603.17";"2";"6.06";"BDBM185608";"O=C(NS(=O)(=O)c1nc2ccccc2s1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"Ki";"'='";"128.53";"nM";"6.89";"";"334801";"UO_0000065";"11.42";"0.23";"0.83";"8.34";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3926997";"";"None";"946.59";"3";"8.69";"BDBM185630";"Cc1nc(OC[C@@H]2CN(C(=O)OC(C)(C)C)CCO2)sc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cnc2[nH]ccc2c1";"Ki";"'='";"46.5";"nM";"7.33";"";"334823";"UO_0000065";"7.75";"0.15";"-1.36";"4.35";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3298852";"";"None";"378.51";"1";"5.07";"2";"O=C(O)[C@@H]1C=C[C@@H]2C[C@H]3[C@H](CCCCCc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"'='";"19200.0";"nM";"4.72";"";"";"UO_0000065";"12.46";"0.23";"-0.35";"8.20";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3298853";"";"None";"406.57";"1";"5.85";"3";"O=C(O)[C@@H]1C=C[C@@H]2C[C@H]3[C@H](CCCCCCCc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"12.05";"0.22";"-0.95";"8.52";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3299033";"";"None";"392.50";"0";"3.96";"10";"O=C(O)C1=C[C@H](O)[C@@H]2C[C@H]3[C@H](CC/C=C/Cc4ccc(O)cc4)[C@H]4C=C[C@@H]1[C@@H]2[C@H]43";"Ki";"'='";"19400.0";"nM";"4.71";"";"";"UO_0000065";"12.01";"0.22";"0.75";"6.06";"0";"CHEMBL3362964";"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297727";"1";"Scientific Literature";"J Nat Prod";"2014";"None";"";"";""
"CHEMBL3699071";"";"None";"818.98";"3";"6.68";"BDBM139045";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)ccc2CCc2ccccc2)cc1[N+](=O)[O-]";"Ki";"'='";"17.0";"nM";"7.77";"";"273179";"UO_0000065";"9.49";"0.18";"1.09";"4.32";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3699076";"";"None";"912.08";"3";"7.13";"BDBM139050";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)sc2CCc2ccccc2)cc1S(=O)(=O)C(F)(F)F";"Ki";"'='";"0.06";"nM";"10.22";"";"273184";"UO_0000065";"11.21";"0.23";"3.09";"5.99";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3699077";"";"None";"930.12";"3";"7.50";"BDBM139051";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2csc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)n2)cc1S(=O)(=O)C(F)(F)F";"Ki";"'='";"0.04";"nM";"10.40";"";"273185";"UO_0000065";"11.18";"0.23";"2.90";"6.09";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3699079";"";"None";"903.05";"3";"6.94";"BDBM139053";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"0.2";"nM";"9.70";"";"273187";"UO_0000065";"10.74";"0.22";"2.76";"5.17";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3699080";"";"None";"839.04";"3";"7.13";"BDBM139054";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)sc2CCCc2ccccc2)cc1[N+](=O)[O-]";"Ki";"'='";"5.0";"nM";"8.30";"";"273188";"UO_0000065";"9.89";"0.20";"1.17";"4.62";"0";"CHEMBL3705507";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay:Test compounds were serially diluted in DMSO starting at 50 .mu.M (2.times. starting concentration; 10% DMSO) and 10 .mu.L transferred into a 384-well plate. The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (K.sub.i) were determined using Wang's equation (Wang, Z. X.).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638521";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"1";"CHEMBL5234933";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3944073";"";"None";"671.87";"2";"8.20";"BDBM209191";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccc4c(c3)CCN(CCC3CCCCC3)C4)c(C(=O)O)n1)CC2";"Ki";"'='";"1.5";"nM";"8.82";"";"369836";"UO_0000065";"13.13";"0.25";"0.62";"8.94";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL602758";"";"None";"332.32";"0";"3.01";"28";"N#Cc1c(-c2ccc3c(c2)OCO3)cc(-c2ccccc2O)[nH]c1=O";"Ki";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"15.93";"0.29";"2.28";"5.55";"0";"CHEMBL2345537";"Binding affinity to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331511";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"Gossypol";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"Ki";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"11.79";"0.22";"-0.27";"3.93";"0";"CHEMBL3736963";"Competitive binding affinity to Bcl-XL (unknown origin) using 5-FAM-Bid-BH3 peptide preincubated for 30 mins before 5-FAM-Bid-BH3 peptide addition and measured 20 mins after 5-FAM-Bid-BH3 peptide addition by fluorescence polarization assayy";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734725";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4515351";"";"None";"908.61";"2";"7.98";"8k";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccc(OCc3ccccc3Br)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3958369";"";"None";"710.83";"2";"6.80";"S55746; BCL201, Servier-1";"O=C(c1cc(-c2cc3c(cc2C(=O)N2Cc4ccccc4C[C@H]2CN2CCOCC2)OCO3)n2c1CCCC2)N(c1ccccc1)c1ccc(O)cc1";"Ki";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"8.84";"0.16";"-0.52";"6.50";"0";"CHEMBL4398471";"Inhibition of Bcl-xL (unknown origin) after 2 hrs by fluorescein-PUMA based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396893";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3287292";"";"None";"430.49";"0";"4.20";"3";"O=C(O)c1cccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"164.0";"nM";"6.79";"";"";"UO_0000065";"15.76";"0.30";"2.59";"7.11";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4455792";"";"None";"712.68";"2";"9.01";"37";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cc(C(=O)O)c4ccn(C)c4c2)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4385924";"Inhibition of FITC-labeled Bak peptide binding to Bcl-xL (unknown origin) after 0.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385603";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3417405";"";"None";"420.49";"0";"4.71";"11";"CCOc1ccccc1N/N=C1\C(=O)N(c2cc(O)cc(-c3cccs3)c2)N=C1C";"Ki";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3417879";"Displacement of FITC-BIM from recombinant human Bcl-XL expressed in Escherichia coli after 30 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414479";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4576854";"";"None";"567.78";"2";"5.49";"24";"CC(C)(C)c1ccc(CN2CCN(S(=O)(=O)Nc3ccc(SCCc4ccccc4)cc3C(=O)O)CC2)cc1";"Ki";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4344318";"Inhibition of N-terminal His6-tagged human Bcl-xL (with internal deletion of 45 to 85 amino acids and C-terminal truncation for 212 to 233 residues) expressed in Escherichia coli Rosetta2 DE3 by fluorescent labeled FAM-Bid peptide based fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4793963";"";"None";"612.51";"2";"6.18";"S1-6e";"N#CC1=C(NCCC(=O)NCc2ccc(C(=O)O)cc2)c2ccc(Sc3ccc(Br)cc3)c3cccc(c23)C1=O";"Ki";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"9.95";"0.21";"-0.09";"5.11";"0";"CHEMBL4705651";"Inhibition of FAM-Bim peptide binding to Bcl-xl (unknown origin) measured after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699647";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"MODULATOR";""
"CHEMBL4785269";"";"None";"568.50";"2";"6.48";"S1-6f";"N#CC1=C(NCCC(=O)NCc2ccccc2)c2ccc(Sc3ccc(Br)cc3)c3cccc(c23)C1=O";"Ki";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"10.47";"0.22";"-0.53";"7.26";"0";"CHEMBL4705651";"Inhibition of FAM-Bim peptide binding to Bcl-xl (unknown origin) measured after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699647";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"MODULATOR";""
"CHEMBL4465826";"";"None";"2682.05";"None";"None";"Lead Bim";"CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC";"Ki";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"3.76";"None";"None";"None";"0";"CHEMBL5234916";"Binding affinity to recombinant His-tagged human Bcl-xL expressed in Escherichia coli assessed as inhibition constant by SPR analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL5092439";"";"None";"719.75";"2";"8.04";"FWJ-D2";"CC(C)c1ccc(Oc2ccc(O)c(O)c2)c(-c2ccsc2S(=O)(=O)NCCNC(=S)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1";"Ki";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"7.38";"0.15";"-2.73";"4.43";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL217354";"";"None";"573.71";"2";"6.90";"TW-37";"CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O";"Ki";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"10.38";"0.20";"-0.95";"4.80";"1";"CHEMBL4685916";"Inhibition of FAM-Bid BH3 peptide binding to recombinant human BCL-XL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680222";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3891330";"";"None";"614.73";"2";"6.73";"11";"Cc1nn(Cc2ccccc2)c(C)c1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"0.044";"nM";"10.36";"";"";"UO_0000065";"16.85";"0.31";"3.63";"9.15";"0";"CHEMBL4730611";"Inhibition of F-Bak (GQVGRQLAIIGDK(6-FAM)INR-amide probe binding to BCL-xl (unknown origin) incubated for 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725425";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5201080";"";"None";"423.51";"0";"2.39";"36; BDA-366";"CCN(CC)C[C@@H](O)CNc1ccc(NC[C@H]2CO2)c2c1C(=O)c1ccccc1C2=O";"Ki";"'>'";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5108734";"Binding affinity to human Bcl-xL assessed as inhibition constant incubated for 15 mins by competition fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107957";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5209122";"";"None";"710.60";"2";"6.66";"14b";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(N4CCOCC4)c([N+](=O)[O-])c3)cc2)cc(C)c1Cl";"Ki";"'='";"7990.0";"nM";"5.10";"";"";"UO_0000065";"7.17";"0.15";"-1.56";"3.49";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3977888";"";"None";"599.67";"2";"6.36";"BDBM209181";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccn(C(=O)c4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"2.0";"nM";"8.70";"";"369826";"UO_0000065";"14.51";"0.27";"2.34";"7.41";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964142";"";"None";"665.82";"2";"6.76";"BDBM209220";"COC1(Cn2nnc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)CCCC(C)(C)C1";"Ki";"'<'";"0.1";"nM";"";"";"369865";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955657";"";"None";"650.81";"2";"7.11";"BDBM209240";"Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC1(C)CCCC(C)(C)O1";"Ki";"'<'";"0.1";"nM";"";"";"369884";"UO_0000065";"";"";"";"";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4439398";"";"None";"908.61";"2";"7.98";"8j";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccc(OCc3ccc(Br)cc3)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL5078562";"";"None";"594.50";"2";"6.03";"TJ-B3";"O=C(NCCNS(=O)(=O)c1cc(-c2ccccc2Oc2ccc(O)c(O)c2)cs1)Nc1cc(Cl)cc(Cl)c1";"Ki";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"9.70";"0.21";"-0.26";"4.21";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3926515";"";"None";"632.72";"2";"5.58";"E-6";"COc1cccc(/C=C/C(=O)Nc2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)c1";"Ki";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"11.00";"0.22";"1.38";"4.44";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3933727";"";"None";"637.14";"2";"6.22";"E-8";"O=C(/C=C/c1ccccc1Cl)Nc1ccc(C(=O)NS(=O)(=O)c2ccc(NCCSc3ccccc3)c([N+](=O)[O-])c2)cc1";"Ki";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"10.86";"0.22";"0.70";"4.69";"0";"CHEMBL3859720";"Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"1; ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<'";"0.1";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4715587";"Inhibition of F-Bak binding to GST-tagged BCL-XL (unknown origin) measured after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706772";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3919185";"";"None";"622.66";"2";"6.39";"BDBM209061";"O=C(Nc1nc2cc(F)c(F)cc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"312.0";"nM";"6.51";"";"369706";"UO_0000065";"10.45";"0.20";"0.12";"5.75";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905518";"";"None";"604.67";"2";"6.26";"BDBM209064";"O=C(Nc1nc2ccc(F)cc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"68.0";"nM";"7.17";"";"369709";"UO_0000065";"11.85";"0.22";"0.91";"6.33";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939121";"";"None";"718.39";"2";"6.49";"BDBM185596";"CN(CCSc1ccccc1)C1CCN(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)CC1";"Ki";"'='";"703.74";"nM";"6.15";"";"334789";"UO_0000065";"8.56";"0.17";"-0.34";"8.07";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3962876";"";"None";"742.75";"2";"9.42";"BDBM185626";"Cc1c(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2Oc2ccccc2)sc2ccc(Cl)cc12";"Ki";"'='";"20.24";"nM";"7.69";"";"334819";"UO_0000065";"10.36";"0.21";"-1.73";"9.75";"0";"CHEMBL3887354";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 M (2 starting concentration; 10% DMSO) and 10 L were transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix was added to each well at final concentrations listed in TABLE 1. The samples are then mixed on a shaker for 1 minute and incubated for an additional 3 hours at room temperature. For each assay, the probe/antibody and protein/probe/antibody were included on each assay plate as negative and positive controls, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak peptide) and 495/510 nm (Tb-labeled anti-Histidine antibody) emission filters.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886289";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"8.84";"0.18";"-0.69";"5.61";"0";"CHEMBL3819991";"Binding affinity to Bcl-XL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL3818394";"";"None";"609.75";"2";"6.47";"10; BCL-LZH-40";"CCOC(=O)C1=C(C)N=c2s/c(=C\c3cn(Cc4ccc(-c5ccccc5)cc4)c4ccccc34)c(=O)n2C1c1ccccc1";"Ki";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.74";"0.24";"1.30";"11.85";"0";"CHEMBL3819999";"Inhibition of FAM-labeled Bim BH3 peptide binding to recombinant human N-terminal GST-tagged Bcl-XL (1 to 212 residues) expressed in Escherichia coli BL21(DE3) cells preincubated for 30 mins followed by FAM-labeled Bim BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL3629834";"";"None";"461.56";"1";"5.68";"19";"Cc1ccccc1N1C(=O)/C(=C/c2cccc(OCc3ccc(C(=O)O)cc3)c2)SC1=S";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3631164";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4637035";"";"None";"375.51";"1";"6.20";"(+)-4k";"CC(C)=CCCC1=CC[C@H](C(=O)Nc2ccc(O)cc2)[C@@H](c2ccccc2)C1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5188517";"";"None";"614.94";"2";"7.57";"14a";"Cc1cc(Oc2ccc(Cn3nc4ccc(Cl)cc4c3C(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc2)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<'";"40.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5079948";"";"None";"827.30";"2";"8.97";"S63845";"Cc1c(-c2c(-c3ccc(F)o3)sc3cccc(OC(Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5035026";"Binding affinity to human Bcl-xl assessed as inhibition constant incubated for 2 hrs in presence of fluorescein-PUMA peptide by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"";""
"CHEMBL4482922";"";"None";"843.74";"2";"7.52";"8h";"COc1ccc2c(c1)c(CC(=O)N[C@@H](Cc1ccc(OCc3cccc(C)c3)cc1)C(=O)NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1)c(C)n2C(=O)c1ccc(Cl)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4341980";"Inhibition of 5-FAM-tagged Bid-BH3 peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340551";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL5288183";"";"None";"349.41";"0";"2.94";"17aa";"CC(C)CN(c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1ccccc1";"Ki";"'='";"154000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL4160782";"";"None";"471.96";"1";"5.20";"(+/-)-4";"Cc1cc(Oc2ccc(S(=O)(=O)N3CC(C(=O)O)Cc4ccccc43)cc2)cc(C)c1Cl";"Ki";"'='";"5010.0";"nM";"5.30";"";"";"UO_0000065";"11.23";"0.23";"0.10";"6.32";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL3896818";"";"None";"622.66";"2";"6.39";"BDBM209106";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(F)c4F)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"18.0";"nM";"7.75";"";"369751";"UO_0000065";"12.44";"0.24";"1.35";"6.84";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL591346";"";"None";"813.45";"2";"7.88";"ABT-737";"CN(C)CCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"Ki";"'<='";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5234928";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL5196373";"";"None";"811.28";"3";"7.62";"S63845";"Cc1c(-c2c(-c3ccco3)sc3ncnc(O[C@H](Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5113901";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113375";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";""
"CHEMBL5079843";"";"None";"594.50";"2";"6.03";"TJ-A3";"O=C(NCCNS(=O)(=O)c1ccc(-c2ccccc2Oc2ccc(O)c(O)c2)s1)Nc1cc(Cl)cc(Cl)c1";"Ki";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"9.70";"0.21";"-0.26";"4.21";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5080325";"";"None";"661.60";"2";"6.76";"TJ-B2";"O=C(NCCNS(=O)(=O)c1cc(-c2ccccc2Oc2ccc(O)c(O)c2)cs1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1";"Ki";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"8.72";"0.18";"-0.99";"4.21";"0";"CHEMBL5034986";"Binding affinity to full length human Bcl-xl expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant preincubated for 30 mins followed by 5-FAM-QEDIIIINIARHLAQVGDSMD-RSIPPG tracer addition and measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3699067";"";"None";"972.15";"3";"7.28";"4; A-1293102";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"Ki";"'='";"0.43";"nM";"9.37";"";"";"UO_0000065";"9.63";"0.20";"2.09";"5.20";"0";"CHEMBL4715587";"Inhibition of F-Bak binding to GST-tagged BCL-XL (unknown origin) measured after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706772";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5278443";"";"None";"1570.90";"None";"None";"1a";"CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)CC)[C@@H](C)CC";"Ki";"'='";"22.2";"nM";"7.65";"";"";"UO_0000065";"4.87";"None";"None";"None";"0";"CHEMBL5234916";"Binding affinity to recombinant His-tagged human Bcl-xL expressed in Escherichia coli assessed as inhibition constant by SPR analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4640382";"";"None";"313.44";"0";"4.53";"(+)-4a";"CONC(=O)[C@H]1CC=C(CCC=C(C)C)C[C@@H]1c1ccccc1";"Ki";"'>'";"23000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4617557";"Inhibition of Bcl-xL (unknown origin)/Bak interaction preincubated for 5 mins followed by fluorescein-labeled peptide addition and measured after 10 mins by fluorescein-labeled peptide displacement based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5307562";"";"None";"794.78";"2";"8.82";"None";"COCCOCCn1nc2c(c1C)-c1c(Cl)ccc3c1c(C)c(C(=O)O)n3CCCOc1cc(cc3c(F)c(Cl)ccc13)CCc1cc(nn1C)CSC2";"Ki";"'>'";"5000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL5304900";"HTRF (BCL2L1)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay publication: Slide 7 in JNJ-4355 Inhibitor for MCL1.pdf";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5303767";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2023";"None";"";"";""
"CHEMBL3925353";"";"None";"602.68";"2";"5.82";"BDBM209071";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3cnn(Cc4cccc(O)c4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"31.0";"nM";"7.51";"";"369716";"UO_0000065";"12.46";"0.23";"1.69";"5.63";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897913";"";"None";"611.69";"2";"5.99";"BDBM209081";"N#Cc1nn(Cc2ccccc2)cc1-c1ccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)nc1C(=O)O";"Ki";"'='";"315.0";"nM";"6.50";"";"369726";"UO_0000065";"10.63";"0.20";"0.51";"4.74";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935029";"";"None";"673.80";"2";"6.06";"BDBM209094";"CN(C)CCOc1ccccc1Cn1cc(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cn1";"Ki";"'='";"16.0";"nM";"7.80";"";"369739";"UO_0000065";"11.57";"0.22";"1.74";"6.20";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938235";"";"None";"636.74";"2";"7.27";"BDBM209207";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(-c3ccc4c(cnn4Cc4ccccc4)c3)c(C(=O)O)n1)CC2";"Ki";"'='";"0.3";"nM";"9.52";"";"369852";"UO_0000065";"14.96";"0.28";"2.25";"8.41";"0";"CHEMBL3888054";"Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) binding assay: Test compounds were serially diluted in DMSO starting at 50 M (2x starting concentration; 10% DMSO) and 10 L transferred into a 384-well plate. Then 10 L of a protein/probe/antibody mix is added to each well at final concentrations listed in Table 1. Protein: GST-Bcl-xL; 1(nM) Probe: F-Bak (GQVGRQLAIIGDK (6-FAM)INR-amide) SEQ ID NO: 1; 100(nM) Antibody: Tb-anti-GST; 1(nM). The samples are then mixed on a shaker for 1 minute then incubated for an additional 2 hours at room temperature. For each assay plate, a probe/antibody and protein/antibody/probe mixture were included as a negative and a positive control, respectively. Fluorescence was measured on the ENVISION plate reader (Perkin Elmer) using a 340/35 nm excitation filter and 520/525 (F-Bak) and 495/510 nm (Tb-labeled anti-his antibody) emission filters. Dissociation constants (Ki) were determined using Wang's equation (Wang, Z.X. An 20 exact mathematical expression for describing competitive binding of two different ligands to protein molecule. FEBS Lett. 1995 360:111-114). The TR-FRET assay can be performed in the presence of varying concentrations of human serum (HS) or fetal bovine serum (FBS).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886553";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1272170";"";"None";"490.51";"0";"4.85";"Apogossypolone";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O";"Ki";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"12.60";"0.23";"1.33";"4.14";"1";"CHEMBL5113849";"Binding affinity to Bcl-XL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113375";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5266994";"";"None";"425.51";"0";"4.61";"22bc";"CC(C)CN(c1ccc(O)c(C(=O)O)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1";"Ki";"'='";"13900.0";"nM";"4.86";"";"";"UO_0000065";"11.41";"0.22";"0.25";"5.12";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL4469869";"";"None";"712.68";"2";"9.01";"VU661013";"Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)[C@H](C)CN(c2cn(C)c4ccc(C(=O)O)cc24)C3=O)cc(C)c1Cl";"Ki";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5096355";"Competitive binding affinity to BCL-XL (unknown origin) using FITC-Bak-GQVGRQLAIIGDDINR-NH2 peptide as substrate incubated for 1.5 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.5 hr";"";""
"CHEMBL5282021";"";"None";"399.47";"0";"4.09";"22bb";"CC(C)CN(c1ccc(O)c(C(=O)O)c1)S(=O)(=O)c1ccc2ccccc2c1";"Ki";"'='";"44600.0";"nM";"4.35";"";"";"UO_0000065";"10.89";"0.21";"0.26";"4.58";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL5272657";"";"None";"441.51";"0";"4.73";"17ag";"CC(C)CN(c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1ccc(Oc2ccccc2)cc1";"Ki";"'='";"17900.0";"nM";"4.75";"";"";"UO_0000065";"10.75";"0.21";"0.02";"4.56";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL5285186";"";"None";"492.52";"0";"4.54";"Apogossypolone";"CC1=C(C2=C(C)C(=O)C3C(C(C)C)=C(O)C(O)=CC3C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O";"Ki";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"12.55";"0.23";"1.64";"4.14";"0";"CHEMBL5234926";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL5279726";"";"None";"425.51";"0";"4.61";"17ac";"CC(C)CN(c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1";"Ki";"'='";"10800.0";"nM";"4.97";"";"";"UO_0000065";"11.67";"0.23";"0.36";"5.23";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL1271764";"";"None";"374.65";"0";"2.56";"3; MLS-0053105";"CN1CCN(C2=C(Cl)C(=O)N(c3ccc(Cl)c(Cl)c3)C2=O)CC1";"Ki";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"11.48";"0.26";"1.74";"9.81";"0";"CHEMBL5163775";"Displacement of fluorescent-labeled BID-BH3 peptide from human BCL-xL expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant by fluorescence polarization-based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154839";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"Venetoclax";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"10.36";"0.20";"0.34";"5.23";"0";"CHEMBL4813626";"Binding affinity to Bc1-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811307";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL2314209";"";"None";"392.28";"1";"5.80";"1";"Cc1cc(OCCCc2c(C(=O)O)[nH]c3cc(Cl)ccc23)cc(C)c1Cl";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
"CHEMBL4165406";"";"None";"504.54";"3";"6.07";"AT-101";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1cc2cc(C(C)C)c(O)c(O)c2c(C=O)c1O";"Ki";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.52";"0.23";"0.25";"4.06";"0";"CHEMBL4147763";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145520";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4098468";"";"None";"687.82";"2";"6.40";"9d";"COc1ccc(S(=O)(=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)Cc2c(C)n(-c3ccc(-c4ccccc4)cc3)c3ccc(OC)cc23)cc1";"Ki";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4046938";"Inhibition of 5-FAM-Bid-BH3 peptide binding to Bcl-XL (unknown origin) pre-incubated for 30 mins followed by further incubation with 5-FAM-Bid-BH3 peptide for 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043209";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL5177177";"";"None";"440.52";"0";"4.73";"12; ZH97";"C=CC(=O)N1CCN(c2c3ccc(-c4cccc(F)c4)cc3nn2Cc2ccccc2)CC1";"Ki";"'>'";"400000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5163787";"Displacement of fluorescein tagged BAK peptide from N-terminal His tagged human BCL-xL (1 to 209 residues) expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant incubated for 1.5 hrs by fluorescence polarization-based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154839";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5266814";"";"None";"504.00";"2";"6.00";"6e-OH";"Cc1cc(Oc2ccc(S(=O)(=O)N(CC(C)C)c3ccc(C(=O)O)c(O)c3)cc2)cc(C)c1Cl";"Ki";"'='";"1630.0";"nM";"5.79";"";"";"UO_0000065";"11.48";"0.23";"-0.21";"5.56";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL5186810";"";"None";"517.43";"2";"6.07";"151";"O=C(O)C1C2CC(Sc3ccccc3[N+](=O)[O-])C(Cl)C2c2cc(Cl)cc3c2N1CC1CC=CC31";"Ki";"'>='";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5113846";"Binding affinity to Bcl-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113375";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";""
"CHEMBL5269202";"";"None";"516.02";"2";"6.29";"17bd";"Cc1cc(Oc2ccc(S(=O)(=O)N(c3ccc(C(=O)O)c(O)c3)C3CCCC3)cc2)cc(C)c1Cl";"Ki";"'='";"1910.0";"nM";"5.72";"";"";"UO_0000065";"11.08";"0.22";"-0.57";"5.49";"0";"CHEMBL5232900";"Binding affinity to BCL-xL (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230167";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"ABT199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"Ki";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"8.43";"0.16";"-1.34";"4.25";"1";"CHEMBL5163775";"Displacement of fluorescent-labeled BID-BH3 peptide from human BCL-xL expressed in Escherichia coli BL21 (DE3) assessed as inhibition constant by fluorescence polarization-based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154839";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"Ki";"'<='";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5234929";"Binding affinity to His-tagged Bcl-xL (unknown origin) assessed as inhibition constant by competitive fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL5086378";"";"None";"450.31";"0";"4.13";"UMI-77";"O=C(O)CCc1cc(NS(=O)(=O)c2ccc(Br)cc2)c2ccccc2c1O";"Ki";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"9.95";"0.23";"0.35";"4.32";"0";"CHEMBL5035032";"Displacement of fluorescent-labeled BID-BH3 peptide from Bcl-xl (unknown origin) incubated for 2 hrs by fluorescence polarization-based competitive binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5173872";"";"None";"829.27";"3";"7.76";"S63845";"Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(O[C@@H](Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl";"Ki";"";"";"";"";"";"NA";"";"";"";"";"";"0";"CHEMBL5106579";"Inhibition of BCL-xL (unknown origin) by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104175";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"";""
